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Abstract 
Multiple Sclerosis is a common disease, affecting 2.5 million people world-wide. The 
clinical course is heterogeneous, ranging from benign disease in which patients live 
an almost normal life to severe and devastating disease that may shorten life. 
Despite much research, a fully effective treatment for MS is still unavailable and 
diagnostic techniques for monitoring MS disease evolution are much needed. 
 
As a non-invasive tool, Magnetic resonance imaging (MRI) plays a key role in MS 
diagnosis. Numerous MRI techniques have been proposed over the years. Among 
most widely used are conventional T1-weighted (T1W), T2-weighted (T2W) and 
FLuid Attenuated Inversion Recovery (FLAIR) imaging techniques. However their 
results do not correlate well with neurological findings. Several advanced MRI 
techniques are also used as research tools to study MS. Among them are 
magnetization transfer contrast imaging (MT), MR spectroscopy (MRS), and 
Diffusion Tensor Imaging (DTI) but they have not penetrated to clinical arena yet.  
 
Gradient Echo Plural Contrast Imaging (GEPCI) developed in our laboratory is a 
post processing technique based on multi-echo gradient echo sequence. It offers 
basic contrasts such as T1W images and T2* maps obtained from magnitude of 
GEPCI signal, and frequency maps obtained from GEPCI signal phase.  
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Phase information of Gradient Echo MR signal has recently attracted much 
attention of the MR community since it manifests superior gray matter/ white matter 
contrast and sub-cortical contrast, especially at high field (7 T) MRI. However the 
nature of this contrast is under intense debates. Our group proposed a theoretical 
framework - Generalized Lorentzian Approach - which emphasizes that, contrary to 
a common-sense intuition, phase contrast in brain tissue is not directly proportional 
to the tissue bulk magnetic susceptibility but is rather determined by the 
geometrical arrangement of brain tissue components (lipids, proteins, iron, etc.) at 
the cellular and sub-cellular levels - brain tissue “magnetic architecture”. In this 
thesis we have provide first direct prove of this hypothesis by measurement of 
phase contrast in isolated optic nerve. We have also provided first quantitative 
measurements of the contribution to phase contrast from the water-macromolecule 
exchange effect. Based on our measurement in protein solutions, we demonstrated 
that the magnitude of exchange effect is 1/2 of susceptibility effect and to the 
opposite sign.  
 
GEPCI technique also offers a scoring method for monitoring Multiple Sclerosis 
based on the quantitative T2* maps generated from magnitude information of 
gradient echo signal. Herein we demonstrated a strong agreement between GEPCI 
quantitative scores and traditional lesion load assessment. We also established a 
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correlation between GEPCI scores and clinical tests for MS patients. We showed 
that this correlation is stronger than that found between traditional lesion load and 
clinical tests. Such studies will be carried out for longer period and on MS subjects 
with broader range of disease severity in the future.  
 
We have also demonstrated that the magnitude and phase information available 
from GEPCI experiment can be combined in multiple ways to generate novel 
contrasts that can help with visualization of neurological brain abnormalities beyond 
Multiple Sclerosis. 
 
In summary, in this study, we 1) propose novel contrasts for GEPCI from its basic 
images; 2) investigate the biophysical mechanisms behind phase contrast; 3) 
evaluate the benefits of quantitative T2* map offered by GEPCI in monitoring 
disease of Multiple Sclerosis by comparing GEPCI results to clinical standard 
techniques; 4) apply our theoretical framework - Generalized Lorentzian Approach 
– to better understand phase contrast in MS lesions. 
  
v 
 
Acknowledgements 
First and foremost I give my sincere gratitude to my advisor Prof. Dmitriy Yablonskiy. This 
thesis is produced under his enormous encouragement and support. I really appreciate his 
help, time, ideas, and funding which make my PhD experience productive and stimulating. I’m 
also very much grateful to my advisor Prof. Joseph Ackerman for introducing me to BMRL 
and allowing me to work freely. They are both resourceful teachers, and have taught me in 
various aspects – MR physics, imaging techniques, writing, academic life, and more. I feel 
fortunate to have met him at my first step into the world of MRI. 
 
Special thanks to Prof. Anne Cross, for leading me to the field of Multiple Sclerosis. It was a 
great pleasure to work with her, and she is a role model for me in many ways. Her expertise 
in MS was essential for the success of our study.  
 
I also would like to thank members from my thesis committee, for their helpful and insightful 
suggestions/comments.  
 
Thank you to Dr. Pascal Sati, I learned a lot from whom when I first stepped in this lab. And 
for the initial work he has done for one of the projects. Thank you to Dr. Xiang He, who has 
been a great collaborator and teacher during my first two years. Thank you to Dr. Andre 
D’Avignon, who have provided generous support with spectroscopy experiment. Thank you to 
Dr. Bharathi Jagandeesan, who brought new insights to improve our technique. Thank you to 
Dr. Robert Schmidt who has generously supported us with his tissue bank and taught us with 
vi 
 
his expertise in pathology. Thank you to Dr. Charles Hildebolt, who offered his expertise in 
statistics. Thank you to Ms. Samantha Lancia and Ms.Susan Fox, who constantly supported 
us on the clinical side. Thank you to Dr. Alexander Sukstanskii, who supported with 
mathematical ideas. Thank you to Aditi Iyer, Britney Johnson, and Bryan Nyguen for helping 
me with experiments. 
 
Dozens of people have helped and taught me immensely at BMRL. I give my heartfelt thanks 
to Dr. Bill Spees, Mr. John Engelbach, Dr. James Quirk, Dr. Adil Bashir, Dr. Jeffery Neil, Dr. 
Joel Garbow, Dr. Larry Bretthorst, Dr. Victor Song who provided generous help and advice, 
both experimentally and theoretically, during my years in BMRL. Also thanks to Ms Debra 
Brouk for help on purchasing and taking care of financial problems. I’m appreciative my fellow 
students and researchers in the lab: Dr. Junqian Xu, Dr. Qing Wang, Dr. William Tu, Dr. Jeff 
Anderson, Dr. Emir Osmagenic, Chiawen Chiang, Qingqing Ye, Xiaojie Wang, Xiaoyu Jiang, 
Donghan Yang, Xiaoqi Wang, Tsen Hsuan Lin, Chenchen Liu, Yue Zhao, Dr.Joonghe Kim, 
Dr. Yong Wang, Dr. Peng Sun, Dr. Xialing Ulrich. 
 
Special thanks to my parents, for they have always allowed and supported me to pursue what 
I want, and to be who I am, which is not typical in Chinese families. Finally, I would like to 
extend my gratitude to my dear friend Zongxi Li and my husband Shiyi Zhang. They have 
always been my sources of encouragement both in science and in life. They are part of my 
motivation to go on. To them I dedicate this thesis.  
  
vii 
 
Table of Contents 
 
Abstract .................................................................................................................ii 
Acknowledgements .............................................................................................. v 
List of Figures .......................................................................................................xi 
List of Tables ...................................................................................................... xiv 
Chapter 1 Introduction .......................................................................................... 1 
1.1 Nuclear Magnetic Resonance Imaging ................................................................ 1 
1.1.1 Nuclear Spin ................................................................................................. 1 
1.1.2 Free Induction Decay .................................................................................... 2 
1.1.3 Imaging Basics – Gradient and K-space ....................................................... 4 
1.1.4 Gradient Echo Sequence .............................................................................. 6 
1.2 Complex MR Signal ............................................................................................. 8 
1.3 Multiple Sclerosis ............................................................................................... 10 
1.4 Magnetic Resonance Imaging in MS ................................................................. 12 
1.5 Dissertation Overview ........................................................................................ 18 
Chapter 2 Biophysical Mechanism behind MR Signal Phase – Susceptibility 
effect ................................................................................................................... 21 
2.1 Introduction ........................................................................................................ 21 
2.2 Theory ............................................................................................................... 22 
2.2.1 Magnetic Susceptibility ................................................................................ 22 
2.2.2 The signal phase that we measure .............................................................. 24 
2.2.3 Frequency shift of MRI signal in a solution surrounding optic nerve: ........... 27 
2.2.4 Frequency shift of MRI signal between inside the nerve and the outside 
solution surrounding optic nerve .......................................................................... 29 
2.3 Materials and Methods ...................................................................................... 30 
2.3.1 Materials ..................................................................................................... 30 
2.3.2 MRI Procedures: ......................................................................................... 31 
2.3.3 Data Processing .......................................................................................... 32 
2.3.4 Field Inhomogeneity Correction ................................................................... 33 
viii 
 
2.3.5 Evaluation of Imaging Errors ....................................................................... 35 
2.3.6 Determination of Magnetic Susceptibility ..................................................... 36 
2.4 Results .............................................................................................................. 37 
2.4.1 In Silico Experiments ................................................................................... 37 
2.4.2 Ex vivo experiments .................................................................................... 41 
2.5 Discussions ....................................................................................................... 49 
2.6 Magnetic Susceptibility and Exchange Effects in External Media ....................... 52 
2.7 Conclusion ......................................................................................................... 55 
Chapter 3 Biophysical Mechanism behind MR Signal Phase – Exchange 
effect ................................................................................................................... 56 
3.1 Introduction ........................................................................................................ 56 
3.2 Materials and Methods ...................................................................................... 59 
3.2.1 Sample Preparation .................................................................................... 59 
3.2.2 Mechanisms Affecting the 1H Water MR Signal Frequency ......................... 59 
3.2.3 Measurement of the Magnetic Susceptibility of BSA ................................... 61 
3.2.4 Separation of Magnetic Susceptibility and Exchange Effects ...................... 64 
3.3 Results .............................................................................................................. 66 
3.4 Discussion ......................................................................................................... 72 
3.5 Conclusion ......................................................................................................... 77 
3.6 Line-Broadening Interaction between TSP and BSA .......................................... 78 
Chapter 4 Gradient Echo Plural Contrast Imaging (GEPCI) – Basic and 
Derived Contrasts ............................................................................................... 80 
4.1 Signal Model and Data Processing of GEPCI .................................................... 80 
4.1.1 Multi-Channel Data Processing ................................................................... 80 
4.1.2 Phase Unwrapping and Multi-Channel Data ................................................ 82 
4.2 Experiment Protocol of Gradient Echo Plural Contrast Imaging ......................... 84 
4.2.1 Protocol Optimization .................................................................................. 84 
4.3 Basic Contrasts of GEPCI ................................................................................. 86 
4.3.1 Generating Basic GEPCI images ................................................................ 86 
4.3.2 Basic GEPCI Images .................................................................................. 87 
4.4 Derived Contrasts of GEPCI .............................................................................. 90 
ix 
 
4.4.1 Generating Secondary Derived GEPCI images ........................................... 90 
4.4.2 Results of Derived Images .......................................................................... 94 
4.4.3 Possible Applications of GEPCI in Clinical Arena ...................................... 101 
4.5 Summary ......................................................................................................... 106 
Chapter 5 Mapping T2* - Application of GEPCI to Monitoring Multiple 
Sclerosis ........................................................................................................... 107 
5.1 GEPCI Images Compared to Clinical Standard Spin Echo Images .................. 107 
5.2 Quantification of Tissue Loss ........................................................................... 110 
5.2.1 Tissue Damage Score (40) ....................................................................... 110 
5.2.2 Reproducibility of the R2* Map .................................................................. 116 
5.3 Bridging the Gap between Radiological and Clinical Measurements of Multiple 
Sclerosis using Quantitative GEPCI Scores .......................................................... 119 
5.3.1 Clinical Tests ............................................................................................. 119 
5.3.2 Baseline Demographics ............................................................................ 120 
5.3.3 Correlations in Clinical and Radiological Measurements ........................... 120 
5.3.4 Differentiating MS subtypes based on GEPCI or Clinical Evaluations ....... 127 
5.3.5 Summary .................................................................................................. 132 
5.4 Preliminary Results of GEPCI in Spinal Cord Imaging ..................................... 132 
5.5 Preliminary Results of GEPCI with Detecting Cortical Lesions in Ex Vivo MS 
Brain ...................................................................................................................... 137 
Chapter 6 Mapping of Phase – Application of GEPCI to Monitoring Multiple 
Sclerosis ........................................................................................................... 140 
6.1 Inconsistency between Magnitude Image and Phase Image of MS Brain. ....... 140 
6.1.1 Overview ................................................................................................... 140 
6.2 Phase Contrast in MS Brain – Theoretical Predictions ..................................... 142 
6.2.1 Phase Contrast in White Matter - Theory .................................................. 142 
6.2.2 Monte-Carlo Simulations of Phase Contrast in Intact and Destructed Tissue144 
6.2.3 Theoretical Predictions of Frequency Shift between Intact Axon and 
Surrounding Tissue – Effect of WM “Darkness” ................................................. 148 
6.2.4 Theoretical Predictions – Frequency Shifts in MS Tissue .......................... 150 
6.3 Phase Mapping in MS - Experimental Results ................................................. 153 
x 
 
6.3.1 Materials and Methods .............................................................................. 153 
6.3.2 Experimental Results ................................................................................ 154 
6.4 Summary ......................................................................................................... 158 
Chapter 7 Conclusions and Future Directions .................................................. 160 
References ....................................................................................................... 163 
 
 
 
  
xi 
 
List of Figures 
 
Figure 1.1 Illustration of spin precession. ........................................................................ 3 
Figure 1.2 Illustration of Free Induction Decay. ............................................................... 4 
Figure 1.3 Illustration of frequency encoding. ................................................................. 5 
Figure 1.4 Illustration of gradient echo sequence diagram. ............................................. 7 
Figure 1.5 Illustration of MR signal components. ............................................................ 8 
Figure 1.6 Example of clinical standard MRI used for monitoring MS. ...........................12 
Figure 1.7 Example of clinical standard MRI used for monitoring MS. ...........................13 
 
Figure 2.1 Schematic of water molecule moving around surrounding susceptibility 
sources ..........................................................................................................................24 
Figure 2.2 Schematic of Lorentzian Sphere Approach ...................................................26 
Figure 2.3 Illustration of the secondary field ..................................................................29 
Figure 2.4 Picture of the experimental setup .................................................................31 
Figure 2.5 An illustration of in silico results and procedure for determining radius of 
the inner cylinder.. .........................................................................................................37 
Figure 2.6 Example of the profiles of phase images obtained from in-silico data ...........39 
Figure 2.7 Representative examples of signal phase evolution along echo time at 
different angles (α) with B0 field .....................................................................................42 
Figure 2.8 Illustration of the results of zero-filling and Hanning filtering of data ..............43 
Figure 2.9 An example of experimental data obtained from a fixed optical nerve ...........43 
Figure 2.10 Example of the profiles of phase images after field correction ....................44 
Figure 2.11 Examples of the angular dependencies of the frequency shifts for one 
fresh nerve and one fixed nerve ....................................................................................46 
Figure 2.12 Results for formalin measurement. .............................................................54 
Figure 2.13 Results for PBS measurement. ...................................................................54 
 
Figure 3.1 Examples of spectra (line broadening apodization filter of 1Hz) obtained 
from the orthogonal tubes experiment. ..........................................................................68 
Figure 3.2 The dependence of magnetic susceptibility induced MR signal frequency 
shifts on protein volume fractions ..................................................................................69 
Figure 3.3 1H MR signal frequency difference of water (triangles) and Dioxane 
(squares) between inner and outer coaxial tubes ..........................................................70 
Figure 3.4 Spectrum (line-broadening apodization filter = 1Hz) from experiment 
employing coaxial tubes ................................................................................................78 
 
xii 
 
Figure 4.1 Example of the phase images before and after channel combination 
procedure ......................................................................................................................83 
Figure 4.2 Comparison between signals result from TR = 40 ms (black) and TR = 
50 ms (blue) ..................................................................................................................85 
Figure 4.3 Signals in different echoes TR = 50 ms ........................................................86 
Figure 4.4 Example the basic contrast images generated by GEPCI technique from 
two axial brain slices ......................................................................................................89 
Figure 4.5 An example of the histogram of GEPCI T1w image ......................................92 
Figure 4.6A and 4.6B. Two examples of standard SWI images, GEPCI-SWI images  
and GEPCI-derived SWI like images .............................................................................97 
Figure 4.7 Examples of the GEPCI-T1f images .............................................................99 
Figure 4.8 Example of the FST2* images .................................................................... 100 
Figure 4.9 Examples of a series of GEPCI images applied to disease of Multiple 
Sclerosis ...................................................................................................................... 102 
 
Figure 5.1 compares the images acquired by clinical standard sequences and 
GEPCI images of a patient with Relapsing-Remitting MS ............................................ 108 
Figure 5.2 compares the images obtained by clinical standard sequences and 
GEPCI images of a patient with Secondary Progressive MS. ...................................... 109 
Figure 5.3 Introduction of GEPCI scores. .................................................................... 114 
Figure 5.4 Illustration of GEPCI score maps obtained from subjects with RRMS and 
SPMS .......................................................................................................................... 116 
Figure 5.5 Illustration of lesion load determined by GEPCI compared to FLAIR 
image. ......................................................................................................................... 116 
Figure 5.6 GEPCI reproducibility tested on healthy volunteer at 1.5 T scanner ............ 117 
Figure 5.7 GEPCI reproducibility on MS subject at 3.0 T scanner ................................ 118 
Figure 5.8 Decision tree and categorization of MS subtypes resulting from using 
GEPCI parameters alone............................................................................................. 128 
Figure 5.9 Decision tree and categorization of MS subtypes resulting from using all 
clinical parameters....................................................................................................... 130 
Figure 5.10 Decision tree and categorization of MS subtypes resulting from using 
clinical parameters excluding EDSS, MSSS and 25' walk. ........................................... 131 
Figure 5.11 Examples of GEPCI-T1w, T2* map and R2* map of the spinal cord ......... 134 
Figure 5.12 Examples of the R2* histograms of c-spinal cord of a healthy control 
and MS subject ............................................................................................................ 135 
Figure 5.13 Images of an MS patient ........................................................................... 135 
Figure 5.14 Demonstration of tissue sample and experimental set-up ......................... 138 
Figure 5.15 Results of GEPCI technique and T2 mapping ........................................... 139 
 
xiii 
 
Figure 6.1 Effect of increasing myelin sheath damage on phase/frequency of MR 
signal derived from computer Monte-Carlo simulations ............................................... 145 
Figure 6.2 Dependence of MR resonance frequency shift, derived from computer 
Monte-Carlo simulations .............................................................................................. 147 
Figure 6.3 Schematic structure of the MR signal phase/frequency change with MS 
lesion severity for two types of tissue destruction ........................................................ 151 
Figure 6.4 Example of a MS lesion (marked by a red rectangle) that has a range of 
TDS represented by colors on vertical bar. .................................................................. 155 
Figure 6.5 Example of data obtained from a subject with SPMS (female, age 49, 
EDSS 6.5) ................................................................................................................... 156 
Figure 6.6 Example of data obtained from a subject with RRMS (male, age 52, 
EDSS 3.5) ................................................................................................................... 157 
 
 
  
xiv 
 
List of Tables 
 
Table 2.1 ..................................................................................................................... 39 
Table 2.2 ..................................................................................................................... 41 
Table 2.3 ..................................................................................................................... 46 
Table 2.4 ..................................................................................................................... 46 
Table 5.1 ................................................................................................................... 120 
Table 5.2 ................................................................................................................... 122 
Table 5.3 ................................................................................................................... 123 
Table 5.4 ................................................................................................................... 125 
 
 
 
[
1 
 
Chapter 1 Introduction 
 
1.1 Nuclear Magnetic Resonance Imaging 
Magnetic Resonance Imaging (MRI), or nuclear magnetic resonance imaging, is a 
medical imaging technique used extensively to visualize detailed internal structures 
of the body. MRI makes uses of the property of nuclear magnetic resonance (NMR) 
to image (most commonly 1H in H2O) nuclei inside the body. The content in this 
section (1.1) can be found in most classical textbooks on the subject (1,2).  
1.1.1 Nuclear Spin 
Spin is the intrinsic quantum property of nucleons. The overall spin of the nucleus is 
determined by the spin quantum number S. The spin of a proton, which is the most 
common signal source in MRI experiment, is 1/2. That means proton has two 
possible spin states m = 1/2 or m = -1/2 (also referred to as spin-up or spin-down). 
When placed in a magnetic field, there are only two energy eigenstates, one 
representing alignment parallel to the field, another anti-parallel. The population 
ratio of the two states is determined by several factors as shown below:  
 ( ) exp( )
( )
Population anti parallel B
Population parallel kT
µ− −
∝  [1.1] 
where µ is magnetic moment of the spin, B is external magnetic field strength, k is 
the Boltzmann constant and T is the absolute temperature. Majority of spin 
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population goes to the lower energy state. Note that with in vivo biological samples 
that we are interested in (physiologic temperature) and with commonly available 
magnets, there is only a slight population difference between two energy states – 
on the order of 1 in a million spins. Fortunately, in biological samples we have huge 
population of 1H (55 Molar), which provides a sufficient signal.  
 
In the field of magnetic resonance, for convenience in describing mechanism of 
signal generation (which is coming not from single spin but from object comprised 
of millions of spins), spins are usually analogued in the context of classical physics. 
Just as a spinning top precesses around the gravitational field, nuclear spin 
precesses around the magnetic field. The frequency of this precession is called 
Larmor frequency 0 0Bω γ= ⋅ , which is proportional to the strength of magnetic field 
B0, and γ  - the gyromagnetic ratio. 
 
1.1.2 Free Induction Decay 
After nuclear spins are polarized under external magnetic field, they reach 
equilibrium, and result in a net magnetization along the B0 field. Upon excitation 
with a 90° pulse (radiofrequency (RF) pulse), which is perpendicular to the 
magnetic field, the spins are forced to precess in the transverse x,y plane. A 
receiver coil is positioned in the transverse plane to pick up the current generated 
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by the precessing magnetization, which is subsequently amplified and becomes 
NMR signal.  
 
 
Figure 1.1 Illustration of spin precession. 
 
The NMR signal, known as free induction decay or FID, decays over time (usually 
on the order of 10-1 - 10-2 s in human tissue). Because microscopic sources of 
magnetic fields including electron magnetic moment and electron orbital currents, 
and also the nucleus itself, create their own local surrounding field, and also 
because of atomic motions, any nucleus in a sample will experience a net magnetic 
field whose direction and strength is fluctuating with time. As a result, all individual 
nuclei precess at slightly different frequencies. They get out of phase with each 
other over time, causing decay of the macroscopic magnetization.  
B0
Spin 
magnetization
Precession
plane
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Figure 1.2 Illustration of Free Induction Decay. 
 
 
1.1.3 Imaging Basics – Gradient and K-space  
 
Applied magnetic field gradients are essential in Magnetic Resonance Imaging 
experiments. A constant field gradient results in magnetic field with a linear 
B0
Spin 
magnetization
Precession
plane
B0
Spin 
magnetization
Precession
plane
x
y
x
yreceiver receiver
‘dephase’‘in phase’
wait for some time 
time 
Mxy
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dependence on position. For example, a gradient in the x-direction, xG , when 
applied in addition to a uniform field B0, gives a spatially dependent field 
0 xB B x G= + ⋅ ; and this field results in a spatially dependent Larmor frequency 
0 xx Gω ω γ= + ⋅ ⋅ . In this way, the location of a nucleus can be tracked by its 
precession frequency, by 0( )
x
x
G
ω ω
γ
−
= . This technique of spatial encoding also 
known as frequency encoding results in a one-dimensional projection of spin 
density (as shown in Figure 1.1, 1.2 and 1.3). In practice, a gradient of equal 
magnitude, opposite direction, and half duration is applied before the frequency 
encoding gradient to form a gradient echo. The MR signal collected during the 
presence of frequency encoding (read-out) gradient around gradient echo time 
(See Figure 1.4 Illustration of gradient echo sequence diagram.Figure 1.4).  
 
Figure 1.3 Illustration of frequency encoding. 
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A two-dimensional image is created with the so called 'phase encoding gradient' 
applied in orthogonal direction to the frequency encoding gradient. Phase encoding 
is accomplished by applying an orthogonal gradient after the RF pulse and before 
the frequency encoding gradient for a short period (typically on the order of 
millisecond). This phase encoding gradient will cause the spins to accumulate 
certain amount of position-dependent phase in its direction. In an imaging 
experiment, the data collected at the gradient echo formed by the frequency 
encoding gradient constitutes a single line of 'k-space'. A full k-space is composed 
of multiple lines of k-space (typically 64,128 or 256 for convenience of Fast-Fourier-
Transform), each line collected with a different phase encoding gradient strength. In 
case of 2D imaging, raw data (k-space) is the 2D Fourier transform of the target 
MR object. Inverse Fourier transform is applied to the k-space data in order to 
obtain corresponding real space image. 
 
1.1.4 Gradient Echo Sequence  
An example of imaging pulse sequence - gradient echo sequence (the most 
important one for our project) is shown below for the 2D version. 
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Figure 1.4 Illustration of gradient echo sequence diagram. 
 
Frequency selective RF pulse (usually a small flip angle rather than 90o) is 
applied in the presence of Gradient along the slice direction, that will excite the 
spins in a targeting slice.  
Followed by a rewinding gradient in the slice direction, which drives back the 
dephasing of spins caused by the slice-select gradient. 
In the phase encode direction, a gradient is applied over certain duration, so 
that spins along this direction will accumulate position-dependent phase. 
In the frequency encode direction (or read out direction), a pre-rewind gradient 
which has power of exactly half of the read-out gradient is applied. It can be 
followed by a delay time before the readout gradient is turned on, which will refocus 
the spins in readout direction at gradient echo time TE (Time of Echo).  
A gradient echo is formed when the spins in the readout direction are pulled 
back in phase. Receiver is turned on during readout gradient to collect signal. 
The time between RF pulse and the echo is called Gradient Echo time. The 
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time delay between two excitation RF pulses is called TR: time of repetition. 
Within one TR, one k space line is collected. 
During repetitive TRs, everything is carried out the same way except that 
phase encode gradient varies from time to time, allowing collection of different k 
space lines. 
 
1.2 Complex MR signal 
 
Figure 1.5 Illustration of MR signal components. 
 
The signal that we measure in MRI is a complex number. It can always be written 
as iA e ϕ−⋅ , where A is the magnitude of signal, that represent signal strength, and 
ϕ  is the phase of signal, that characterizes rotational evolution of nuclear 
magnetization overtime.  
M
ϕ
y
x
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Over years most MRI research and applications were directed to searching for 
information from the magnitude of signal. It can be weighted by different signal 
decay mechanisms by carefully designed pulse sequences. Pulse sequences 
based on contrast mechanisms such as T1, T2, spin density, FLAIR, diffusion, 
magnetization transfer, etc., are now commercially available from most MRI 
manufactures. 
 
The phase information of Gradient Echo MRI signal has recently attracted much 
attention of the MR community. Part of the reason why people did not consider 
phase information useful is because field variations at all different scales will affect 
signal phase, and these variations are not only due to intrinsic properties of sample, 
but largely affected by environmental factors (anything that will affect field 
homogeneity). However, since It manifests superior gray matter/ white matter 
contrast and sub-cortical contrast at high field (7 T) (3), and it is extremely easy to 
obtain – by simple gradient echo sequence, it has become a hot topic in the field of 
MRI in recent years. However, the nature of phase contrast is under intense 
debates. By studying properties of protein solutions and rat optical nerve (as model 
systems) our group has contributed to deciphering the main mechanisms 
contributing to the phase contrast. This will be discussed in Chapters 2 and 3. 
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1.3 Multiple Sclerosis  
Multiple sclerosis (MS) is a common disease, affecting 2.5 million people world-
wide. The clinical course is heterogeneous, ranging from benign disease in which 
patients live an almost normal life to severe and devastating disease that may 
shorten life. Despite much research, a fully effective treatment for MS is still 
unavailable.  
 
There are three subtypes of MS, classified according to their patterns of 
progression (4-6). 1) Relapsing-Remitting (RRMS), characterized by unpredictable 
relapses followed by months to years of relatively quiet periods with no signs of 
disease activity before another relapse. It is the majority of MS population (85-
90%), and is the only clinical subtype that responds well to current immuno-
modulatory drugs (IMDs). 2) Secondary-Progressive (SPMS) evolves from over 
50% of RRMS cases. Patients entering this stage will begin to have progressive 
neurologic decline between acute attacks. 3) Primary Progressive (PPMS) occurs 
in about 10% of MS patients. In this case patients have a steady neurologic decline 
with superimposed attacks from onset.  
 
Symptoms of MS patients are very diverse. It can be almost any neurological 
symptoms, including changes in sensation, muscle weakness, difficulty moving, 
difficulties with coordination and balance, problems in speech or swallowing, visual 
11 
 
problems, fatigue, acute or chronic pain, and bladder and bowel dysfunctions. 
Cognitive impairment of varying degrees and emotional symptoms of depression of 
unstable mood are also common. The main clinical measure of disability 
progression and symptom severity is the Expanded Disability Status Scale 
(EDSS)(7). 
 
Cause of MS is not definite. It is likely to occur as a result of some combination of 
genetic, environmental and infectious factors (4), and possibly other factors like 
vascular problems (8). 
 
The pathology of this disease is rather complex - many processes co-exist in the 
CNS (e.g. inflammation, demyelination, axonal damage and repair mechanisms). 
Inflammatory CNS demyelination with relative preservation of axons has been 
considered the pathologic hallmark of MS, but it has been known for many years 
that axonal loss also frequently occurs in MS (9,10). In principle, the functional 
deficits in MS caused by inflammation and demyelination can be reversible. In 
contrast, the damage to axons and neurons is likely to be irreversible. 
 
Complexity of MS and lack of clinical diagnostic tools capable of identifying different 
specific aspects of MS stimulate numerous investigators to continue search for new 
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diagnostic methods. Especially important is a problem of early diagnostic as much 
accumulating data indicate that early treatment is beneficial to decrease ultimate 
disability in MS (11). 
 
1.4 Magnetic Resonance Imaging in MS 
As a non-invasive tool, Magnetic resonance imaging (MRI) plays a key role in MS 
diagnosis (12,13). Numerous MRI techniques have been proposed over the years. 
Among most widely used are conventional T1-weighted (T1W), T2-weighted (T2W) 
and FLuid Attenuated Inversion Recovery (FLAIR) imaging techniques.  
 
Figure 1.6 Example of clinical standard MRI used for monitoring MS (obtained in 
our laboratory). a) T1-weighted image, b) T2-weighted image, c) FLAIR. 
 
As shown in Figure 1.6, in T2W image, WM appears dark, and CSF appears bright, 
with GM in between of them. MS lesions show heterogenous intensity between WM 
and CSF, but are always brighter than WM – so called hyperintense appearance. In 
FLAIR images CSF signal is suppressed, so that lesions are visually more 
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detectable. This is most frequently used in clinical scans in MS subjects. In T1W 
image on the other hand, WM demonstrates itself as bright, and GM as gray, CSF 
as dark gray. MS lesions that show up on T2w images do not always came out on 
T1w image. Those that show up on T1w as hypointense are often called black-
holes or grey-holes, indicating severer tissue damage than those that are not seen 
on T1w. This is the only conventional sequence that provides information about the 
severity of the MS lesion 
 
Figure 1.7 Example of clinical standard MRI used for monitoring MS. left: T1-
weighted spin echo image; right: T1w-SE image with Gd-enhancement. 
 
T1w image is also used for detecting ‘active lesions’, where administration of 
gadolinium (Gd) based contrast agent is needed. Because Gd shortens T1 
relaxation time constant, the T1w image post-contrast will immediately have 
brighter blood vessels. Thus if there is a leak in blood-brain barrier (BBB), Gd will 
    T1w SE                      T1w SE (Gd) 
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find its way in brain tissue – lesion area – and the lesion will light up as ‘enhanced 
lesions’. Since BBB breakdown allows immune cells to infiltrate in the brain tissue, 
causing the known demyelination (14), the Gd-enhanced lesions are often referred 
to as ‘active lesions’. 
 
The volume of T2W lesions is often used as a secondary endpoint in clinical trials, 
but it does not correlate well with MS disability (11). This is due to multiple factors, 
including not only inherent imaging limitations, but also that volumetric measures 
do not take into consideration lesion locations which determine the functional 
systems affected, do not include most gray matter lesions. This paradox has been 
attributed to the complexity and heterogeneity of the underlying tissue damage in 
MS, to the different effects on function caused by different lesion locations, as well 
as to variable degrees of neural plasticity among patients. Lack of strong 
correlation between clinical findings and standard imaging is especially noted in the 
progressive clinical subtypes (15,16), the subtype where effective treatments are 
most needed. Indeed, a “plateau effect” between T2W lesion volume and disability 
has been reported after MS disability reaches a certain level (15,16). Better 
quantitative imaging is particularly urgently needed for evaluation of new therapies 
for progressive MS subtypes in a timely fashion(17,18). 
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Several advanced MRI techniques are also used as research tools to study MS. 
Among them are magnetization transfer contrast imaging (MT), MR spectroscopy 
(MRS), and Diffusion Tensor Imaging (DTI). 
MT measures the exchange of nuclear magnetization between bound 
(macromolecular associated) and free (mobile) water 1H in tissue (19,20). Following 
selective saturation of the pool of bound 1H using a radiofrequency pulse, the 
image intensity of mobile 1H2O is reduced due to the magnetization exchange 
process. The ratio of MR signal intensities of selectively saturated vs. non-
saturated experiments, defined as magnetization transfer ratio (MTR) changes with 
loss of myelin and axons in MS and can be used as a measure of MS pathology 
(21,22), and correlates inversely with disability (23). Thus far, MT has not been 
widely used except in research studies. MTR would be difficult to use as a 
surrogate endpoint in multi-center trials due to site-to-site differences.  
 
Another imaging method used primarily in research studies to assess underlying 
pathology in individual MS lesions is MR spectroscopy (MRS). In CNS, in vivo 1H 
MRS measures the presence and relative amounts of various tissue metabolites 
such as N-acetylaspartate (24), choline, creatine, etc. (25). Because NAA derives 
almost exclusively from mature axons and neurons (9), its persistent reduction is 
considered a specific indicator of axon loss, damage, or dysfunction. Moreover, 
reduced NAA is found in the NAWM of some relapsing-remitting (RRMS), 
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secondary progressive (SPMS), and primary progressive (PPMS) MS patients (26), 
and the degree of reduction may differentiate SPMS from RRMS (27). Overall, NAA 
appears to be a meaningful neuroimaging marker for evaluating MS pathology, 
specifically axonal injury (28,29). However, MRS suffers from long acquisition time, 
coarse spatial resolution limiting its sensitivity and universal applicability. 
 
Diffusion Tensor Imaging (DTI) provides quantitative data on the rate and direction 
of water diffusion (30). DTI has the potential to identify and differentiate axon 
loss/injury from demyelination, as shown in several animal model studies (31-35). 
The major limiting issue with DTI at present is that it is still labor-intensive to obtain 
high quality quantitative data routinely.  
 
So far, amongst the best of the correlations between standard imaging methods 
and clinical function occurs with chronic T1W hypointensities. The volume of T1W 
hypointensities, or “black holes,” correlates, albeit modestly, with disability 
(11,16,18). The better correlation between “black holes” volumes and disability is 
likely because chronic MS lesions that are hypointense on T1W have more axon 
loss than those that are not (18,36). However, even the determination of what 
constitutes a “black hole” is subjective and non-quantitative. There are degrees of 
“blackness” of T1W hypointense lesion. Just because two “black holes” may 
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occupy the same volume doesn’t mean they have the same severity of underlying 
pathology.  
 
The image contrast in the standard “weighted” spin-echo sequences depends not 
only on the MR relaxation time constants of the brain tissue but also on the 
parameters of the pulse sequence. This non-biological dependence may lead to an 
incorrect estimation of the black hole load, as lesions may not be apparent when 
image contrast is poor. These shortcomings can be overcome by using recently-
proposed approaches based on measuring tissue T2 and T1 relaxation times 
instead of using T2- and T1-weighted images(37,38). Based on published data, this 
would also allow improved differentiation among types of MS pathologies. 
Importantly, a recent study in autopsied MS brain tissue showed good correlation 
between T1 and T2 relaxation time constants and MS pathology (38). Correlations 
with another imaging measure, magnetization transfer ratio, MTR were not as 
strong. These new findings opened a door for using MRI relaxation time constants 
as quantitative markers of tissue damage in MS. However, the proposed 
quantitative methods (37,38) are not practical, even for clinical trials, because of 
the long time needed to produce accurate quantitative T1 and T2 maps.  
 
GEPCI technique developed in our laboratory (39-41) can aid in solving this 
problem and differentiate the degree of “blackness” by quantitatively measuring 
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tissue T2* relaxation time constant in a clinical acceptable time (< 8 min). It offers a 
scoring method for monitoring Multiple Sclerosis based on the quantitative T2* 
maps generated from magnitude information of gradient echo signal. Herein we 
demonstrated a strong agreement between GEPCI quantitative scores and 
traditional lesion load assessment. We also established a correlation between 
GEPCI scores and clinical tests for MS patients. We showed that this correlation is 
stronger than that found between traditional lesion load and clinical tests. Such 
studies will be carried out for longer period and on MS subjects with broader range 
of disease severity in the future.  
 
1.5 Dissertation Overview 
 
Chapter 2 and Chapter 3 focus on studying the biophysical mechanism behind 
phase contrast in brain tissue. Experiments are carried out on carefully designed 
model systems.  
Chapter 2 deals with magnetic susceptibility effects. The theory of correctly relating 
susceptibility to the frequency shift that we measure is proposed. Validation 
experiments in silico as well as ex vivo are described in this chapter.  
Chapter 3 is about the relative magnitude of susceptibility effect mentioned in the 
previous chapter and the exchange effect which also shifts MR frequency. The 
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experimental setup that allows clean separation of these two effects is described; 
experimental results and validation experiment of this method are also presented in 
detail. 
Chapter 4, Chapter 5 and Chapter 6 brings our investigation in vivo, which include 
both healthy volunteers and MS subjects.  
Chapter 4 lays out all the experimental considerations in GEPCI technique involved 
in the following chapters. The first section describes the parameter optimization; 
model of the signal is discussed in the second section, multiple derived contrasts 
from GEPCI technique are also included in this chapter.  
Chapter 5 presents the method for implementing GEPCI technique to assist with 
evaluation of the MS disease. Quantitative tissue damage score is introduced, 
applied to MS subjects. Comparison between GEPCI measurement and clinical 
standard evaluations is performed.  
Chapter 6 presents the application of the theory described in chapter 2 to the MS 
disease. It made the effort of bridging understanding of MR signal frequency to the 
pathology of MS. MS abnormalities on phase images are identified. And theoretical 
explanation of data and its relationship to corresponding pathology is presented.  
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Chapter 7 closes out the dissertation by summarizing the specific accomplishments 
of this study, and also proposes several interesting future directions beyond this 
study. 
[  
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Chapter 2 Biophysical Mechanism behind MR Signal 
Phase – Susceptibility effect1  
 
2.1 Introduction 
Phase MR images obtained by gradient-recalled echo protocols provide greatly 
enhanced contrast in the brain at high magnetic fields (3,42-45), which allows 
visualization of biological structures within gray matter (GM) (46) and white matter 
(WM) that are distinct from conventional T1-weighted and T2-weighted images. 
However, the biophysical origin(s) of the phase (frequency) contrast is not well 
understood, and has been ascribed to a variety of phenomena: (i) susceptibility 
effects induced by differing tissue chemical composition, specifically including 
differences in iron (47-49), deoxyhemoglobin (50,51), proteins (52,53), and myelin 
content (54); (ii) magnetization exchange effects between “free” water and 
macromolecules (42,55,56) and (iii) possible anisotropy of tissue magnetic 
susceptibility (57,58). A role for myelin was suggested by a report demonstrating 
that demyelination leads to a loss of phase contrast between WM and GM (54,59). 
It has also been shown that the phase contrast between WM and cortex can be 
principally attributed to variations in myelin content (60). However in 
contradistinction phase contrast is very small between WM, a myelin rich structure, 
                                               
 
1 Part of contents in this chapter have been published in Luo J, He X, Yablonskiy DA. Magnetic susceptibility 
induced MR Signal frequency shift in white matter. Proc. Int. Soc. Magn. Reson. Med. 2012; 415.  
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and cerebrospinal fluid (CSF) where myelin is essentially absent (3,61). To explain 
this curious phenomenon, He and Yablonskiy (61) introduced a new theoretical 
concept called the Generalized Lorentzian approach. An important insight from this 
conceptual framework is that the local contribution to the MRI signal phase does 
not depend solely on the bulk magnetic susceptibility of the tissue, but also on the 
“magnetic architecture” of the tissue – i.e., the distribution of magnetic susceptibility 
inclusions (lipids, proteins, iron, etc) at the cellular and sub-cellular levels. This 
theory explained why phase contrast is essentially absent between WM and CSF 
and provided a conceptual platform for quantitative interpretation of data from MR 
phase imaging of white matter diseases. 
Herein the of “Generalized Lorentzian” concept is validated using ex vivo rat optic 
nerve as a model system. Representative of pure white matter, the simple 
geometry of isolated optic nerve provides a well-defined cylindrical shape that 
minimizes global magnetic field distortions and contamination from neighboring 
tissues.  
 
2.2 Theory 
2.2.1 Magnetic Susceptibility 
Magnetic susceptibility describes how a substance reacts to the presence of 
external magnetic field B . M Bχ= ⋅ . M  is magnetization defined as a substance 
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magnetic moment per unit volume. There are three different kind of materials 
categorized according to their reaction to magnetic field: paramagnetic, 
diamagnetic, and magnetically ordered substances (ferromagnetic, anti-
ferromagnetic and ferrites). 
 
Paramagnetic substances usually have unpaired electrons and positive χ  on the 
order of 10-3 at room temperature Their M has the same sign as B. Diamagnetic 
substances have no unpaired electrons their χ  is 10-3 smaller than paramagnetic 
substance – it is on the order of ppm, and it is negative - M has an opposite sign 
compared to B. In magnetically ordered substances unpaired electrons are aligned 
with respect to each other and their magnetic susceptibility can be several orders of 
magnitude bigger than in paramagnets. 
 
As it comes to human brain tissue that we are interested in, majority of the mass is 
diamagnetic, such as water, lipids, proteins. Iron (Fe2+ or Fe3+) on the other hand is 
paramagnetic. Since there is only trace amount of iron (usually about 10-5 g/g wet), 
overall magnetic susceptibility of brain tissue is negative. It is not surprising to find 
that as complex structure as brain, its susceptibility is not homogenous. For 
example myelin with susceptibility of mχ , has magnetization m mM Bχ= ⋅  which is 
different from magnetization of surrounding substances and will create additional 
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magnetic field upon itself and surrounding cytosol environment, resulting in an 
inhomogenous magnetic field at the cellular and subcellular levels.  
 
Since signal phase is often thought of as directly related to magnetic field 
distribution, the variations of susceptibility of brain tissue, although small, plays a 
very important role in the phase contrast that we observe in the brain. To unveil the 
relationship between the tissue susceptibility and signal phase that we measure, 
we need to answer two questions: 1) what is field b in the tissue area, and 2) what 
is the relationship between b field and MR signal phase? 
 
2.2.2 The signal phase that we measure 
 
 
Figure 2.1 Schematic of water molecule moving around surrounding susceptibility 
sources. 
 
B0
Susceptibility   
sources
Water 
molecule
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In brain imaging, MRI signal coming from a given voxel is the sum of all signals 
generated by nuclei in the specific voxel.  
 ( ) exp( ( ))n
n
S t i tϕ= −∑  [2.1] 
As drawn in Figure 2.1 there are multiple susceptibility inclusions in the voxel – 
lipids, proteins, iron (all marked with blue dots). Water molecule (green dot) is 
moving around them all the time due to diffusion. So phase accumulated by single 
nucleus should be expressed by the integral of b field felt by this water molecule 
through the trajectory over time. ( )b r  at each given point is affected by all of its 
surrounding susceptibility inclusions. Since water molecules that are within 
characteristic diffusion distance (about 1µm) sample experience more or less the 
same environment, their signal phase can be expressed as proportional to b< > .  
 
One way to find b< >  is called ‘Lorentzian Sphere Approach’. It borrows the idea 
proposed by Lorenz (1901), that b< > can be considered as a sum of farb< > and 
nearb< > - two parts separated by an imaginary sphere (demo in Figure 2.2).  
 
near farb b b< >=< > + < >
Lorentz HA. The Theory of Electrons. 1909 
= +
0 0
4
3
b B SF Bπ χ χ< >= ⋅ ⋅ + ⋅ ⋅
0nearb< > =
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Figure 2.2 Schematic of Lorentzian Sphere Approach. 
Due to diffusion and the fact that average field outside a dipole is zero, the nearb< >
field is zero. The farb< >  on the other hand (since all the susceptibility inclusions 
are far away from the nuclei of interest) can be seen as a field generated by a 
homogenous media. Thus b< >  depends on two things: 1. Lorentzian factor, that is 
a spherical boundary with vacuum on the inside and susceptibility χ  on the 
outside; 2. The Shape Factor, which varies from different global shapes of the 
whole object. For example, if global shape of object is also a sphere, then Shape 
factor will be ( 4 / 3)π− , if it is an infinitely long cylinder, SF will be 22 sinπ α− ⋅ .  
 
Frequency shift f∆  due to the presence of external magnetic field can be 
expressed as a sum of two terms (62). First term describes effects of global shape 
of the sample:  
 
0 shape
f SF
f
χ∆ = ⋅  [2.2] 
and the second term describes the short-range, structure specific effects (i.e., 
dependent upon the specific spatial arrangement of magnetic particles/dipoles) and 
is generally referred to as the contribution from Lorentzian sphere: 
 
0
4
3
f
f
π χ∆ = ⋅  [2.3] 
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Here 0f
 
is the base Larmor frequency, χ  is the volume magnetic susceptibility of 
the liquid sample, and SF is a shape factor dependent on a global shape of the 
object. 
 
The Generalized Lorentzian Approach (He and Yablonskiy) adds a very important 
consideration to the Lorentzian Sphere Approach – symmetry of the tissue 
microscopic structure. It says that if tissue has very regular architecture that has a 
scale much larger than the characteristic distance of water diffusion, then the 
selection of lorentzian cavity needs to be modified based on the actual 
arrangement of macromolecule/susceptibility inclusions. Particularly in the brain 
white matter, the axons have very specific geometry. A large amount of magnetic 
inclusions are aligned along axonal direction such as neurofilaments, and myelin 
sheath. Some can run for cm’s long. When doing separation of nearb< >  and 
farb< >  as we did before, we need to choose our Lorentz cavity as a cylinder. Then 
Lorenz factor will be 22 sinπ α− ⋅ , and shape factor depends on brain geometry on 
the macroscopic level. 
 
2.2.3 Frequency shift of MRI signal in a solution surrounding optic 
nerve: 
The magnetic susceptibility of the nerve is comprised of magnetic susceptibility of 
longitudinal components/structures Lχ  and magnetic susceptibility of isotropic 
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components/structures isoχ .The homogeneous medium surrounding the nerve has 
magnetic susceptibility eχ . In the imaging plane which presents a cross-sectional 
view of the nerve in the NMR tube, the nerve-induced frequency shift 0/ef f∆  
experienced by the homogeneous medium outside the nerve is described by the 
well-known equation as follows:  
 
0
2 20
0
2 ( ) ( ) cos(2 ) sine iso L e
r r
f r
f r
π χ χ χ θ α
>
∆
= ⋅ + − ⋅ ⋅ ⋅  [2.4] 
 
The frequency shift is proportional to the bulk (total) magnetic susceptibility 
difference between the nerve ( iso Lχ χ+ ) and the surrounding solution ( eχ ). Moving 
radially away from the nerve, the frequency shift decays as 21 / r , 0r  is the radius of 
the nerve. The angular dependence of the pattern of the frequency shift in the MR 
imaging slice plane is described by the angle θ  between coordinate of interest in 
the plane and the projection of magnetic field B0 onto plane (Figure 2.3); α is the 
angle between B0 and long axis of the nerve. When 0α = ° , the nerve is parallel to 
B0, there should be no frequency shift in the homogeneous medium outside the 
nerve; whereas when 90α = ° , the frequency shift effect is maximal. Integrating 
over all angles , the average frequency shift induced by the nerve on the external 
medium is zero. 
θ
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Figure 2.3 Illustration of the secondary field, generated by the optic nerve when B0 
is perpendicular to the axis of the nerve Eq. [2.4].  
 
2.2.4 Frequency shift of MRI signal between inside the nerve and the 
outside solution surrounding optic nerve 
When B0 field is parallel to the long axis of the nerve, the global shape factor SF = 
0 (long cylinder approximation), and the optic nerve frequency shift induced by the 
longitudinal structures within the nerve is equal to zero (Eq. [2.2] : Lorentzian 
cylinder). In this case, the only frequency shift observed between inside the nerve 
and the external homogeneous medium 0/i ef f−∆  is that induced by the isotropic 
components, 4 ( )
3 iso e
π χ χ⋅ −  per Lorentzian sphere, Eq. [2.3]. In the case when B0 
forms an angle with the long axis of the sample, the global shape factor 
22 ( ) siniso L eSF π χ χ χ α= − ⋅ + − ⋅ , the Lorentzian cylinder contribution of the intra-
nerve longitudinal structures is 22 sinLπ χ α= ⋅ ⋅ , and the Lorentzian sphere 
contribution of isotropic structures is still 4 ( )
3 iso e
π χ χ⋅ − . Including a possible 
macromolecule exchange effect (which would not depend on the angle between the 
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long axis of the nerve and B0) (42,55), the average frequency shift 0/i ef f−∆  
between inside the nerve and the homogeneous external medium (per Eq. [2.4] the 
average field induced by the nerve itself in the surrounding media is zero) is: 
  2
0
42 ( ) sin ( )
3
i e
iso e iso e
f MWE
f
π χ χ α π χ χ−∆ = − ⋅ − ⋅ + ⋅ − +
 
 [2.5] 
A very important feature of Eqs [2.4] and [2.5] is the difference in their dependence 
on magnetic susceptibility: while Eq. [2.4] depends on the total magnetic 
susceptibility of the optical nerve ( iso Lχ χ+ ), Eq. [2.5] depends only on the isotropic 
component isoχ (longitudinal structures do not contribute to the frequency shift in 
circular structures)! This would not be the case in a traditional use of the Lorentzian 
sphere approach where both Eqs. [2.4] and [2.5] would depend on the total 
magnetic susceptibility ( iso Lχ χ+ ). 
 
2.3 Materials and Methods 
2.3.1 Materials  
Pairs of rat optic nerves are harvested from three euthanized rats (Sprague-
Dawley). For each subject, one nerve was soaked in 1% PBS buffer, and examined 
2~3 hours after death. The other nerve was subsequently fixed with 10% formalin, 
and examined 1~2 days later. 
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Two pieces of thin coated copper wires (30 micron diameter) were used to tie the 
optic nerve at both ends. The [wire-nerve-wire] structure was then threaded through 
an NMR tube with two open ends. The free ends of the copper wires are then 
wrapped around both ends of the NMR tube (2.97 mm ID), with the nerve 
suspending in the middle of the tube (as shown in Figure 2.4). The NMR tube was 
filled with either 1% PBS or 10% formalin fixative, and sealed tight with parafilm. 
 
Figure 2.4 Picture of the experimental setup. 
2.3.2 MRI Procedures: 
Experiments were performed on an Angilent/Varian DirectDriveTM MR scanner 
based on a 4.7-T horizontal-bore superconducting magnet with a 21 cm diameter 
inner bore gradient and shim assembly, using a 1.5 cm diameter, laboratory 
constructed, surface transmit/receive RF coil. Localized shimming employed a 
STEAM sequence on a 5 x 5 x 5 mm3 voxel, selected at the mid-point of the optic 
nerve’s longitudinal length. Typical linewidth ~ 8 Hz (range 5 to 12 Hz) was 
achieved. Data were acquired using a multi-echo gradient echo sequence, on a 1-
mm thick slice with 75 x 75 µm2 in plane resolution. TR 170 ms, first TE 7.4 ms, 
echo spacing 13.176 ms, flip angle 30 deg, imaging matrix 128 x 128, total 
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acquisition time 17 min (with 50 averages). The tube was first oriented parallel to 
B0 and then rotated 6 times by ~15 degree each time until a perpendicular 
orientation was reached. Following each rotation, (i) the exact orientation of each 
rotation was determined from scout images; (ii) the imaging plane of the multi-echo 
gradient echo sequence was oriented perpendicular to the optic nerve; (iii) localized 
shimming was performed to minimize field distortions. (Note that if the optic nerve 
and NMR tube were not perfectly parallel, then imaging plane was made sure to be 
perpendicular to the nerve.) Experiments were repeated three times on each pair of 
optical nerves. 
 
2.3.3 Data processing 
Data were processed with Matlab® software (The MathWorks, Inc.). Eight fold 
zero-filling was applied to k-space data in order to increase digital resolution for 
more accurate estimation of optic nerve radius 0r . Then the data were Fourier 
transformed into imaging domain (63) and a Hanning filter was applied to reduce 
Gibbs-ringing and signal leakage. 
 
Frequency maps f  were determined from phase maps ϕ  corresponding to 
different gradient echo times TE according to equation 0 2 f TEϕ ϕ π= + ⋅ ⋅ . Phase 
unwrapping was preliminary performed in the time-domain for each voxel as 
described in (39). 
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Evaluation of the optical nerve position and radius: 
 
Knowledge of the radius 0r  of the optic nerve is required to determine the magnetic 
susceptibility of the optic nerve as per Eq. [2.4]. To find the center of the optic nerve 
and subsequently measure its radius, a map of the image intensity gradient was 
generated based on the magnitude image I(x,y), Eq. [2.6]:  
 2 2( , ) [ ( 1, ) ( 1, )] [ ( , 1) ( , 1)]G x y I x y I x y I x y I x y= + − − + + − −  [2.6] 
where x and y are voxel coordinates in the imaging plane. Starting from an initial 
estimate of the nerve’s center coordinate (origin), radial rays were traced across 
and covering the nerve’s full circumference at 2° intervals (i.e., 180 rays in total). 
Coordinates of maximal ray intensity (maximal image gradient) at each 2° 
increment outline the first estimate of the edge of the optic nerve. An updated 
estimate of the nerve’s center was found by averaging coordinates of the edge 
points and the entire process was repeated until convergence was achieved. 
Finally, 0r  was determined by calculating average distance from the center point to 
all the edge points.  
2.3.4 Field inhomogeneity correction  
Before determining the susceptibility of the optic nerve based on the frequency 
maps, account must be taken of the background field inhomogeneities. This was 
done by expanding the angular dependence of the frequency map in terms of a 
Fourier series: 
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0( , ) ( ) cos( ) ( ) sin( ) ( )nc nsf r f r n f r n f rθ θ θ= + ⋅ ⋅ + ⋅ ⋅∑ ∑  [2.7] 
where θ is the azimuthal angle, n=1,2,… and r  is the distance from the nerve 
center (Figure 1). The coefficients in this series can be expressed in a standard 
manner: 
 
0
1 1 1( ) ( , ) sin( ) ; ( ) ( , ) cos( ) ; ( ) ( , ) ;
2ns nc
f r f r n d f r f r n d f r f r dθ θ θ θ θ θ θ θ
π π π
= ⋅ = ⋅ =∫ ∫ ∫  
 [2.8] 
All coefficients in front of the harmonics can be further expressed as Taylor series: 
 ( ) mn nmf r a r= ⋅∑  [2.9] 
where m=0,1,2,… The only exception to this expression is the 2 ( )cf r term is 
associated with cos(2 )θ  because the field generated by the optical nerve also 
contains the term cos(2 )θ , Eq. [2.4], hence this term should be written as 
 2 2 22 2 0( ) 2 ( ) sin
m
c m iso L ef r a r r rπ χ χ χ α
−= ⋅ + + − ⋅ ⋅ ⋅∑  [2.10] 
As the dipolar term is proportional to 21 / r , when one is close to the inner cylinder 
(the minimum point) the local field is mainly affected by this term, while at larger r , 
distant from the inner cylinder, the field inhomogeneity plays bigger role. The ( )f r  
curves are first calculated by numerical integration of frequency maps for the 
distant regions ( ) according to Eqs. [2.8]. Then coefficients anm are 
calculated by fitting Eqs. [2.9] and [2.10] to these curves. Finally, fitting results are 
used to calculate all terms in Eq. [2.7] (usually up to second order) for all  and ; 
02r r>
r θ
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the frequency maps are subsequently corrected by subtracting these terms except 
for the term . 
2.3.5 Evaluation of imaging errors 
In-silico experiments - computer simulations of the MRI experiment were conducted 
to evaluate errors in parameter estimates that might have been introduced by the 
imaging protocol itself. All programs for data generation and analysis were written 
in Matlab®. Imaging protocol parameters in the simulations were set to reproduce 
experimentally employed parameters. 2D in-silico imaging data mimicked cross-
sectional slices of two infinitely long co-axial cylinders filled with different 
homogenous media.  
The inner cylinder had radius r0 = 0.32 mm, corresponding to the optic nerve, and 
the outer cylinder had radius R = 1.87 mm, corresponding to the NMR tube. The 
field of view was 9.6x9.6 mm2 and the matrix size was 128 x128. The k-space 
sampling of the object was calculated according to the following equation:  
 ( , ) ( , ) exp( 2 ( ) ( , ) ( ))x y x yS k k x y i k x k y i b x y TE t dxdyρ π γ= ⋅ − ⋅ ⋅ ⋅ + ⋅ + ⋅ ⋅ ⋅ + ⋅∫ ∫ [2.11] 
where TE is the gradient echo time, t is time during readout ( 2 x xk G tπ γ= − ), γ  is 
the gyromagnetic ratio and b(x,y) is the secondary field generated by the 
susceptibility difference ( i eχ −∆ ) between the different homogeneous medium 
assumed to fill the inner and outer cylinders. This susceptibility difference was set 
according to a preliminary evaluation measurement: i eχ −∆ = - 9.287 ppb. In 
simulations, b(x,y) inside the inner cylinder was described by the Lorentzian sphere 
2cos(2 ) ( )cf rθ ⋅
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approach, in this case requiring shape factor of cylinder and Lorentzian factor of 
sphere, hence b(x,y) = 0(2 / 3) i e Bπ χ −− ⋅ ∆ ⋅ . The field surrounding the inner cylinder 
(present in the annulus between the two concentric tubes) is b(x,y) = 
20
02 ( ) cos(2 )i e
r B
r
π χ θ−⋅ ∆ ⋅ ⋅ ⋅ . To focus on magnetic susceptibility effects the global 
field inhomogeneity was neglected and the T2 relaxation time constant was 
assumed to be infinite for both compartments. The integral in Eq. [2.11] was 
calculated as a discrete sum over 2048 x 2048 points which is 16x16 times greater 
than the simulated imaging resolution (128 x128). 
Effects of different data processing procedures, such as zero filling and Hanning 
filtering were evaluated with cylinders perpendicular to B0. Different combinations 
of spin densities of inner and outer cylinders (in:out) were selected as 1:2, 2:1, 3:2 
and 2:3, bracketing that observed in actual experiments. Finally, the specific TE, 
image intensity, and b field corresponding to experimental data presented in 
Results were used to estimate 0r  from simulated data with B0 parallel to the axis of 
the concentric cylinders. These results were subsequently used for correction of the 
0r  estimated from experimental data.  
2.3.6 Determination of Magnetic Susceptibility 
The bulk magnetic susceptibility of the nerve was determined following field 
inhomogeneity correction using Eq. [2.10]. Fitting  against  yields the 
coefficient , which is then fit to a linear function of 
2 ( )cf r
2r−
2 2
02 ( ) siniso L e rπ χ χ χ α+ − ⋅ ⋅
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 to yield . Since  is known from measurements 
described above, the bulk (total) susceptibility  is obtained. 
The frequency shift experienced in the interior of the inner cylinder or optic nerve 
vs. surrounding homogeneous-medium was also determined after field 
inhomogeneity correction. The average frequency shift experienced by the 
surrounding medium is zero. The frequency shift experienced in the interior of the 
inner cylinder or optic nerve is calculated by averaging over the area inside the 
cylinder/nerve (an area around the center point covering less than half of the 
cylinder/nerve diameter to avoid partial volume effects).  
 
2.4 Results 
2.4.1 In Silico Experiments  
 
Figure 2.5 An illustration of in silico results and procedure for determining radius of 
2sin α 202 ( )iso L e rπ χ χ χ+ − ⋅ 0r
( )iso L eχ χ χ+ −
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the inner cylinder (input value: 35 pixels). Left panel - results without including 
susceptibility effect in the simulation; Right panel - results with susceptibility effect. 
a,a' - objects created for simulation; b,b' - original magnitude images obtained from 
simulated data; c,c' - magnitude images obtained after zero filling and Hanning 
filter; d,d' - field maps used in simulations; e,e' - original phase images obtained 
from simulated data; f,f' - phase images obtained after zero filling and Hanning 
filter; g,g' - gradient maps of the magnitude of the processed image (c,c' 
respectively); h,h' - plots of radius vs. sample points around the cross-section of the 
inner cylinder. 
 
Two examples of the results of in-silico experiment are shown in Figure 2.5. Limited 
imaging resolution, partial volume effects, and Gibbs ringing artifacts create 
uncertainties in determining the inner cylinder radius. Even with no susceptibility 
difference between the two compartments, the simulated data do not provide for an 
exact determination of the radius of the inner cylinder. The different combinations of 
spin densities showed the same effect (Table 2.1). In the presence of magnetic-
susceptibility-induced field inhomogeneities, the measured radius deviates more 
from the true (input) r0, shown in Fig 2.5h’. Moreover, distortion of the cylinder is 
demonstrated clearly in the plot of radius as measured at different angles about the 
inner cylinder. This effect results from the static inhomogeneous b field, which adds 
an additional gradient (although small) to the imaging gradient. Herein, since the 
simulation employed a susceptibility difference between actual nerve tissue and 
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surrounding solution that was close to the experimental value, it is possible to use 
the in-silico results as correction factors in the processing of the experimental data.  
Spin Density Ratio 
(Inner : Outer) 
Estimated 0r  
at χ = 0 
Estimated 0r  
at χ = - 9.287 ppb 
Deviation from 
Input (%) 
2 : 1 34.7070 33.0829 -5.4% 
3 : 2 34.7070 32.1771 -8.0% 
1 : 2 34.7070 36.0424 2.98% 
2 : 3 34.7070 36.7514 5.01% 
Table 2.1 In-silico measured radius of inner cylinder obtained for different 'spin 
densities' (input radius is 35); simulation was performed with assuming the echo 
time TE of 20 ms; both Hanning filter and zero filling were applied during data 
processing.  
 
 
Figure 2.6 Example of the profiles of phase images obtained from in-silico data for 
B0 oriented perpendicular to the cylinder axis along the read out direction. The 
frequency distribution arising in the simulation (Lorentzian sphere approach) 
resulted from an assumed susceptibility for homogeneous medium in the inner 
cylinder of χ = -9.287 ppb. Vertical scale is phase value in radians; Horizontal scale 
is pixel number with origin at the center of inner cylinder. a) Profiles through the 
0 50 100 150 200
-1.5
-1
-0.5
0
0.5
1
1.5
0 50 100 150 200
-1.5
-1
-0.5
0
0.5
1
1.5
a. b.
40 
 
center of the inner cylinder along B0 direction; b) Profiles through the center of the 
inner cylinder perpendicular to B0 direction. Solid black lines represent resulting 
phase after simulation (processed with zero-filling and Hanning filter), blue dotted 
lines represent the “ideal” phase result which is proportional to the input of 
susceptibility induced b field.  
 
Figure 2.6 shows phase distortions revealed by the in in-silico procedure, which 
arise from magnetic susceptibility effects. Major deviations from the input model 
parameter are seen at the edges of the inner cylinder. However the central portion 
and the “tails” of frequency maps around the inner cylinder more closely follow the 
ideal phase. In fitting in silico data to Eqs. [2.9] and [2.10], the data points to be 
modeled are chosen be sufficiently far from the edge of the nerve so as to avoid the 
distortions shown in Figure 2.6. For the case of B0 perpendicular to the cylinder, the 
frequency shift between the inner cylinder and the average frequency shift outside 
of the inner cylinder is:
 0
2
3
i e
i e
f
f
π χ− −
∆
= − ⋅ ∆ . Considering only the central area of the 
inner cylinder (avoiding partial volume effects) yields i eχ −∆ = 9.2875 ppb which is 
practically identical to the input parameter i eχ −∆ = - 9.2867 ppb. Considering the 
frequency shift outside of the inner cylinder yields, Eq. [2.4], i eχ −∆  = 9.3023 ppb, 
which differs from the input model parameter by only 0.016 ppb or 0.17%.  
 
Spin Density Ratio 
(Inner : Outer) 
Fresh Optic 
Nerve Mimic 
Deviation 
from Input 
Fixed Optic 
Nerve Mimic 
Deviation 
from Input 
41 
 
(pixels) (%) (pixels) (%) 
3 : 2 34.5537 -1.28% 34.0043 -2.84% 
1 : 2 35.4734 1.35% 36.7754 5.07% 
Table 2.2 Examples of error in  measured when coaxial cylinders (inner and 
outer) are parallel to B0. Input  was 35 pixels; b(x,y) inside inner cylinder was 
modeled as having essentially the same frequency shifts as encountered in the 
actual optic nerve experiments. Top row shows the cases when cylinder spin 
density ratio inner : outer = 3 : 2, sampled at TE = 7 ms; Bottom row shows the 
cases when spin density ratio inner : outer = 1 : 2, at TE = 25 ms. 
 
2.4.2 Ex vivo experiments 
Figure 2.7 demonstrates dependence of the signal phase inside the optical nerve 
on gradient echo time TE. The data shows that the linearity of phase as function of 
TE is very good (R2 >0.99), which means that a set of echo times used in our 
experiments is not sensitive to the non-linear phase behavior observed in (64-66). 
Figure 2.8 and Figure 2.9 show examples of magnitude and phase images 
obtained from the optical nerve. 
 
0r
0r
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Figure 2.7 Representative examples of signal phase evolution along echo time at 
different angles (α) to B0. Experimental data.were taken from inside the optic nerve. 
The phase at TE=0 was set to zero. The solid lines are linear fits. All four data sets 
show good linearity.  
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Figure 2.8 Illustration of the results of zero-filling and Hanning filtering of data. 
Images shown are obtained while optic nerve is perpendicular to the B0 direction. 
Profiles through the center of the optic nerve are displayed. a) Profile directly 
resulting from IFFT of k-space data. b) Profile after Hanning filter was applied to a) 
to eliminate Gibbs ringing artifact. c) Profile after eight fold zero filling was applied 
to b) to increase digital resolution. e) Profile after only eight fold zero filling was 
applied to a), i.e., no Hanning filter. Magnitude and phase images corresponding to 
cases a) and c) are displayed in d) and f), respectively. 
 
 
Figure 2.9 An example of experimental data obtained from a fixed optic nerve. 
Upper row - magnitude images, middle row - corresponding frequency maps, and 
bottom row - frequency maps after field correction. Maps from left to right show 
9.8 Hz
- 9.8 Hz
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cross-sections of the optic nerve as the nerve was rotated from parallel to B0 to 
perpendicular to B0 in steps of 30 degrees.  
 
 
 
Figure 2.10 Example of the profiles of phase images after field correction. Profiles 
are drawn through the center of the nerve. Vertical scale is value of phase in 
radians, horizontal scale is pixel number in the image matrix. a) Profile along 
readout direction when nerve is parallel to B0; b) profile along phase encode 
direction when nerve is parallel to B0; c) profile along readout direction when nerve 
is perpendicular to B0; d) profile along phase encode direction when nerve is 
perpendicular to B0. 
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Field corrected profiles of the phase images for parallel and perpendicular cases 
are displayed in Figure 2.10. Profiles are taken through the center of the nerve in 
both horizontal and vertical directions. The frequency shifts described in Eq. [2.4] 
are clearly demonstrated here. When the nerve is parallel to B0, it does not induce 
frequency shift in the surrounding media, whereas when nerve is perpendicular to 
B0, it induces maximal frequency shift to the surrounding that decays as 1/r2. In 
agreement with theoretical prediction, the readout and phase encode directions 
show frequency shift with opposite signs [as cos(2θ) changes from 1 to -1].  
 
Magnetic Susceptibility Measurements 
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Figure 2.11 Angular dependencies of the frequency shifts for one fresh nerve and 
one fixed nerve. Filled circles - experimental data; lines - linear fits against 2sin α . 
Panels A) and C) are frequency shifts of inside nerve vs. surrounding media; B) and 
D) are coefficients in front of 20( / )r r  in Eq. [2.10] describing frequency shifts 
induced outside the nerve by magnetic susceptibility difference between nerve and 
surrounding media. 
Fitting Results [ppm] 2 ( )iso L eπ χ χ χ+ −  R2 
2 ( )iso eπ χ χ−
 
MWE R2 
Fresh 
nerve 
Rat 1 -0.043 0.978 -0.021 -0.003 0.99 
Rat 2 -0.050 0.999 -0.025 0.002 0.98 
Rat 3 -0.040 0.989 -0.0232 -0.003 0.91 
Average +/- 
std 
-0.044 ± 0.005  -0.023 ± 0.002 -0.001 ± 
0.003 
 
Fixed 
nerve 
Rat 1 -0.062 0.997 -0.052 -0.017 0.99 
Rat 2 -0.056 0.998 -0.049 -0.004 0.99 
Rat 3 -0.049 0.995 -0.035 -0.013 0.97 
Average +/- 
std 
-0.056 ± 0.006  -0.045 ± 0.009 -0.011 ± 
0.007 
 
Table 2.3 Summary of fitting results from three fresh and three fixed optical nerves 
without correction to radii of optic nerves. 
[ppb] 
Uncorrected 
     
Fresh Optic Nerve -7.0 ± 0.8 -3.5 ± 0.3 -3.4 ± 0.7 -2.2 -9.2 ± 0.8 
Fixed Optic Nerve -8.9 ± 1.0 -7.2 ± 1.4 -1.6 ± 0.6 0 -8.9 ± 1.0 
[ppb] 
Corrected 
     
Fresh Optic Nerve -7.0 ± 0.9 -3.5 ± 0.3 -3.3 ± 0.8 -2.2 -9.2 ± 0.9 
Fixed Optic Nerve -9.6 ± 1.7 -7.2 ± 1.4 -1.9 ± 0.5 0 -9.6 ± 1.7 
Table 2.4 Summary of magnetic susceptibilities calculated from Table 2.3. 
Numbers represent mean ± standard deviation.  
 
After background field is removed, dependency of the frequency shifts on 2sin α  is 
plotted in Figure 6. Fitting results from three data sets of both fresh nerves and 
0r
iso L eχ χ χ+ − iso eχ χ− Lχ e wχ χ− iso L wχ χ χ+ −
0r
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fixed nerves are recorded in Table 2.3. If the Lorenzian sphere approximation 
would be valid, the magnitude of the slopes in 0/i ef f−∆  vs. 
2sin α  plot and 
00
/ |e r rf f >∆  vs. 
2sin α  plot would have been the same. As we can see, none of the 
fresh nerve data agree with the prediction from the Lorentzian sphere 
approximation. Hence Generalized Lorentzian approach should be applied to 
explain our observations. For fresh nerve, the average result of 2 ( )iso L eπ χ χ χ+ −  
is (-0.044 ± 0.005) ppm, and 2 ( )iso eπ χ χ−  is (-0.023 ± 0.002) ppm. The 
subsequently estimated iso eχ χ−  and Lχ  are - (3.5±0.3) ppb and - (3.5±1.1) ppb, 
respectively. Further, the linearity of fittings is good, which means that the 4sin α  
term, as proposed in (57) to describe the susceptibility anisotropy, is negligible in 
our data. On the other hand, the magnetic susceptibility of longitudinal structures, 
Lχ , observed in fixed nerves is much smaller. Also note that the bulk susceptibility 
difference between nerve and surrounding media is consistently different for fresh 
nerve and fixed nerve by ~ 20%. This difference can be attributed to the difference 
in experimental conditions – fixed nerves were studied in 10% formalin solution 
while fresh nerves were studied in 1% PBS solution. To take into account these 
differences we measured magnetic properties of formalin and PBS and results are 
presented in section 2.6. While no measurable susceptibility difference between 
formalin solution and water was found, the susceptibility difference between PBS 
and water is - 2.2 ppb.  
Finally, the intercept of plot 0/i ef f−∆  vs. 
2sin α  is equal to 
4 ( )
3 iso e
MWEπ χ χ⋅ − +  
, Eq. [2.5], allows estimation of the water-macromolecule exchange effect in the 
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optic nerve. Result shows that MWE in fresh nerve is negligible, while MWE in fixed 
nerve is around 0.038 ± 0.007 ppm. These results however cannot be directly 
attributed to water-macromolecule exchange inside the optical nerve. Indeed, data 
in Appendix show that both formalin and PBS shift water frequency by non-
susceptibility mechanism.  
Possible error introduced by the data processing procedure is investigated in the in 
silico experiments. And a major source of error comes from image distortions as 
demonstrated in Figure 2.5 and Figure 2.6, which has significant effect on the 
measurement of radius of the optical nerve. If correct number for radius is used, the 
error of resulting bulk susceptibility measurement is within 0.2%. Since the data we 
use to fit curves described in Eqs. [2.9] and [2.10] are far away from the edge of 
nerve, this step should not be affected by the imaging distortion at the edge of 
nerve. And also according to Eq. [2.4], when nerve is parallel to B0, there will be no 
additional field outside nerve, which indicate least asymmetric distortion. We 
decided to correct the radius of nerve measured in parallel cases, and then use that 
as 'real r0' when calculating susceptibility. Corrections on r0 are applied to 
experimental data and reported for reference in Table 2.4.  
On the other hand, measurement of susceptibility from inside of the nerve is 
independent on the radius, and thus very accurate. Errors here might come from 
the fact that the nerve tissue actually has more than one frequency 
compartments(64-66). Though this effect is not apparent in our data, see Figure 
2.7. 
49 
 
2.5 Discussions 
It is generally understood that the MRI signal frequency shift induced in biological 
objects due to magnetic susceptibility effects is dependent on the objects bulk 
magnetic susceptibility and shape. However, this is not adequate to explain 
frequency shifts observed in brain white matter. For example, the Lorentzian 
sphere approach predicts equal slope magnitudes comparing a plot of  vs. 
 and a plot of 
00 , 0
/ |e r rf f θ= =∆  vs. . The fresh nerve results presented 
herein are clearly not in agreement with this prediction. The Generalized Lorentzian 
Approach (61) proposed that the underlying microstructure of the object at the 
cellular and sub-cellular levels should also be included in the model describing the 
MR signal frequency shift. This is especially important for brain structures such as 
white matter composed mainly from longitudinally arranged cells (i.e., neurons). 
Demonstrating this phenomenon in the brain is highly challenging because of 
complicated underlying structure and generally sufficient resolution of MRI 
experiments. Herein, the MR signal frequency shift induced by a tract of white 
matter was determined and compared to the predictions of two theoretical concepts 
– Lorentzian sphere approach and the generalized Lorentzian approach (cylinder 
model). The cylindrical geometry of isolated optic nerve, a tract of axonal bundles 
running parallel to each other, provides a well-defined shape that minimizes 
distortions in B0 and eliminated contamination from neighboring tissues. These 
attributes make it possible to accurately measure the bulk magnetic susceptibility of 
0/i ef f−∆
2sin α 2sin α
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freshly harvested optic nerve ( ) as well as the 
longitudinal component ( ). 
 
Quantitative measurement of frequency shifts is crucial for this study. Simulations 
generating in silico image data were performed to test the bias of post-processing 
procedures. As demonstrated in Figure 2.6, the transition point from inner cylinder 
to outer cylinder is greatly affected by imaging resolution and also field distortions. 
Similar profiles are also observed in ex vivo data (Figure 2.10). Moreover image 
definition of the circular edge of inner cylinder can be distorted when the cylinder is 
not parallel to B0 (Figure 2.5h’). Fitting data outside the nerve substantially distant 
from the transition point ( ) and then extrapolating the back to smaller r 
avoids this artifact and provides an accurate determination of 
. Employing the exact  and , the deviation 
between the derived susceptibility and the ‘true value’ (model parameter value(s) 
input to the simulation) is only 0.17%. 
With this insight gained from the simulations, the radius r0 of the nerve measured 
with cylinder parallel to B0, was used in combination with simulation results in Table 
2.2 to get “true r0” when calculating susceptibility since Eq. [2.4] shows that when 
the nerve is parallel to B0 there will be no additional field outside the nerve and thus 
the least asymmetric distortion. Experimental results on susceptibilities are reported 
with and/or without corrections on r0 in Table 2.4. Finally, although 
9.2  0.8 ppbiso L wχ χ χ+ − = − ±
3.4  0.7 ppbLχ = − ±
02r r>
2 2
02 ( ) siniso L e rπ χ χ χ α+ − ⋅ ⋅ 0r α
2sin α
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determined each time the tube was rotated is, of course, not be perfectly accurate, 
fitting to multiple measurements at 5 to 7 different values of  ensures the 
accuracy of the final result. While the frequency shift inside of the nerve is, in 
principle, independent of the nerve radius 0r , partial volume effects on the 
measurement were avoided by evaluating only the area for which 02r r< . 
 
Effects of magnetization exchange might also be a significant factor in determining 
the frequency shifts in the biological tissue (42, 55-56). In the experiments herein, 
magnetization exchange will contribute to the frequency shifts separately from the 
susceptibility effect. As magnetization exchange will not be dependent on the angle 
formed between nerve tissue and B0, it enters Eq. [2.5] as a constant term. In 
principle, these experiments should allow determination of the exchange effect, as 
described in “Results”. These findings, however, cannot be directly attributed to 
water-macromolecule exchange inside the optical nerve since data in the 
“Appendix” show that both formalin and PBS shift the water MR frequency by non-
susceptibility mechanisms and the volume fraction of either formalin or PBS that 
penetrates inside of the nerve is unknown.  
 
A multiple compartment model has been proposed to explain the MR frequency 
shifts between grey matter and white matter (64-66). The measurements obtained 
from voxels inside the optic nerve would need to be reexamined if multiple 
α
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frequency compartments were found to originate within one voxel. This 
phenomenon does not appear to be significant (Figure 2.7) within the TE range that 
used here. 
 
Anisotropic susceptibility of white matter has also been proposed to explain MR 
frequency shifts observed in white matter. Experimental data herein demonstrate 
that the MR frequency shifts observed in optic nerve tracts can be fully described 
by the generalized Lorentzian concept (Lorentzian cylinder model) in the absence 
of postulating an anisotropic susceptibility for white matter. 
 
2.6 Magnetic Susceptibility and Exchange Effects in External Media 
Separate measurement of susceptibility and exchange effects were performed to 
exclude the contribution from external media in our experimental setup. Since the 
fresh nerve was measured while suspended in 1% PBS solution, and fixed nerve 
was done in formalin.  
NMR Experiments: This experiment applied the method for simultaneously 
determining the susceptibility effect and exchange effect employed in a previous 
publication (Luo et al.) details of experiments can be found there (or in Chapter 3). 
A scheme employing coaxial tubes was employed. The inner tube (2mm outer 
diameter) was filled with water and 0.5% Dioxane; the outer tube (5mm outer 
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diameter) was filled with aqueous solutions containing either 1% PBS or 10% 
formalin (exact same solutions that were used in optic nerve experiments), 
including 0.5% Dioxane. MR experiments were conducted on a Varian INOVA 500-
MHz (11.74-T) vertical bore analytical spectrometer. Samples did not contain D2O, 
which is commonly used for field/frequency locking and shimming. A separate 
coaxial tube containing a D2O/H2O mixture was used for shimming (maximizing B0 
homogeneity). After shimming, the sample was loaded, and FIDs were collected. 
Radiation damping was minimized by detuning the receiver coil and employing a 
reduced filling factor (5 mm outer tube diameter in a RF coil greater than 10 mm in 
diameter). 
Results:  
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Figure 2.12 Results for formalin measurement. 
 
Figure 2.13 Results for PBS measurement. 
 
As spectra in Figure 2.12 and Figure 2.13 show, the MR frequency near 3.6 ppm is 
identified as dioxane and the peak near 4.7 ppm is identified as water. Regarding 
neighbor resonances originating from the same 1H species, the resonance with 
greater intensity is from species in the outer tube of the co-axial set, and the lower 
intensity resonance is from species in the inner tube. Since the dioxane MR 
frequency is considered reflective only of a susceptibility effect, the frequency shifts 
between dioxane in the inner and outer tubes reflects the susceptibility deviation of 
PBS or formalin solutions (here compared to pure water). Formalin did not induce 
discernible frequency shift on dioxane resonances, whereas PBS induced a -
0.0093 ppm shift compared to pure water. However, the 1H water MR resonance 
frequency is affected not only by the susceptibility effect, but also by other effects - 
pH, exchange with other labile protons, etc. Figure 2.12 shows that the principal 
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formalin 1H resonance has a frequency shift induced by non-susceptibility effects of 
+0.050 ppm. Figure 2.13 shows that the PBS solution has frequency shifts induced 
by non-susceptibility effects of -0.013 ppm. These results are important factors to 
consider when understanding the results of the current manuscript and other such 
experiments in fixed tissue. 
2.7 Conclusion 
The Generalized Lorentzian Approach well-describes the MR frequency shifts in 
white matter. Freshly harvested nerve and fixed nerve show quite different results 
for the longitudinal component of susceptibility, which suggest that care should be 
taken when analyzing phase data in fixed tissue and projecting findings to in vivo or 
freshly excised tissues. 
 
[  
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Chapter 3 Biophysical Mechanism behind MR Signal 
Phase – Exchange effect2  
 
3.1 Introduction 
Gradient recalled echo (GRE) MR phase images acquired at high magnetic field 
strength show remarkably enhanced contrast between gray matter (46) and white 
matter (WM) in human (3) and animal (43) brain. The contrast-to-noise ratio in MR 
phase images shows an almost 10-fold improvement over conventional MR 
magnitude images. Anatomic/functional structures that are not apparent on 
magnitude images can be visualized in phase images. Indeed, phase contrast has 
been explored for applications such as the study of multiple sclerosis (67) and 
Alzheimer’s disease (68). While the remarkable contrast observed at high field with 
phase imaging is provocative, the biophysical origins of this contrast are poorly 
understood. For example, phase variations have been observed across different 
brain regions (3), in both healthy and diseased brains. To fully quantify the 
anatomic, functional, and physiological information contained within phase images, 
it is crucial to understand the biophysical underpinnings of the MR “phase image” 
signal formation. 
                                               
 
2 All contents in this chapter have been published in Luo J, He X, d’Avignon DA, Ackerman JJH, Yablonskiy DA. 
Protein-induced water 1H MR frequency shifts: Contributions from Magnetic Susceptibility and Exchange. J. Magn. 
Reson. 2010; 202:102-108. 
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The MRI signal phase is determined by frequency shifts caused by multiple 
effectors. One group of effects relates to magnetic susceptibility variations within 
the tissue. Such tissue components as lipids (3), non-heme iron (3,69-71), 
deoxyhemoglobin in the blood (3,49,72), and proteins (53,73) were suggested as 
possible sources of susceptibility variation. Importantly, He and Yablonskiy (74) 
showed that the MR signal frequency shift depends not only on tissue chemical 
composition but also on tissue architecture at the cellular and subcellular levels 
(i.e., geometrical distribution of cells and structures within the cells). They proposed 
a new theoretical concept for evaluation of the frequency shifts that lead to tissue 
phase contrast between GM/WM/CSF. Their theory provides a means to predict 
tissue frequency shifts from the known tissue architecture and magnetic 
susceptibilities of proteins, lipids, tissue iron and deoxyhemoglobin in the blood. 
The derived shifts agree very well with the experimental results of Duyn et al. (3). 
Importantly, the work by He and Yablonskiy successfully explained the lack of 
phase contrast (3) between WM and CSF in the motor cortex area of the human 
brain. 
 
However, another mechanism - the water-macromolecule exchange effect - has 
been suggested as an alternate or contributing cause of GM/WM phase image 
contrast (42). The association of water and hydrophilic groups on the surface of 
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macromolecules, including labile 1H sites, and resultant exchange between “bound” 
and “free” water, is known to substantially contribute to the water 1H T1 and T2 
relaxation times due to the abundant macromolecular content in vivo, especially 
proteins (75-79). Although a water-macromolecule association/exchange 
mechanism cannot solely explain both the lack of contrast between CSF and WM 
(3) (protein contents are different - 10.9% in WM (24) and 0.015%~0.045% in CSF 
(80)) and the orientation dependence of phase contrast in white matter (43), it 
remains important to assess the roles of exchange vs. susceptibility in the 
formation of phase contrast. 
 
Proteins constitute one of the major components of brain tissue (~50% of dry tissue 
weight). Thus, it is reasonable to hypothesize that proteins could play a dual role – 
modulating both magnetic susceptibility and water-macromolecule exchange - in 
shifting the water MR frequency. Understanding the extent to which these roles are 
in play is important to quantitative interpretation of the contrast in GRE phase MR 
images. Hence, the major goal of this manuscript is to separate and scale the 
contributions of protein-induced magnetic susceptibility and exchange effects to the 
observed shifts in MR signal frequency. 
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3.2 Materials and Methods 
An aqueous solution of BSA (bovine serum albumin) was chosen as a model 
system to study the effects of protein content on the water 1H MR signal frequency. 
1,4-Dioxane ("Dioxane"), which has been reported to be an appropriate internal 
reference in protein solutions (81), was employed as an internal 1H MR frequency 
reference. 
3.2.1 Sample preparation 
To prepare a stock protein solution, 10g BSA (99% purity, Sigma, [CAS No. 9048-
46-8]) was dissolved in de-ionized water (with 0.5% v/v Dioxane) to a final volume 
100ml. The solution was clear to the eye, indicating the lack of residual insoluble 
components. Additional BSA samples were prepared from this stock solution by 
dilution with de-ionized water (which also contained 0.5% v/v Dioxane) to 
concentrations of 25, 50, 75, 100 mg (BSA)/ml (solution). The BSA volume fraction 
of the stock solution was calculated by weighing the volumetric flask before and 
after making the solution; from the mass of the BSA powder and the mass of the 
total solution, the mass of de-ionized water was determined. Knowing the density of 
water at the relevant temperature, the water and BSA volume fractions were 
derived. 
3.2.2 Mechanisms Affecting the 1H Water MR Signal Frequency 
The magnetic resonance frequency f  of a spin immersed in a homogeneous 
media containing macromolecules can be described by several additive 
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components: (i) a component 0 0f Bγ= ⋅ , the base Larmor resonance frequency, 
where γ  is the gyromagnetic ratio and B0 is the main static field, (cgs units are 
used throughout this paper), (82) a component fχ∆  due to the magnetic 
susceptibility of the media, (iii) a component ef∆  due to chemical exchange 
between free (bulk) water and bound water, typically that associated with 
hydrophilic groups on the surface (and perhaps interior) of macromolecules, and 
(83) a component -σf0 due to the local, electronic shielding provided by the “host” 
water molecule (shielding factor σ): 
 0 0    ef f f f fχ σ= + ∆ + ∆ − ⋅ . [3.1] 
 
The frequency component fχ∆  due to magnetic susceptibility for a homogeneous, 
isotropic liquid (media) can be described as a sum of two terms. The first term 
arises from the presence of the media’s external boundary: 
 0/f f A χ∆ = ⋅ , [3.2] 
where χ is the volume magnetic susceptibility of the media. Here for simplicity we 
only consider media whose boundary can be described by an arbitrary ellipsoidal 
shape. Hence, the magnetic field inside the boundary containing the media is 
homogeneous with the factor A depending on the specific shape of the media 
boundary (see the discussion in (62)). For example, if the media boundary forms an 
infinitely long cylinder, oriented with angle θ  between the cylinder's main axis and 
B0, 22 sinA π θ= − ⋅ , while for a spherical boundary 
4
3
A π= − . The second term 
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describes the frequency shift caused by neighboring molecules, which in the 
Lorentzian sphere approximation can be represented as: 
 0
4/
3
f f π χ∆ = ⋅ . [3.3] 
The concept embodied in the Lorentzian sphere approximation has played an 
important role in the evaluation of magnetic susceptibility effects on the MR 
frequency shift f∆ . It is based on the assumption that for a homogeneous, isotropic 
solution the microscopic local field acting on a spin can be evaluated as if this spin 
were moving inside a hollow sphere embedded in the magnetized media, while the 
media outside the Lorentz sphere can be modeled as a homogeneous and isotropic 
continuum. With these assumptions, the frequency shift f∆  in the presence of 
external static field B0 is described by Eq. [3.3]. It should be noted, however, that in 
biological tissues exhibiting anisotropic structure (i.e., white matter in the brain), the 
Lorentzian sphere approximation is no longer valid and a more general approach 
should be used (74). 
3.2.3 Measurement of the Magnetic Susceptibility of BSA 
A scheme employing orthogonal tubes was applied to measure the volume 
magnetic susceptibility of the BSA solutions (62). Standard, 5mm diameter, 7’’ long, 
glass "NMR tubes" were filled with degassed BSA solutions and sealed with 
parafilm. A given tube was first oriented parallel to the magnetic field and then 
perpendicular to the field. Under these conditions, the MR signal frequency 
difference between the two orthogonal orientations will be determined only by the 
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susceptibility effects created by the boundary of the tube (coefficient A in Eq. [3.2]). 
Any other factors remain constant and, thus, are cancelled out. 
 
During the experiment, since the tube is positioned in air instead of a vacuum, the 
frequency difference between the two orientations will be (the same for both water 
and Dioxane): 
 02 ( ) Bsolution airf π χ χ γ∆ = ⋅ − ⋅ ⋅ , [3.4] 
where 
 ( ) ( )solution water protein protein water Dioxane Dioxane waterχ χ ζ χ χ ζ χ χ= + ⋅ − + ⋅ −  [3.5] 
and ζ indicates the relevant solution-component volume fraction. Thus, by 
measuring f∆  at different volume fractions of BSA ( proteinζ ), the volume magnetic 
susceptibility difference between BSA and water ( protein waterχ χ− ) can be 
determined. Further, since waterχ  is a known parameter, the volume magnetic 
susceptibility of BSA can be determined. 
 
Susceptibility measurement experiments were performed on a Varian DirectDrive™ 
MR scanner based on a 4.7T horizontal-bore superconducting magnet with a 
21cm-bore inner-diameter gradient and shim assembly using a 1.5cm diameter, 
laboratory constructed, surface transmit/receive RF coil. A PRESS sequence was 
employed for localized shimming and data acquisition from a 4×4×4mm3 voxel 
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selected at the mid point of the cylinder's axial length. Forty minutes prior to 
initiating experiments, a thermometer and all the tubes to be scanned were 
positioned at one end of the magnet for temperature stabilization. As noted above, 
each sample tube was first oriented parallel to the magnetic field B0 and shimming 
was performed on the selected voxel. The 1H resonance frequencies of water and 
Dioxane were measured. Then, immediately following data acquisition, the tube 
was carefully rotated about the voxel position so as to align it perpendicular to the 
magnetic field and the signal frequencies were determined again. For both 
orientations, the shim settings (currents in the shim coils) and the voxel positioning 
were kept the same. At each orientation, thirty individual (not summed) free 
induction decays were acquired with 4,000Hz bandwidth, 3s data sampling period, 
and 10s TR. 
 
Frequencies for both water and Dioxane 1H resonances were determined 
separately for each of the 30 individual spectra using Bayesian probability analysis 
(84). During the 5min total acquisition time, the water frequency drifted about 
0.022ppm while the Dioxane frequency fluctuated around a mean ± SD of 7.1187 ± 
0.0002ppm, indicating that field drift was minimal. The water frequency drift was 
presumably reflective of a ~ 2°K temperature decrease (~ -0.011ppm/°K) (85)). }) 
associated with relocating the sample to the observation coil. If any untoward 
field/frequency shift was detected during the experiment, e.g., if a light rail train 
passed by the scanner site (the scanner is ~ 150' feet distant from the train track), 
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the experiment was repeated. The 1H resonance frequency of Dioxane (the mean 
of all 30 individually analyzed data sets) was used to determine the frequency 
differences between orthogonal orientations of the same sample contained in a 
given tube. 
 
3.2.4 Separation of magnetic susceptibility and exchange effects 
To separate susceptibility and exchange effects, a scheme employing coaxial tubes 
was employed. The inner tube (2mm outer diameter) was filled with aqueous 
solutions containing different concentrations of BSA, including 0.5% Dioxane; the 
outer tube (5mm outer diameter) was filled with water (no BSA) and 0.5% Dioxane. 
Accordingly, the magnetic susceptibility of the BSA solution in the inner tube was 
defined by Eq. [3.5], and the magnetic susceptibility of the reference solution (no 
BSA) in the outer tube is: 
 (1 )ref Dioxane water Dioxane Dioxaneχ ζ χ ζ χ= − ⋅ + ⋅ . [3.6] 
Since the orientation factor A in Eq. [3.2] nulls when both coaxial compartments are 
parallel to the B0 field, the 1H MR signal frequency shift induced by the 
susceptibility difference between inner and outer tubes is: 
 0
4 4/ ( ) ( )
3 3inner outer protein protein water
f f π πχ χ ζ χ χ∆ = ⋅ − = ⋅ ⋅ −  [3.7] 
Dioxane is not expected to undergo exchange or physically/chemically associate 
with BSA molecules. Thus, the frequency difference of Dioxane resonances 
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between inner and outer tubes is taken to reflect a pure susceptibility effect per Eq. 
[3.7]. However the water frequency difference between inner and outer tubes 
reflects both the protein induced susceptibility and exchange effects: 
 0
4/ ( )
3water e inner outer
f f f π χ χ∆ = ∆ + ⋅ − . [3.8] 
Note that ef∆  is also proportional to the volume fraction of BSA. Therefore, by 
subtracting the frequency shift of Dioxane from the frequency shift of water, the net 
frequency shift due to water-BSA exchange can be quantified. 
 
The coaxial tubes MR experiment was conducted on a Varian Inova 500MHz 
(11.74T) vertical bore high resolution spectrometer. The probe was equipped with a 
variable temperature controller and all samples were stabilized at a fixed 
temperature before and during the measurement. Data was acquired at two 
temperatures: 286.5°K (same as with the 4.7T imaging scanner) and 310°K (similar 
to body temperature). Samples did not contain D2O, commonly used for 
field/frequency locking and shimming. A separate coaxial tube containing a 
D2O/H2O mixture was used for shimming. After shimming, thirty individual free 
induction decays were collected on each of the relevant coaxial samples, with 
10,000Hz bandwidth, 2s acquisition time, and 10s TR. Radiation damping was 
eliminated by detuning the receiver coil and employing a reduced filling factor (5mm 
outer tube diameter in a RF coil greater than 10 mm in diameter). 
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Because data were acquired without a field/frequency lock, and there was not 
enough SNR for accurate evaluation of the Dioxane frequency in the inner tube 
from a single acquisition, the following procedure was used to correct for field drift. 
In each data set composed of 30 individual FIDs, the first FID acquired was used 
as a reference; the frequency shift caused by field drift was calculated by 
comparing the phase of the water signal in each of the 29 subsequent FIDs to the 
reference FID. The time domain data from each individual acquisition were then 
frequency shifted correspondingly and averaged (sum of 30 FIDs) after this 
correction. The frequencies of each resonance (water and Dioxane) in the coaxial 
tubes were determined from the summed FIDs for different protein concentrations 
using Bayesian probability analysis (84). 
 
3.3 Results 
Examples of water and Dioxane spectra obtained in an orthogonal tubes 
experiment and a coaxial tubes experiment are shown in Figure 3.1a and b. Double 
peaks for water and Dioxane can be observed for the coaxial tubes experiment. 
These peaks correspond to water and Dioxane in the outer (large amplitude 
signals) and inner tube (small amplitude signals) compartments. 
67 
 
    
a)                                                                  b) 
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Figure 3.1 Examples of spectra (line broadening apodization filter of 1Hz) obtained 
from the orthogonal tubes experiment. (a), and the coaxial tubes experiment after 
averaging (b). The Dioxane resonances are shown vertically expanded (50x) in the 
insets. Both experiments were carried out at the same temperature (286.5°K) and 
the protein solutions in both experiments contained 7.5% (v/v) BSA and 0.5% 
Dioxane. Resonance frequencies were determined by Bayesian probability analysis 
(84). Estimated uncertainties of resonance frequencies in (a) are: 1.3E-5 ppm for 
water and 2.5E-4ppm for Dioxane. Estimated uncertainties of resonance 
frequencies in (b) are: outer-tube water 1E-5ppm, inner-tube water 3.9E-5ppm, 
outer-tube Dioxane 9.7E-5ppm, inner-tube Dioxane 1E-3ppm. 
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Figure 3.2 The dependence of magnetic susceptibility induced MR signal frequency 
shifts on protein volume fractions. solutionf∆  is the Dioxane MR signal frequency 
difference between cylindrical NMR tube orientations parallel and perpendicular to 
B0 in the rotating tube experiment. 
 
Figure 3.2 illustrates the observed frequency difference in the orthogonal tubes 
experiment at different protein concentrations. Fitting Eq. [3.4] to the solutionf∆  vs. 
volume fraction of BSA data yields (mean ± SD): protein waterχ χ−  = (-0.107 ± 0.009) 
ppm and ( )water air Dioxane Dioxane waterχ χ ζ χ χ− + ⋅ −  = -(0.7513 ± 5E-4) ppm. Given the 
susceptibility of water (-0.719ppm (86)), the estimated volume magnetic 
susceptibility of BSA can be derived: 
 ( 0.826 0.009)ppmBSAχ = − ± . [3.9] 
 
Further, given Dioxaneχ = -0.596 ppm (86), the magnetic susceptibility of air can be 
derived, airχ  = (0.0317 ± 5E-4) ppm. The positive magnetic susceptibility of air is 
caused by the presence of O2, which is paramagnetic. This result is in excellent 
agreement with the susceptibility of oxygen in air as estimated from first principles 
using the Curie law, oxigenχ  = 0.0316 ppm, given the known molar magnetic 
susceptibility of pure O2 ( 3 12( ) 3372m O ppm cm molχ
−= ⋅ ⋅  at 13°C (86)) and its 
volume fraction in air (21%). While this effect is small, it should be taken into 
account for accurate measurements of magnetic susceptibility. 
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Figure 3.3 1H MR signal frequency difference of water (triangles) and Dioxane 
(squares) between inner and outer coaxial tubes 0( ) /inner outerf f f−  measured at 
13.5°C (solid symbols) and 37°C (open symbols). Lines represent linear 
regressions. The slopes of the fitted lines are: ( 0.45 0.03) [ppm]− ±  for Dioxane, 
and ( 0.28 0.03) [ppm]− ± for water at 13.5°C; ( 0.445 0.03) [ppm]− ±  for Dioxane 
and ( 0.216 0.004) [ppm]− ± for water at 37°C. 
 
Figure 3.3 shows the 1H MR signal frequency difference between inner and outer 
tubes for water and Dioxane in the coaxial tubes experiment at two temperatures. 
Note that the 1H frequency shift of water is the sum of the magnetic susceptibility 
effect and the water- exchange effect. Since Dioxane does not associate with BSA 
71 
 
(vide infra), the frequency shift of Dioxane can be attributed solely to a susceptibility 
effect: 
 0 0/ | / | (0.45 0.03)  ppmsusceptibility Dioxanef f f f ζ∆ = ∆ = − ± ⋅ . [3.10] 
 
As calibrated by Dioxane's pure susceptibility induced frequency shift, a BSA 
induced susceptibility effect will decrease the water 1H resonance frequency. This 
is in agreement with our previous orthogonal tubes measurement.  
 
Having quantified the magnetic susceptibility effect, the contribution of water-BSA 
exchange to the water MR signal frequency shift can be estimated by subtracting 
susceptibility frequency shifts from the observed water frequency shifts: 
at 13.5°C: 0 0 0/ | / | / | (0.17 0.03)  ppmexchange water Susceptibilityf f f f f f ζ∆ = ∆ −∆ = ± ⋅ , [3.11] 
at 37.0°C: 0 0 0/ | / | / | (0.23 0.03)  ppmexchange water Susceptibilityf f f f f f ζ∆ = ∆ −∆ = ± ⋅ . [3.12] 
 
Hence, water exchange/association with BSA increases linearly with protein 
concentration as would be expected. It results in a frequency shift in opposite 
direction to that caused by protein susceptibility. 
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3.4 Discussion 
The present work examines the homogenous model system of a native protein in 
solution. Two mechanisms through which proteins affect the water 1H MR signal 
frequency are considered: magnetic susceptibility and water-protein 
exchange/association. The magnetic susceptibility of a substance is related to the 
electronic structure of its atoms. Protein density (g/ml) is greater than that of water. 
The presence of proteins in aqueous solution increases the density of circulating 
electrons (within molecular orbitals), thus making the solution more diamagnetic. 
(Recall, diamagnetism is related to changes in the molecular electron currents 
induced by the magnetic field.) According to Eq. [3.10] this decreases the water 1H 
MR signal frequency. Water-protein exchange can be envisaged as a rapidly time 
modulated interaction/association between water and multiple exchangeable sites 
on protein residues (primarily –NH-, -NH2, -OH, -SH and –COOH). The overall 
effect is a shift of the water 1H MR signal to higher frequencies. On a protein 
volume fraction basis, the susceptibility effect is twice that of, and in opposition to, 
the exchange effect. As shown in Figure 3.3, the susceptibility induced frequency 
shift is not affected by temperature (as expected because small temperature 
variations have little effect on molecular electronic structure), while the exchange 
induced frequency shift is affected by temperature. This is also expected because 
temperature influences the rates of kinetic processes including protein 
conformational dynamics, which consequently alters exchange/association 
phenomena between water and protein (87). 
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As noted above, in native BSA solution at 37°C the amplitude of the exchange 
effect is one half and opposite in sign to that of the susceptibility effect. It is likely 
the water-protein exchange effect is even smaller in biological tissues where 
proteins are often cross-linked, associated with membranes or other proteins and 
sites for water association are reduced in number. Indeed, as a globular protein, 
BSA has a hydrophobic core and a hydrophilic surface, which makes it soluble in 
water. Its structure is representative for a large group of proteins: hemoglobulins, 
immunoglobulins, albumins, enzymes, etc. Considering brain in vivo, apart from the 
soluble proteins, the other major protein class is insoluble in water (88-90), namely, 
fibrous proteins (scleroproteins), which form neurofilaments and microtubules, etc. 
These proteins are found as aggregates due to hydrophobic groups that stick out of 
the molecules, providing mechanical strength and rigidity for the tissue as well as 
for physiological functions. Due to their aggregated structural features, protons on 
the surface of fibrous proteins are more likely to have very short 1H T2 relaxation 
time constants, further resulting in a reduction of water frequency shifts due to 
exchange effects. Hence, comparing with the model native protein solution 
employed herein, it is likely exchange effects in vivo will contribute even less to the 
water MR signal frequency shift. At the same time, protein contribution in vivo to 
tissue magnetic susceptibility will remain the same as measured herein. (The 
reader is reminded that the contribution of highly anisotropically organized protein 
structures to the water 1H MR signal frequency shift cannot be described in terms of 
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the Lorentzian sphere approximation, Eq. [3.3], a more general approach must be 
applied (74).) 
 
This method employed herein for separating magnetic susceptibility and exchange 
effects relies on having a reliable internal reference, Dioxane, that does not 
interact/associate with BSA. Several lines of evidence support the choice of 
Dioxane for this purpose. First, the Dioxane 1H MR signal in the compartment with 
BSA showed no line broadening, consistent with a lack of significant 
interaction/association between Dioxane and BSA. Second, measurements of 
Dioxane frequency shift vs. protein concentration at 13.5°C and 37°C (see Figure 
3.3) showed no temperature dependence, again consistent with a lack of significant 
interaction/association between Dioxane and BSA (as was not the case for water, 
Figure 3.3). Third, comparison of results obtained in the orthogonal tubes 
experiment with those from the coaxial tubes experiment further confirms that 
Dioxane exhibits no (or negligible) interaction/association with BSA. Indeed, we 
have determined from the orthogonal tubes experiment that the magnetic 
susceptibility of BSA is ( 0.826 0.009)ppmBSAχ = − ± , see Eq. [3.9]. Substituting this 
value into Eq. [3.7] we can predict that the frequency shift of the Dioxane MR signal 
between inner and outer compartments in the coaxial tubes experiment should be 
0( / ) (0.45 0.04)  ppmDioxanef f ζ∆ = − ± ⋅ . This follows only if the frequency shift of the 
Dioxane signal is solely due to the magnetic susceptibility effect. Direct 
measurement as described in Eq. [3.10] is in an excellent agreement with this 
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prediction. That is, the frequency shift of Dioxane between inner and outer tubes is 
not affected by exchange/association with BSA, and reflects a pure susceptibility 
effect. 
 
Although some studies suggest that Dioxane and water could affect each other’s 
frequencies by ‘bifunctional hydrogen bonds’ (91), the absolute frequencies of 
Dioxane and water are not important in these measurement. Further, the same 
Dioxane concentration is maintained in both inner and outer coaxial tubes, thus the 
frequency difference between the two coaxial tubes is due solely to protein content. 
 
These quantitative results regarding volume susceptibility are reported with respect 
to the volume fraction of BSA, which was calculated based on directly weighing 
protein powder and the measurement of solution volume. The estimated protein 
density in our solution was 1.332 g/cc, which is lower than the density of fully “dry” 
serum albumin reported as 1.381 g/cc (92). It is known, however, that crystalline 
protein is likely to contain approximately 10% (w/w) of water (83). Hence, from the 
density difference we can estimate that the water content in our purchased BSA is 
10.6% (w/w) – similar to previously reported. Accordingly, we can recalculated the 
volume susceptibility of “pure” BSA as ( ) 0.841pure BSA ppmχ = −  and the gram 
susceptibility as 
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 ( ) 0.609 [ / ]g pure BSA ppm ml gχ = − , [3.13] 
which is in good agreement with previously reported “common gχ  value” of 
proteins: -(0.587 ± 0.005)*10-6ml/g (93). Using the corrected value, we can re-
examine the contribution of “pure” proteins to the water MR signal frequency shift at 
37°C: 
 
0
0
/ 0.51  ppm
/ 0.26  ppm
puresusceptibility
pureexchange
f f
f f
ζ
ζ
∆ = − ⋅
∆ = ⋅
 [3.14] 
 
The possible role of water-protein exchange effects in the formation of 1H water MR 
signal frequency shifts was first addressed by Zhong et al. (42). Data presented 
herein are different from their results, which utilized TSP as an internal reference. 
While TSP is broadly used in high resolution 1H NMR experiments, our 
experimental data (see Appendix) suggests that TSP exhibits significant interaction 
with BSA. The line width of TSP in the coaxial tube with BSA is largely broadened 
compared to the line width of TSP in the coaxial tube without BSA. The frequency 
shift of TSP between the two coaxial tubes per unit volume BSA (-1.03 ± 0.07ppm) 
does not match the susceptibility effect determined by our orthogonal tube 
experiment (-0.45 ± 0.04 ppm), indicating the TSP frequency shift results from more 
than just the susceptibility effect of BSA. It is well known that an important function 
of serum albumin is to bind long-chain fatty acids and other like molecules, serving 
as a major transporter for free fatty acids via the plasma (94,95). Although the TSP 
is only equivalent to a 5-carbon chain, it is possible that BSA weakly binds with 
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TSP, resulting in a certain degree of exchange driven frequency shift. Earlier 
studies have reported that the chemical shift of TSP was dependent on the protein 
concentration ((81)). 
 
3.5 Conclusion 
In this study, the effects of protein content on water 1H frequency shifts were 
examined. These shifts will contribute to the phase shift in vivo at high field. Two 
previously suggested mechanisms were determined separately and quantitatively 
by an experiment employing coaxial tubes and native protein (BSA) solutions. 
Results indicate that the protein susceptibility effect is twice that of, and in opposite 
direction to, the exchange effect. Excellent agreement between protein 
susceptibility measurement employing coaxial tubes and measurement employing 
an orthogonal tube protocol confirmed that Dioxane is a reliable marker for 
separation of magnetic susceptibility and exchange effects. This is further 
supported by a frequency shift, temperature dependence study. These 
experimental findings with native protein solution provide insights into the influence 
of protein content on water 1H MR signal frequency. For structurally cross-linked 
proteins in vivo, the susceptibility effect is expected to play an even more 
substantial role in affecting the water 1H MR frequency. 
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3.6 Line-broadening interaction between TSP and BSA 
TSP (2,2,3,3-tetradeuterio-3-trimethylsilyl-propionate, 0.5% (w/w), 29mM) powder 
was added to the BSA stock solution and a control solution without BSA. The same 
experiment employing coaxial tubes as described in the main text was conducted to 
compare the TSP 1H MR signal frequency change with that of Dioxane. However, 
the BSA solution was placed in the outer tube for improved detection (TSP has a 
broad line width in the presence of BSA). 
 
 
Figure 3.4 Spectrum (line-broadening apodization filter = 1Hz) from experiment 
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employing coaxial tubes. Concentric tubes were positioned parallel to the B0 field, 
with temperature stabilized at 37°C. The solution in the outer tube contained 7.5% 
(v/v) BSA, 0.5% Dioxane, and 0.5% (w/w) TSP; the solution in the inner tube 
contained 0.5% Dioxane and 0.5% (w/w) TSP. Dioxane and TSP resonances are 
vertically expanded (50x) in the insets.  
 
Figure 3.4 demonstrates a significantly broadened TSP resonance in the presence 
of BSA. Line broadening is not observed for the Dioxane resonance. With regard to 
the frequency shifts at this particular protein concentration: TSP is shifted by -
0.072ppm whereas Dioxane is shifted by -0.031ppm. If TSP is taken as an internal 
reference and the BSA exchange effect on signal frequency is calculated, it would 
be +0.055ppm instead of +0.015ppm (using Dioxane as reference), a substantial 
systematic error. 
[  
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Chapter 4 Gradient Echo Plural Contrast Imaging 
(GEPCI) – Basic and Derived Contrasts3 
 
4.1 Signal Model and Data Processing of GEPCI 
4.1.1 Multi-channel data processing  
Multi-channel data were combined using a generalization of previously developed 
algorithm (82) that allows for the optimal estimation of quantitative parameters, 
such as MR signal decay rate constants. In original implementation it was assumed 
that the data from different channels are already phased coherently. Applying this 
algorithm for multi-gradient echo signal obtained from an M-channel RF coil, we get 
the following result:  
 1
1
1( ) ( ) ( )
M
comb n m m m n
m
S TE S TE S TE
M
λ
=
= ∑  [4.1] 
where index n enumerates gradient echoes, index m enumerates RF channels, 
( )comb nS TE  is a combined signal corresponding to the gradient echo time TEn, 
( )m nS TE  are signals from individual channels, and parameter mλ  is 
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 [4.2] 
                                               
 
3 Most contents in this chapter have been published in Luo J, Jagadeesan BD, Cross AH, Yablonskiy DA. Gradient 
Echo Plural Contrast Imaging – Signal model and derived contrasts. NeuroImage 2012; 60:1073-1082 
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Here mσ  are noise amplitudes (r.m.s.) in corresponding channels (m). They are 
calculated by averaging data from 10x10 pixel area in the corner of magnitude 
images ( )m nS TE . Since noise levels of each acquisition (echo times) are similar, 
they are subsequently averaged to obtain mσ  for a single channel. The Rician 
nature of noise in magnitude images does not affect estimate of parameters mλ  
since they are ratios of 2mσ . The parameters mλ  provide additional signal weighting 
and reduce contribution of RF channels with high noise level.  
Generalizing this consideration for complex data leads to the following algorithm for 
data combination: 
 1
1
1( ) ( ) ( )
M
comb n m m m n
m
S TE S TE S TE
M
λ
=
= ∑  [4.3] 
where 1( )mS TE  is a complex conjugate of the signal from channel m at the first 
gradient echo time TE1. Since signal phases of different channels differ by their 
initial values 0mϕ  but have the same frequency f, as described in   
 0( ) 2m n m nTE f TEϕ ϕ π= + ⋅  [4.4] 
this procedure removes destructive interference of data due to the term 0mϕ  from 
multiple channels. The procedure described by Eq. [4.3] is applied to each voxel in 
the image. 
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4.1.2 Phase Unwrapping and Multi-channel data  
In order to generate GEPCI images, data from multi-channel RF coil should first be 
combined in a single data set. Figure 4.1 demonstrates the phase unwrapping and 
channel combination procedure proposed in this manuscript (see detail description 
in the Methods section). From phase maps shown in the top two rows of Figure 4.1, 
we can see that combining phase images from different channels requires solving 
two problems. First, individual receivers have different phase offsets, as described 
in Eq.[4.4]. To address this issue,for each voxel we multiplied signal from each 
channel by the complex conjugate of data from the first echo of the corresponding 
channel, thus eliminating the phase offsets of each receiver coil. Data from all 
channels were then averaged with their sensitivity weighting per Eq.[4.3] to achieve 
optimal SNR with minimum error in parameters estimate (82). Second problem is 
that phase images are affected by ‘wraps’, where jumps of 2π happen between 
adjacent voxels due to phase values of 2πm + θ (m is integer) are encoded as 
identical. This problem becomes more pronounced at longer echo times. Usually 
phase unwrapping is accomplished in the image domain, where different algorithms 
have been used (see for example (96,97)). Here we take advantage of having 
gradient echoes corresponding to multiple TE and unwrap signal phase in the time 
domain for each imaging voxel. Frequency maps were then generated by fitting 
phase data for each voxel as function of the gradient echo times per Eq. [4.4]. Note 
that difference in wrapping pattern in the phase image corresponding to different 
TE does not affect this fitting procedure and resultant frequency maps. Though for 
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areas of the brain with strong field inhomogeneities additional unwrapping of the 
frequency map in the image domain might be required, this was not the case in any 
of our data.  
 
Figure 4.1 Example of the phase images before and after channel combination 
procedure. Top two rows show phase images at TE equals 4 ms, 12 ms, 20 ms, 28 
ms from 2 different channels; Third row shows combined phase images obtained 
after channel combination according to Eq. [4.3]. First image in this row is zero 
because the phase of the first echo is compensated during channel combination. 
Bottom row shows phase images after unwrapping in the time domain as discussed 
in the methods section.  
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4.2 Experiment Protocol of Gradient Echo Plural Contrast Imaging 
Brain images were collected from 5 healthy volunteers and one subject with 
Relapsing-Remitting MS who underwent brain MRI studies on a Siemens 3T Trio 
MRI scanner (Siemens, Erlangen, Germany). A 12-Channel phased-array head coil 
was used to obtain a 3D version of the multi gradient echo sequence with a 
resolution of 1x1x2 mm3 or 1x1x3 mm3, FOV of 256 mm x 192 mm and 11 gradient 
echoes (TR = 50 ms; minTE = 4 ms; delta-TE = 4 ms; bandwidth = 510Hz/Pixel; FA 
= 30°). Further effective resolution enhancement was achieved with zero-filling in k-
space. Standard SWI images were also acquired with the same resolution and 
TR=27 ms, TE=20 ms, bandwidth 120Hz/Pixel, FA=15° for healthy volunteers; and 
standard FLAIR images were acquired for the MS patient with resolution 1.3x0.9x3 
mm3 by turbo spin echo sequence: TR=10 s, TI=2600 ms, TE=82 ms, turbo factor = 
13, Echo trans per slice = 15. All studies were conducted with the approval of 
institution IRB.  
 
4.2.1 Protocol Optimization 
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Figure 4.2 Comparison between signals result from TR = 40 ms (black) and TR = 
50 ms (blue). Circles represent gray matter; triangles represent white matter.  
 
Since in GRE it takes very long TR to get proton density weighting, in GEPCI, S0 is 
targeted to be T1 weighted. We are trying to find an optimal combination of TR and 
flip angle for contrast between gray matter and white matter within reasonable time, 
and with sufficient SNR. From Figure 4.2, it is obvious that TR 50 ms gives both 
better signal and contrast than TR 40 ms. From Figure 4.3, we can get some 
phenomenological information on the GM/WM contrast. Black lines represent signal 
intensity of GM (from a single channel, before combining) and blue lines represent 
signal intensity of WM. A series of signals from 6 echoes are displayed. As we can 
see, the contrast between gray matter and white matter switches at around α = 18o, 
which is also when signal reaches maximum. As α increases, contrast between GM 
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and WM increases yet signal intensity decreases. Flip angle of 30o was finally 
selected for the best contrast-to-noise ratio (CNR), with TR of 50 milliseconds.  
 
Figure 4.3 Signals in different echoes TR = 50 ms. Blue lines represent white 
matter; black dotted lines represent gray matter.  
 
 
4.3 Basic Contrasts of GEPCI 
4.3.1 Generating basic GEPCI images 
Combined data are analyzed assuming mono-exponential signal decay and taking 
into account Eqs. [4.3] and [4.4]: 
 2 1 1*( ) 2 ( )20( ) n n
R TE TE i f TE TE
comb nS TE S e e
π− + −= ⋅ ⋅  [4.5] 
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Before fitting Eq. [4.5] to complex data (magnitude and phase images), the phase 
data were unwrapped for each voxel in a time domain using 11 data points (TEn). If 
the frequency for some areas is high enough to cause multiple phase wraps within 
delta TE (that is 250Hz for our delta TE of 4 ms), then after time domain 
unwrapping there will be isolated areas in the frequency map that should be further 
unwrapped in spatial domain. Though most parts of the brain frequency map gets 
unwrapped already after the time domain procedure. The fitting procedure 
produces three naturally co-registered basic GEPCI images: a quantitative 
R2*=1/T2* map, a T1-weigted (S0) image and a frequency (f) map. The frequency 
maps are then subsequently high-pass filtered to remove effects of macroscopic 
field inhomogeneities. Herein we use a 7x7 (out of 256x256) averaging matrix. Note 
that this filter is a rough approximation. Application of recently proposed advanced 
phase processing methods, e.g. SHARP method (98) or the projection onto dipole 
fields (99), could result in a more accurate removing of the artifacts related to 
macroscopic field inhomogeneities. 
 
4.3.2 Basic GEPCI images 
Example of basic GEPCI images is shown in Figure 4.4. The frequency map 
presents significantly different contrast from the corresponding magnitude image 
(T1w) or the R2* map. White matter (WM) showed up darker than the cortex and 
caudate, putamen in the deep grey matter area on frequency map; this contrast is 
reversed on T1w image; on the R2* map however, WM showed up darker than the 
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caudate and putamen, although still brighter than the cortex region. The nature of 
WM “darkness” on phase images was explained in (61) based on the introduced 
there Generalized Lorentzian approach. According to this theory, the longitudinal 
structures (myelin sheaths, axons, neurofilaments, etc.) that comprise WM do not 
contribute to the total frequency shift for the cylindrical axonal tracts even though 
WM has higher magnetic susceptibility than the GM. The frequency map allows 
superior delineation of the caudate, internal capsule, pallidum and putamen, 
whereas the differentiation is not as clear on T1 weighted image or R2* map. Grey 
matter/White matter boundaries are also clearly depicted on frequency maps. 
These results are similar to previously reported with high field MRI (3). 
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Figure 4.4 Example the basic contrast images generated by GEPCI technique from 
two axial brain slices (first and second rows). Lower row shows detail picture of the 
part of the images identified by a square. As described in Eq.[4.5], S0 is the T1w 
image, R2* map is derived from the magnitude of the signal decay, and the third 
image is a frequency map (f). The scale bar shows distribution of frequencies. 
Structures pointed out on the frequency map are: 1) Optic Radiations, 2) Splenium 
of Corpus Callosum, 3) Caudate, 4) Internal Capsule, 5) Putamen, 6) Pallidum, 7) 
Internal Capsule. 
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4.4 Derived Contrasts of GEPCI  
4.4.1 Generating secondary derived GEPCI images  
Several derived images can also be generated based on these basic GEPCI 
images. First, a positive Frequency contrast Mask (FM) is created by setting 
negative frequency values to unity, and normalizing positive frequency values to be 
ranged from 0 to 1, such that 1 corresponds to zero frequency and 0 corresponds 
to highest frequency. This procedure is similar to creating phase masks in standard 
SWI procedure (100).  
 
4.4.1.1 SWI-like images are generated using the following equation 
 2* 40( )
R TE
SWI likeS TE S e FM
− ⋅
− = ⋅ ⋅  [4.6] 
Here the T1 weighted image S0 is T2* weighted with a certain TE (we used 
TE=20ms, which is typical echo time used for the SWI sequence on 3T systems) 
and is multiplied 4 times by the frequency mask (FM), which generates an image 
that mimics the standard SWI contrast (100).  
 
4.4.1.2 GEPCI-SWI images are generated as follows 
 2* 4( ) R TEGEPCI SWIS TE e FM
− ⋅
− = ⋅  [4.7] 
GEPCI-SWI images are free from T1 contrast contamination characteristic to the 
standard SWI because they are generated using pure T2* weighting and phase 
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contrast without S0 term. Here we also use TE=20ms and multiply the magnitude 
image 4 times with a frequency mask just as in original SWI (100).  
Minimum intensity projection (minIP) images using seven slices were also 
calculated for both the SWI-like and the GEPCI-SWI images.  
 
4.4.1.3 GEPCI-T1f images  
GEPCI-T1f images are derived by using only T1-weighted image (S0) and 
frequency contrast mask:  
 41 0GEPCI T FS S FM− = ⋅  [4.8] 
In these images GM/WM contrast is enhanced. 
 
4.4.1.4 Fluid Suppressed T2* images (FST2*) 
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Figure 4.5 An example of the histogram of GEPCI T1w image. Different brain tissue 
components are indicated on the histogram：white matter (WM), grey matter (46), 
cerebrospinal fluid (CSF). X0 is the position of the WM peak. The vertical line 
indicates selected threshold that is used for CSF suppression in the FST2* images. 
 
The goal here is to produce FST2* images that are T2* images with suppressed 
CSF signal that would “look similar” to FLAIR (fluid attenuated inversion recovery) 
T2 weighted images. Standard FLAIR-T2 images are obtained by using a long 
inversion pulse that suppresses the signal from CSF (long T1 component), and a 
long TE that produces heavy T2 weighting (101). To produce FST2* images we 
create a CSF mask (MCSF) using the T1-weighted image (S0). The S0 image is first 
processed by FMRIB’s Automated Segmentation Tool (FAST) (102-104) to remove 
the bias in image intensity caused by RF field inhomogeneities. Example of the 
distribution of the corrected S0 values (T1w image) is plotted in a histogram, Figure 
4.5; the signal intensities are ranked as S(WM)>S(46)>S(CSF), thus highest peak 
on the right corresponds to WM. Gaussian fitting was done on the right half of the 
main peak in this histogram determining peak position, X0, and standard deviation, 
STD. This allows thresholding of CSF signal. In this paper voxels that have S0 
values that are bigger than (X0 – 1.96 * STD) were considered as non-CSF area 
and their values were set as unity in MCSF mask. Voxels with intensity below (X0 – 
1.96 * STD) were normalized from 0 to 1, so that the darkest-appearing voxels on 
T1w image is 0, and brightest-apprearing voxels (those that are close to gray 
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matter) is 1. The FST2* images are produced by multiplying the T2* map with the 
CSF mask n times. 
 2* 2 *
n
FST CSFS T M= ⋅  [4.9] 
Since the voxels that are set to 1 in the mask will not get much attenuation in the 
resulting image, the threshold should be selected within the grey matter area to 
achieve a better suppression of CSF signal. In this manuscript we have compared 
several choices of parameter n (1~4). The optimal choice of threshold and ‘n’ is 
subject to further discussion. These images look like FLAIR images in the way that 
they have essentially T2* contrast (similar to T2 weighting) with strongly attenuated 
CSF signal. 
 
4.4.1.5 T2*-SWI Images 
In some applications like multiple sclerosis (MS) it might be advantageous to 
generate images that simultaneously show venous structure and T2 hyperintense 
lesions (105). Using GEPCI, this can be achieved by combining GEPCI-SWI and 
GEPCI FST2* images. Indeed, GEPCI-SWI data shows veins as dark contrast but 
are insensitive to hyperintense lesions. On the other hand, T2 hyperintense lesions 
are also hyperintense on FST2* images. We found that good visualization of the 
combined distribution of T2 hyperintense lesions and veins (and possible iron 
deposition) is achieved by multiplication of FST2* and GEPCI-SWI images so that 
T2 hyperintense lesions are contrasted by hypointense veins running through: 
94 
 
 2* 2*FST SWI FST GEPCI SWIS S S− −= ⋅  [4.10] 
It can also be applied to assess vascularity of tumors where tumors are bright on 
FST2*, and vascular structures inside tumors are dark.  
 
4.4.2 Results of Derived Images  
4.4.2.1 GEPCI-SWI and SWI-like Images 
In this study, by combining basic GEPCI data sets in a manner analogous to 
standard SWI approach, we generated SWI like images and compared them to the 
Siemens scanner generated SWI data (Figure 4.6A and 4.6B). The images 
resulting from the standard SWI sequence were as usually contaminated by T1-
weighting. This remains the case when GRE with several gradient echoes is used, 
although multi gradient echo approach allows increasing the signal to noise ratio 
(SNR) and contrast to noise ratio (CNR) of brain SWI images (106). The most 
obvious consequence of this T1 contamination is the ‘dark CSF’ area, particularly in 
the mIP images, which reduces contrast between the veins and CSF (Figure 4.6A 
and 4.6B). One way to resolve this issue was suggested by Haacke et al (107), that 
is to use small flip angles to minimize darkening of CSF area. Imaging parameter 
on 3.0T MRI scanner was proposed: FA 12-17 degrees, TR 25-35 ms, TE 20 ms, 
BW 80-100 Hz/pixel. As our images showed, although imaging parameters we 
used for the standard SWI imaging is within the recommended range, additional 
adjustments shall be made to get desirable SWI contrast. Further, using small flip 
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angle to minimize darkening of CSF area will inevitably result in loss of grey white 
contrast on the SWI images.  
Using GEPCI approach allows overcoming this problem without losing signal. 
Indeed, GEPCI data were acquired with imaging parameters that maximize the T1-
weighted contrast for S(108) as well as preserving SNR characteristic for optimal 
flip angle. In contrast to the SWI–like images and the standard scanner generated 
SWI images, GEPCI-SWI images had preserved bright CSF signal as well as 
preserved GM/WM contrast. This phenomenon maybe particularly useful in 
characterizing the deep veins in the area of the lateral ventricles. Such information 
about the deep veins is likely to be useful in surgical planning for patients who are 
set to undergo procedures such as placement of deep brain stimulators (109). Note 
that, the GEPCI-SWI image is as sharp as or even sharper than conventional SWI 
images with regard to vessel delineation. Also note that the GEPCI-SWI 
significantly enhances the gray and white matter interfaces, as seen in Figure 4.6A 
and 4.6B.  
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Figure 4.6A. 
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Figure 4.6B. 
Figure 4.6A and 4.6B. Two examples of standard SWI images (left column - a,b), 
GEPCI-SWI images (middle column - c,d) and GEPCI-derived SWI like images 
(right column – e,f). The bottom row is the minIP corresponding to the images in the 
upper row. Standard SWI images (a & b) are obtained from Siemens automatic 
reconstruction. The rest of the images (c-f) are all derived from the same GEPCI 3D 
data set. 
 
4.4.2.2 GEPCI-T1f Images 
Another novel combination of the GEPCI basic images incorporates the frequency 
map and the T1-weighting (S0). The grey matter area on T1-weighted images is 
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darker than white matter. Considering the fact that grey matter tends to present 
more positive frequencies in frequency maps than white matter, plus the transition 
between gray and white matter on frequency map is more sharply delineated, we 
explored enhancement of GM/WM contrast by multiplication of the GEPCI T1w 
image with the frequency mask. The Resulting images (Figure 4.7) did indeed 
demonstrate more crisp GM/WM borders as well as enhanced GM/WM contrast 
compared to the T1w images. Deep grey matter structures such as caudate and 
putamen nuclei are also clearly outlined on the GEPCI-T1f images. These images 
are likely to be very useful in detecting malformations of cortical development in 
patients with intractable epilepsy, since they are more likely to be sensitive to 
blurring of the GM/WM interface from subtle cortical migrational abnormalities 
(110). Multiple sclerosis lesions in cortex, typically not clearly resolved by standard 
MRI (111), might be more clearly seen. Additionally, these images also offer a 
promising new method to achieve GM/WM segmentation which will result in more 
accurate volumetric data as well as improve data from cerebral perfusion studies.  
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Figure 4.7 Examples of the GEPCI-T1f images obtained according to Eq. [4.8] (top 
row), comparing with basic GEPCI-T1 weighted images (bottom row). GEPCI-T1f 
images show excellent GM/WM matter contrast. Deep grey matter structure such 
as caudate and putamen nuclei are also clearly outlined on the GEPCI-T1f images. 
 
4.4.2.3 FST2* Images 
Example of GEPCI FST2* image is shown in Figure 4.8. These images are similar 
to FLAIR images in the way that CSF is suppressed based on tissue T1 properties. 
However, unlike T2 weighted FLAIR images which are based on T2 weighting, 
FST2* image is based on T2* map. Since difference between T2 and T2* values is 
usually small, especially in well shimmed white matter areas (112) FST2* images 
could be used to detect T2 sensitive changes in the brain, such as visualizing 
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edema, hyperintense lesions (in multiple sclerosis (40)), cerebral infarctions, which 
are usually well detected on the FLAIR sequences. Various degree of fluid 
suppression has been shown in Figure 4.8, as we go from n=1 to n=4. Choice may 
be made for different applications. For example, in MS brain part of the MS lesions 
can be suppressed together with CSF signal when bigger ‘n’ is applied. We could 
choose n=1 in order to maintain hyper-intensity of the lesions. Or since MS lesions 
are likely to appear in white matter areas, we could avoid suppression of lesions by 
designing WM masks based on GEPCI-T1w images. Additionally, based on its 
quantitative T2* nature, it could also be used to detect T2* sensitive changes, such 
as microbleeds or microcalcifications in the brain. Indeed, the fluid suppression 
based on the GEPCI-T1w image will not suppress artery signals on the T2* map, 
yet it should not affect most brain area. 
 
Figure 4.8 Example of the FST2* images (obtained using Eq. [4.9] with different 
parameter n), and corresponding FLAIR T2 images. Top row – images from a 
subject with relapsing remitting MS, bottom row - images from a healthy subject. 
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Different degree of suppression is shown from first column through fifth column, as 
parameter n grows from 0 to 4 in Eq. [4.9]. The case with n=4 for the MS patient 
shows image resulted from applying suppression of n=4 with exclusion of white 
matter area. 
 
4.4.3 Possible applications of GEPCI in Clinical Arena 
4.4.3.1 GEPCI in MS 
GEPCI technique could also be applied to monitoring patients with multiple 
sclerosis. Typical MRI protocol for detecting MS includes FLAIR (fluid-attenuated 
inversion recovery), T2-weighted spin-echo, and T1-weighted spin-echo (including 
with and without Gd-enhancement) (113,114). Phase imaging and susceptibility 
weighted imaging has also been proposed for identification of MS lesions (47,115). 
While typical MRI protocol aims at imaging the contrast due to variations in the 
tissue characteristic relaxation rates, which are likely to represent lesions that are 
the result of myelin and/or axonal loss, or inflammation, the SWI and phase 
imaging are able to visualize small veins within white matter, which might help 
resolve the timing of interactions between venous structures and MS lesions. With 
the whole set of GEPCI images, as shown in Figure 4.9, we can obtain information 
on both the MS lesions and white matter veins within a single acquisition.  
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Figure 4.9 Examples of a series of GEPCI images applied to disease of Multiple 
Sclerosis. a) GEPCI-T1weighted image; b) frequency map; c) GEPCI-T1f image; d) 
GEPCI-SWI image; e) T2*-SWI, result from d multiplied by FST2* image; f) FLAIR 
image. Most MS lesions (hyperintence on e and f) are seen around veins; green 
arrow indicates example of lesion that is not affiliated with identifiable blood 
vessels.  
 
MS lesions are identified as hypointense on GEPCI-T1w image (Figure 4.9a), and 
hyperintense on FST2* (Figure 4.8) due to increased T1 and T2* relaxation times. 
The T2* values in the lesion area could be further used for more quantitative 
assessment of MS lesions (40). GEPCI-SWI image (Figure 4.9d) shows veins 
without apparent indication of lesions. Lesions that are slightly hyperintense on 
frequency maps are darkened on T1f (Figure 4.9c) compared to T1weighted image 
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(Figure 4.9a). Veins also appeared on T1f image because of frequency map. Thus 
visualization of the distribution of lesions and their relation to veins (and possible 
iron deposition) is achieved by multiplication of FST2* and GEPCI-SWI images 
(Figure 4.8 with n=4 and Figure 4.9d), so that hyperintense lesions are contrasted 
by dark veins running through. This idea is similar to that recently proposed in (105) 
who combined FLAIR images acquired at 3.0 T and SWI acquired at 7.0 T. 
However, with GEPCI images, we easily achieve similar contrast from a single 
acquisition and complete, intrinsic co-registration. Comparing Figure 4.9e and 
Figure 4.9f, lesions that are hyperintense on standard FLAIR images are also 
clearly seen on the fusion of FST2* and SWI image where veins associated with 
MS lesions are readily observed. However, not all lesions in Figure 4.9 are 
associated with veins (e.g. green arrow on Figure 4.9e and 4.9f), and the 
underlying relationship between veins and pathology of MS remains to be 
investigated.  
 
4.4.3.2 Other Possible Applications 
The advantage of having a battery of images with multiple contrasts can have 
advantages for numerous clinical applications. For example, combining GEPCI-
SWI and GEPCI-T1f images, can potentially be used to correct for venous 
contamination in dynamic susceptibility contrast MR perfusion maps such as 
obtained in stroke patients (116). In some patients, cavernous malformations can 
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be associated with epilepsy. With co-localized both SWI and T1f contrasts (venous 
and GM/WM delineation), it is possible to visualize the cavernous malformation and 
also evaluate its relationship to the adjacent cerebral cortex. This may provide new 
insights into the mechanism of epileptogensis in these patients and allow for better 
surgical planning (117,118). This combined contrast could also be useful in co-
localizing subtle cortical malformations which may be found in the vicinity of 
complex venous abnormalities in some patients with epilepsy. The preservation of 
cortical GM/WM detail and representation of venous anatomy is also likely to be 
useful in surgical planning in patients with brain tumors who are set to undergo 
biopsies or curative resections (119,120). Based on these images, the surgeon will 
be better able to avoid prominent veins at the tumor margins as well as estimate 
the relationship of the tumor resection margins to eloquent areas of the cerebral 
cortex at the same time.  
 
4.4.3.3 Potential Improvements 
Although a number of novel contrast mechanisms have been highlighted in this 
manuscript, several limitations of the present study must also be mentioned. Most 
importantly, in this manuscript we have not discussed issues related to magnetic 
field inhomogeneities and their influence on quantitative results obtained with 
GEPCI technique, especially on quantitative evaluation of T2* relaxation time 
constant. Influences of field inhomogeneities are particularly significant around the 
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tissue/bone or tissue/air interfaces such as sinuses, ear canals, etc. However, 
away from these areas and for high resolution imaging as was used herein, this 
issue creates only minor problems in most parts of the brain. Detailed discussions 
of these issues can be found elsewhere (see for example (72,121,122)) and will 
also be addressed in our future publications. On the other hand, the non-local 
nature of frequency shift should also be noted when interpreting the derived 
contrasts based on application of the frequency masks. For example, the edge of 
the brain has some artifacts due to improper removal of the background field. 
Another example would be where there are sharp transitions in susceptibility of the 
brain tissue, e.g. the deep nuclei or ventricles. One might notice that the structures 
in frequency map are not always the same as that in magnitude images. In such 
cases tissue magnetic susceptibility will affect frequency map not only at the 
location of susceptibility variations but also in the surrounding areas. One of the 
ways to deal with this problem is already mentioned in the introduction quantitative 
susceptibility mapping (59,98,123-127).  
Another potential area of improvement includes accounting for the multi-
compartment tissue structure. Quantification of myelin-bound and free water 
fractions by a multiexponential analysis of the T2 decay has been discussed 
(128,129). Signal obtained based on a Carr-Purcell-Meiboom-Gill (CPMG) or Turbo 
Spin-Echo (TSE) sequence with multiple TEs was modeled by three pool model 
(130), or four pool model (131), or by non-negative least squares (132). Recently, it 
has been shown that T2* decay, which is measured by multi-echo gradient echo 
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sequence, could also be used for extraction of myelin water fraction (133,134). 
However these issues are beyond the scope of the current manuscript. 
 
4.5 Summary  
The GEPCI technique based on post processing of the multi-echo GRE data 
produces high quality frequency maps, high resolution R2* maps and T1-weighted 
images. These data sets can then be combined in novel ways to produce high 
resolution images which can offer excellent depiction of the intracranial venous 
system (SWI like and GEPCI-SWI images), images which promise to significantly 
improve the delineation of cerebral grey and white matter interfaces (GEPCI-T1f 
images) and GEPCI-FST2* images that look similar to FLAIR images. These novel 
imaging data sets can potentially find clinical applications in studying a variety of 
common neurological disorders. They can also find applications in basic neuro-
anatomical and neuropathological research. Most importantly, these images with 
novel contrast properties can be obtained without any increase in acquisition time, 
and they are naturally co-registered obviating additional costs in terms of scanner 
time and personnel.  
[  
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Chapter 5 Mapping T2* - Application of GEPCI to 
Monitoring Multiple Sclerosis 
 
5.1 GEPCI images compared to Clinical Standard Spin Echo images  
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Figure 5.1 compares the images acquired by clinical standard sequences and 
GEPCI images of a patient with Relapsing-Remitting MS. Red arrows point to MS 
lesions; Blue arrows point to veins.  
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Figure 5.2 compares the images obtained by clinical standard sequences and 
GEPCI images of a patient with Secondary Progressive MS.  
 
Clinical images: T1w (T1-weighted), T2w (T2-weighted), FLAIR (Fluid Attenuated 
Inversion Recovery). GEPCI images, as introduced in Chapter 4, are: T1w -S0 
(GEPCI T1 weighted), T2* (GEPCI T2* map), FST2* (Fluid Suppressed T2* map), 
T1f (GEPCI T1 frequency image), SWI (GEPCI Susceptibility Weighted Image), 
T2*-SWI (GEPCI T2* map - SWI). 
 
Tissue delineation is similar between the first panel (clinical images) and the 
second panel (GEPCI images) in Figure 5.1 and Figure 5.2. MS lesion contrast is 
well resolved with GEPCI (hypointense on T1w image and hyperintense on T2* 
map), thus allowing standard identification of MS lesions. All lesions that are seen 
on SE sequences (T1w, T2w, FLAIR) are also revealed by GEPCI. 
 
Images shown above (Figure 5.1 and Figure 5.2) demonstrated several advantages 
of GEPCI over standard SE sequences for evaluation of MS. First, images obtained 
with GEPCI appear highly similar to standard scans; hence, they can be used in a 
reliable and conventional way for a clinical evaluation of the disease. Second, 
GEPCI-T1w images, GEPCI-T2* maps and FST2star maps are generated from a 
single dataset; that is, they are inherently coregistered. Third, the GEPCI technique 
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is based on gradient echo MRI and uses small flip angles as compared to spin-
echo based techniques; hence it can be safely used in high-field MRI. Fourth, the 
acquisition time for simultaneous generation of these three images is considerably 
reduced compared with their equivalent SE sequences (6 min 40 sec) for GEPCI 
against a total of 15 min scan time for three scans in a standard clinical protocol. 
Fifth, GEPCI offers additional contrasts compared to SE sequences that might 
provide more insights to disease evaluation. 
 
More importantly, the major advantage of GEPCI approach is its quantitative nature 
(T2* relaxometry) which can be used to quantitatively evaluate the severity of tissue 
damage in MS brain, based on the scoring method introduced in next section 5.2. 
 
5.2 Quantification of Tissue Loss4  
5.2.1 Tissue Damage Score (40) 
To utilize the quantitative nature of GEPCI-T2* map, we introduce quantitative 
parameters to score the severity of the disease based on T2* (or R2*) changes in 
MS lesions. 
                                               
 
4 Most contents in this section have been published in Sati P, Cross AH, Luo J, Hildebolt CF, Yablonskiy DA. In 
vivo quantitative evaluation of brain tissue damage in multiple sclerosis using gradient echo plural contrast imaging 
technique. NeuroImage 2010; 51:1089-1097. 
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Each MS lesion voxel in GEPCI technique is characterized by an associated 
quantitative T2* relaxation time constant. We hypothesize that the R2* relaxation 
rate constant (R2*=1/T2*) will provide information on lesion severity. This 
hypothesis is a natural step because MS tissue damage involves loss of myelin 
lipids accompanied to a variable degree by loss of intracellular proteins, including 
axon proteins. In this process, R2* relaxation rate constant will progressively 
decrease from normal tissue values to values typical for interstitial fluid or CSF that 
is practically devoid of macromolecules. This supposition is in agreement with 
correlation established between tissue T1 and T2 values and tissue damage in MS 
reported in Schmierer et al. (2008) and Seewann et al. (2009). Recall, that 
R2*=R2+R2′, where R2=1/T2 and R2′ reflects contribution from mesoscopic field 
inhomogeneities generated mostly by the presence of blood vessel network in the 
brain tissue (122). Recent work has evaluated the tissue-specific R2′ relaxation rate 
in the healthy human brain (He and Yablonskiy, 2007). Using this data, we found 
R2′ value for white matter at 1.5 T to be equal to 0.35 s−1, and at 3 T it is 0.7 s−1, 
both are much smaller compared with the typical white matter R2 value that is 
approximately equal to 15–16 s−1 (Neema et al., 2009). The GEPCI technique, 
therefore, provides a quantitative measure of a tissue specific relaxation time T2* 
(equal to 1/R2*) that is very close to T2 measured using spin-echo sequences. 
Based on this consideration, we adopted the following procedure for estimation and 
scoring of tissue damage in MS. 
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First: design masks that contain only white matter, including both normal-appearing 
and lesioned areas. These masks are drawn manually on GEPCI-T1w images 
using home-built Matlab programs. All gray matter structures (cortical and deep) 
are excluded. Masks are applied on both GEPCI-T1w images and GEPCI-T2* 
maps. Then R2* histograms of the voxels inside masks of all slices are generated 
using a bin width of 0.3 s−1 ranging from 0 s−1 up to 30 s−1. For control subjects 
these histograms look almost like ideal Gaussian distributions. For subjects with 
MS these histograms have a large peak with a quasi-Gaussian shape 
[corresponding to normal-appearing white matter (NAWM)] and a strongly elevated 
non-Gaussian tail on the left resulting from the presence of the MS lesions (see 
example in Figure 5.3). Second: define the level of tissue damage, or tissue 
damage score (TDS), for each voxel in MS lesions based on the tissue R2* value. 
The characteristics of the WM peak are determined using a standard Gaussian 
function that is fitted to the R2* distribution. To remove any influence on the fit from 
the tail existing in the R2* distribution of MS patients, we fit only the upper half of 
the R2* histogram. We define the “normal reference” R2* value as corresponding to 
the center of the NAWM peak (R2*c) obtained from the fitting procedure. As we 
already mentioned, in MS, tissue damage occurs through the loss of 
macromolecules, mainly myelin and proteins in axons, leading to reduction in tissue 
R2*. Hence, for each voxel in MS lesion with a given R2* value, the tissue damage 
score (TDS) is determined as: 
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In addition to defining TDS for each voxel, we can also define the tissue damage 
load (TDL) for a given patient. This is done by summing TDS over all the voxels in 
MS lesions: 
 
 
N
TDL V TDS= ⋅∑  [5.2] 
where N represents the total number of voxels in the MS lesions in cerebral white 
matter. We have also multiplied the sum by the voxel volume V (mm3) to make this 
definition independent of the voxel resolution of the MRI pulse sequence. The 
tissue damage load, thus, assesses both the lesion load and the degree of severity 
of the MS lesions. Additionally, a mean tissue damage score (MTDS) can also be 
obtained by averaging TDS over all the lesions:  
 /MTDS TDL LL=  [5.3] 
This mean score provides an estimate of the average severity of abnormal white 
matter tissue in the subject's brain. 
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Figure 5.3 Introduction of GEPCI scores. 
 
To apply Eqs. [5.1] and [5.2], we need to define a method for separating “normal” 
brain tissue from MS lesions. This procedure is always ambiguous because lesions 
almost never have sharp boundaries. Also, the distribution function of R2* values of 
normal WM has a Gaussian type shape. As for any Gaussian distribution, 95% of 
R2* values are located around peak center in the interval R2*=R2c*± 1.96σ, and 
99% of values are in the interval R2*=R2c*±2.58σ, where σ is the distribution width. 
This means that even in the normal brain there are voxels that have “abnormal” 
GEPCI scores. Hence separation of tissue into “normal” and “abnormal” is always 
somewhat subjective. Visual examination by a neurologist (A.H.C.) of GEPCI and 
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standard clinical images from subjects with MS suggested that the threshold of 
1.96σ separates most of the MS lesions from normal appearing tissue. We will use 
this threshold in this pilot study leaving more detailed examination for future work. 
In addition, all the voxels that have R2* below selected threshold and are isolated 
(single voxels) or have only one neighbor (hanging voxels) are eliminated from 
consideration to reduce influence of noise on our quantitative estimates. Moreover 
the characteristics of the main part of R2* distribution could also reveal info on MS 
disease (ref NAWM, peak shift). So we also take width, center, and w/c as part of 
GEPCI measures.  
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Figure 5.4 Illustration of GEPCI score maps obtained from subjects with RRMS and 
SPMS. They are made by overlapping colored TDS indices on T1 weighted images. 
 
Figure 5.5 Illustration of lesion load determined by GEPCI compared to FLAIR 
image. Left: FLAIR image; Middle: FLAIR image with highlighted lesion area; Right: 
GEPCI score map.  
 
5.2.2 Reproducibility of the R2* map 
Tissue-specific parameter, R2* (= 1/T2*) is not used as commonly as R2 or R1 in 
clinical studies, and is usually considered susceptible to field inhomogeneity. To 
ensure that TDS and other GEPCI scores are suitable for longitudinal studies, we 
tested the reproducibility of R2* measurement by GEPCI technique.  
 
Experiments are performed on one healthy volunteer and one MS subject with the 
same protocol on 1.5 T scanner and 3.0 T scanner respectively. First run: standard 
GEPCI acquisition; second run: a consecutive scan immediately following first run; 
third run: subject was pulled out from scanner, tilted head while he was lying on the 
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table, sent back in the scanner, and then scanned with the same sequence after 
careful shimming of the field.  
 
  
Figure 5.6 GEPCI reproducibility tested on healthy volunteer at 1.5 T scanner. 
Images on top shows T1w (S0) images from run 1 to run 3. Histograms at bottom 
left show reproducibility of T1w image; histograms at bottom right show 
reproducibility of T2*. Blue, red and green points correspond to run1, run2, and 
run3 respectively. 
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Figure 5.7 GEPCI reproducibility on MS subject at 3.0 T scanner. Images on top 
shows T1w (S0) images from run 1 to run 3. Histograms at bottom left show 
reproducibility of T1w image; histograms at bottom right show reproducibility of T2*. 
Blue, red and green points correspond to run1, run2, and run3 respectively. 
 
Histograms are chosen to characterize the reproducibility of T2* measurements. As 
shown in Figure 5.6 and Figure 5.7, T2* histograms show great reproducibility for 
all three scans both on healthy volunteer and patient. On the other hand, T1w 
intensity histograms show that after tilting head, T1 weighting shifted significantly 
due to different distribution of RF coil sensitivity.  
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5.3 Bridging the gap between radiological and clinical measurements of 
multiple sclerosis using Quantitative GEPCI Scores 
5.3.1 Clinical tests  
For each visit, patients are scanned with the standard MRI protocol introduced in 
Chapter 4, and also evaluated with clinical standard tests. EDSS (Expanded 
Disability Status Scale) evaluation is performed by experienced doctors. It is the 
“gold standard” for assessing impairment in MS (7). The MS Severity Score, a 
measure of aggressiveness of MS, was calculated based on the EDSS and 
duration of disease (135). MSFC (Multiple Sclerosis Functional Composite) is less 
subjective and more quantitative than EDSS, making it more amenable to statistical 
comparisons (136,137). The MSFC measures function, whereas the EDSS is 
neurologic examination. MSFC is comprised of timed 25 foot walk (test of 
ambulation), 9 hole peg test (test of upper extremity function) and 3 second paced 
auditory serial addition task (PASAT). PASAT is a standardized 10 minute test of 
information processing speed and attention/working memory, cognitive processes 
that are commonly impaired in MS. Since many of our early MS subjects score 
normal on the PASAT 3 sec version, we also include the 2 sec version. Symbol 
Digital Modality Test (SDMT) is also added in the protocol, it is demonstrated to be 
less susceptible to the practice effect than PASAT in measuring cognitive 
functions(138).  
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5.3.2 Baseline demographics  
Characteristics  Values     
 overall  RRMS  PPMS  SPMS  
Number of subjects 30  10  10  10  
Age. y. median (range)  51.5 (27 to 70)  44 (27 to 52) 54.5 (40 to 70) 52.5 (41 to 64) 
Gender. F:M  16:14 6:4 6:4 4:6 
EDSS. median (range)  5.5 (1.5 to 8.0)  2.5 (1.5 to 6.5)  5.75 (3.5 to 8.0)  6.0 (4.0 to 6.5)  
Disease Duration. y. 13 (3 to 34)  7 (3 to14)  9 (4 to 26)  25.5 (17 to 34)  
MSSS. median (range) 5.25 (2.08 to 9.86) 4.27 (2.60 to 8.31) 7.11 (2.08 to 9.86) 5.25 (2.99 to 6.39) 
Table 5.1 Baseline demographics 
A group of 30 subjects - ten subjects each representing RRMS/SPMS/PPMS 
clinical subtypes (EDSS ranges 1.5-6.5/4.0-6.5/3.5-8.0) were recruited. The EDSS 
scores in each subgroup are chosen to be overlapping as much as possible. The 
RRMS group is younger than the other two groups. Since SPMS subjects by 
definition is at a fairly late stage of the disease, the disease duration of the SPMS 
subjects is much longer than the RRMS subjects. 
 
5.3.3 Correlations in Clinical and Radiological measurements 
Since our subject groups is small, and all parameters are not normally distributed, 
we used non-parametric Spearman ρ to examine cross correlations both within and 
between clinical measurements and traditional imaging measurements and GEPCI 
scores (we use the all 30 subjects as one group).  
 
Correlations within clinical scores are shown in Table 5.2. EDSS is shown to highly 
correlate with MSSS, which is natural since EDSS is one of the determinants in 
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MSSS. On the other hand EDSS correlates poorly with all cognitive tests (PASAT 
3'', 2'' and SDMT), suggesting that it reflect little cognitive dysfunctions. Although 
EDSS correlate highly with both MSFC 3'' and MSFC 2'', it is plausible to suggest 
that this correlation is driven by the 25' walk and 9-HPT components (especially the 
25' walk which shows the strongest correlation with EDSS). MSSS and 25' walk 
show similar correlation patterns with other parameters as EDSS - poorly correlated 
with cognitive tests. MSSS shows weaker correlations with all other tests compared 
to EDSS, suggesting that the disease duration component in it does not play much 
role in functional tests. PASAT 2'' correlates strongly with PASAT 3'', and they both 
show similar correlations with other tests. As composite scores, MSFC 2'' and 
MSFC 3'' both find good correlation with all other parameters (except for MSSS). 
The 9-HPT test - as the upper extremity component of MSFC - correlated well with 
all other parameters, which indicates that this test is not limited to the upper 
extremity function. 
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 EDSS  MSSS  PASAT 3’’  MSFC 3’’  PASAT 2’’  MSFC 2’’  SDMT  25’ Walk  9-HPT  
EDSS   0.727 *****  -0.420 *   -0.679 *****  -0.364  -0.669 ***** -0.359  -0.866 *****  -0.623 ****  
MSSS    -0.372 *  -0.541 ***  -0.179  -0.463 *  -0.263  -0.562 ***  -0.566 ***  
PASAT 3’’     0.822 *****  0.761 *****  0.705 *****  0.703 *****  0.339  0.583 ***  
MSFC 3’’      0.752 *****  0.940 *****  0.643 ****  0.711 *****  0.854 *****  
PASAT 2’’       0.834 *****  0.669 ****  0.478 *  0.522 ***  
MSFC 2’’        0.652 ****  0.7235 *****  0.824 *****  
SDMT         0.384 *  0.545 ***  
25’ Walk          0.565 ***  
9-HPT           
Table 5.2 Spearman ρ between Clinical Scores. p: Probability > |ρ|. * p<0.05, ** p<0.01, *** p<0.005, **** p<0.001, ***** p<0.0001.
123 
 
 
 TDL  LL  MTDS  Width  Center  w/c  
TDL        
LL  0.977 *****      
MTDS  0.624 ****  0.471 **     
Width  0.363 * 0.241 0.743 *****     
Center  -0.284 -0.250 -0.331 0.096   
w/c  0.408 * 0.276 0.821 ***** 0.946 ***** -0.175  
       
LL- FLAIR  0.914 ***** 0.867 ***** 0.669 ***** 0.476 ** -0.406 * 0.546 *** 
Table 5.3 Spearman ρ between GEPCI scores. * p<0.05, ** p<0.01, *** p<0.005, **** 
p<0.001, ***** p<0.0001. 
 
Correlations within MRI parameters are examined in Table 5.3. GEPCI scores are 
aiming to characterize two major features in the diseased brain - lesions and the 
brain as a whole. The TDL, LL and MTDS are defined as characteristics of lesion 
area. While LL is lesion load volume, TDL is the load of tissue damage weighted by 
damage severity. The strong correlation between TDL and LL could be due to the 
fact that by definition our TDL is also heavily weighted by lesion load, and the fact 
that patients with larger lesion load tend to have more severe damage (especially in 
SPMS subjects). The correlation between LL and MTDS also supports that. Global 
measures of the brain tissue are supposed to reflect properties of so-called 'normal 
appearing white matter (NAWM)', since although many parts of the brain do not show 
any abnormality (appear normal) in MRI scans, they have a lot of pathology under 
microscope (139). Width show very strong correlation with the MTDS. That could be 
partially due to our way of choosing the lesion 'cut-off' - we propose to do it at the 
R2*=R2c* - 1.96σ, this inevitably means that when the width is broader, the lesions 
are cut at lower R2*, their mean tissue damage load will be higher. On the other 
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hand, center did not correlate with any of the other GEPCI parameters. As the mean 
value of the whole brain R2* distribution, the center might be affected by different 
factors other than the disease. For example, R2* would increase with iron 
accumulation, which is known to happen along the process of aging (140). Also, 
while we expect R2* decrease with neuronal tissue loss -> more water in the tissue, 
the brain suffers from atrophy at the same time, which reduces the total brain 
volume, thus counteracts the decrease of macromolecule concentration in tissue.  
 
We have also calculated the lesion load based on the standard MRI technique – 
FLAIR and examined correlations with all GEPCI parameters. Strongest ones are 
with TDL and LL, which is expected. The correlation between FLAIR results and 
global GEPCI parameters is much weaker. 
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EDSS  MSSS  PASAT 3’’  MSFC 3’’  PASAT 2’’  MSFC 2’’  SDMT  25’ Walk  9-HPT  
TDL  0.343 0.116 -0.314 -0.524 *** -0.458 * -0.644 **** -0.444 *  -0.461 *  -0.454 *  
LL  0.311 0.104 -0.292  -0.500 **  -0.447 *  -0.630 ****  -0.429 *  -0.458 *  -0.402 *  
MTDS  0.176 0.033 -0.186 -0.298  -0.283  -0.344  -0.321  -0.196  -0.382 *  
Width  0.127 -0.162 -0.083 -0.074 -0.130  -0.146  -0.141  -0.066  -0.166  
Center  -0.017 -0.005 -0.038 0.088 0.004 0.057  0.073  0.088  0.120  
w/c  0.142 -0.170 -0.069 -0.102 -0.061 -0.140 -0.136  -0.098  -0.193  
          
LL- FLAIR 0.348 0.088 -0.254 -0.455 * -0.307 -0.544 ***  -0.423 *  -0.405 *  -0.461 *  
Table 5.4 Spearman ρ between GEPCI scores, FLAIR and Clinical measurements of disability. p: Probability > |ρ| 
* p<0.05, ** p<0.01, *** p<0.005, **** p<0.001, ***** p<0.0001. 
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Table 5.4 shows correlations found between radiological and clinical scores. TDL and LL 
both correlate with MSFC 3'', MSFC 2'' and each of their components (except for PASAT 
3'') and also SDMT, albeit not very strong with most of them. The fact that significant 
correlation does not exist between TDL and PASAT 3'' but does exist with the more 
sensitive PASAT 2'' indicates that GEPCI has high sensitivity in measuring brain 
abnormality. Subsequently, the stronger correlation between TDL and MSFC 2'' than 3'' 
is driven by the cognitive component. Note that the correlation between TDL and MSFCs 
is the strongest among all other scores, indicating that this correlation is not driven by 
any single component of MSFC. The lack of correlation between GEPCI and EDSS or 
MSSS (though both TDL and LL correlated with 25' walk moderately) show that GEPCI 
still in need of elements that assess other parts of CNS to perform more comprehensive 
evaluations for MS (same statement holds true for FLAIR-based lesion load count).  
 
TDL did consistently better than LL with all their correlations, indicating that incorporating 
severity of lesion in the assessment does allow a stronger relationship between the 
radiological findings and functional impairments. No significant correlation is found 
between GEPCI global measures of the brain and disability tests. This might be 
attributed to the need of GEPCI data correction for magnetic field inhomogeneities which 
is a subject of current effort. 
 
The FLAIR based lesion load assessment performs weaker than GEPCI scores (weaker 
in every correlation it has except for 9-HPT). We did not find correlation of FLAIR-LL with 
either PASAT 3'' or PASAT 2'', but there is some correlation between FLAIR-LL and 
SDMT.  
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5.3.4 Differentiating MS subtypes based on GEPCI or Clinical evaluations 
As shown in the baseline demographics, this patient cohort is chosen to have three 
subtypes of MS patients, 10 each. In this section we try to determine how well GEPCI 
could discriminate the MS subtypes, and compare it with clinical scores' performance.  
 
To accomplish that, we utilize the 'Decision Tree' method in the partition platform in 
JMP® (108). This program is convenient for exploring relationships without having a 
good prior model. In our case, the factor variables (X) are continuous, and the response 
variables (Y) are categorical (RRMS/PPMS/SPMS). The program recursively partitions 
data according to a relationship between X and Y values, creating a tree of splits. It finds 
a set of groupings of X values that best predict a Y value. It does this by exhaustively 
searching all possible groupings, and find the best among all candidates in X to do one 
split. Repeatedly splitting the data results in branches and leaves of the tree.  
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Figure 5.8 Decision tree and categorization of MS subtypes resulting from using GEPCI 
parameters alone. 
 
First, we put all GEPCI parameters as potential factors to predict 30 subjects' MS 
subtypes. As shown in Figure 5.8, the decision tree started splitting by a global 
parameter in GEPCI 'width'. The left leaf corresponding to width >= 4.73, has 18 
subjects, including all SPMS, 4 RRMS and 4 PPMS; the right leaf corresponding to width 
< 4.73, has 12 subjects, 6 RRMS and 6 PPMS. Then the tree grows with utilizing TDL as 
another factor. Groups of subjects are further split based on their tissue damage load. 
The w/c factor is used at last, but the final split does not affect the grouping results. In 
short, GEPCI is able to correctly identify all 10 SPMS subjects, 7 RRMS and only 4 
PPMS, which adds up to total of 70% correctly grouped. The SPMS has broad width and 
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large TDL as expected; the PPMS group has small width and small TDL, which might be 
due to the reason that many PPMS subjects tend to have more lesions in their spinal 
cord; the RRMS group however, has either small width and large TDL or broad width and 
small TDL. The way RRMS group formed is very interesting. It might indicate that the 
inflammations in RRMS brains are highly dynamic processes, or that there are two kind 
of pathways for the disease to develop - finally they merge to SPMS (big width, big 
lesion). The high number of misclassification in RRMS and PPMS calls for extra 
information in GEPCI technique - spinal cord will definitely help! & measurement of brain 
atrophy may also improve the technique.  
 
 
 
Count
Total %
1 2 3
RRMS 6 4 0 620.00
PPMS
4 9 1 1446.67
SPMS
0 1 9 1033.33
10
33.33
10
33.33
10
33.33
3080% correct!
Clinical RRMSPPMS
SPMS
130 
 
Figure 5.9 Decision tree and categorization of MS subtypes resulting from using all 
clinical parameters. 
 
In Figure 5.9 Decision tree and categorization of MS subtypes resulting from using all 
clinical parameters., 80% of all subjects are correctly identified. Among all clinical 
measurements, the program chose EDSS and MSSS for the entire grouping (the final 
split by PASAT did not affect results). Since the EDSS is the clinical 'gold standard' in 
measuring disabilities, and MSSS is result from EDSS and disease duration, they are 
expected to be strong in differentiating these MS subtypes. For example, 6 of RRMS and 
9 of SPMS are identified by using EDSS alone (<3.5 and >5 respectively); also 6 PPMS 
got identified at the high end of MSSS since they progress from the disease onset 
without any recover episodes as RRMS.  
 
Considering the fact that these clinical measurements are somewhat already affected 
doctor's judgments of MS subtypes, while GEPCI had no such advantages, it performs 
quite nicely in grouping MS subjects. Moreover, among 9 misclassified subjects by 
GEPCI, and 6 misclassified by EDSS and MSSS, they only have 1 (RRMS grouped as 
PPMS) in common, which suggests that the criteria offered by GEPCI and EDSS might 
have very different underlying mechanism. Larger sample size is needed for further 
validation of our observations. 
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Figure 5.10 Decision tree and categorization of MS subtypes resulting from using clinical 
parameters excluding EDSS, MSSS and 25' walk. 
 
Figure 5.10 shows results from using only cognitive tests to classify subjects. 21 out of 
28 are correctly classified (2 missing values in PASAT 2''). The 7 misclassifications here 
also have only one overlapped with GEPCI (a PPMS grouped as RRMS by GEPCI, and 
grouped as SPMS by cognitive tests). And there are 3 misclassifications overlapped with 
EDSS/MSSS. 
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5.3.5 Summary  
In summary, GEPCI offer multiple parameters in evaluating brain abnormality. TDL 
incorporates tissue damage severity in lesions; Lesion load provided by GEPCI scores 
correlate highly with clinical standard imaging FLAIR; GEPCI also provides measures 
beyond the lesions - distribution width and center assess changes in the NAWM. Among 
correlations between GEPCI and clinical tests, TDL and MSFC 2'' is the strongest 
(Spearman ρ = -0.644), and it's not driven by single component in MSFC. Both TDL and 
LL perform slightly better than FLAIR-LL. Although NAWM measures do not show 
correlations with clinical disability measurements, the 'width' does help with 
differentiating MS subtypes. GEPCI alone was able to correctly group 70% of all 
subjects, while EDSS/MSSS did 24/30, and cognitive scores did 21/28. This is not 
possible by using FLAIR-LL alone.  
 
Although it remains a huge challenge to relate brain tissue damage in MR imaging to 
patients’ clinical manifestations, compared to standard MRI scans, GEPCI is a big step 
forward in filling the gap between clinical and radiological measures. 
 
5.4 Preliminary results of GEPCI in Spinal Cord Imaging5  
As an important part of the CNS evaluation, spinal cord imaging is valuable in both 
diagnosis and ongoing evaluation of patients with multiple sclerosis (MS) (141). 
However, assessment of spinal cord damage using MRI lags behind the development of 
                                               
 
5 All contents have been published in Luo J, Cross AH, Yablonskiy DA. Quantitative evaluation of spinal cord tissue 
damage in MS patients using Gradient Echo Plural Contrast Imaging. Proc. Intl. Soc. Magn. Reson. Med. 2011; 2176. 
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brain methodology. Given GEPCI technique promise to provide substantial improvement 
in image quality and MRI acquisition time as compared to clinical sequences, and has 
already been used to quantitatively evaluate white matter tissue damage in brains of MS 
patients (40), it is tempting to use GEPCI technique to discriminate tissue damage in 
spinal cord of MS patients against normal subjects. This is an important step in 
development the GEPCI technique as a comprehensive tool for quantifying the extent of 
tissue damage of the whole CNS, and monitoring MS disease progression. Herein we 
provide preliminary results obtained in this direction. 
 
Methods and Data Analysis: Data from the cervical spinal cord of healthy volunteers 
and relapsing-remitting MS patients were acquired using a Siemens® 3.0T Trio MRI 
scanner. A 3D version of GEPCI sequence was used with high isotropic resolution of 
1x1x1 mm3 and 11 gradient echoes (8min32s acquisition time). Further effective 
resolution enhancement was achieved with zero-filling in the k-space. A set of five 
standard clinical 2D turbo spin echo T1w and T2w images were acquired with a total 
imaging time of 16 min. Saturation band was applied on the anterior portions of the 
torso, to suppress motion artifacts. GEPCI technique simultaneously generates naturally 
co-registered quantitative T2* and R2*=1/T2* maps, along with T1-weighted (T1w) 
images. Data were analyzed using Matlab®. Isotropic resolution allows image 
reconstruction in arbitrary plane, thus providing great advantages over clinical methods. 
Mask for spinal cord area including both white matter and gray matter was obtained with 
segmentation based on the T1w-GEPCI images. R2* histogram of the whole cord is 
generated using a bin width of 0.3 s-1 ranging from 0 s-1 up to 30 s-1.  
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Results and Discussion: 
  
Figure 5.11 Examples of GEPCI-T1w (left column), T2* map (middle column) and R2* 
map (right column) of the spinal cord. Bottom row is the sagittal view; Upper row - 
magnified views of the transverse cut through the spinal cord corresponding to the red 
line on the sagittal view. All images are reconstructed from the same GEPCI 3D data set. 
The image on the right represents anatomy of spinal cord at a similar level;  
 
In Figure 5.11, characteristic butterfly pattern of the grey matter is clearly seen on axial 
GEPCI R2* map. Remarkably, the grey matter is also seen on the sagittal views (bright 
T2* / dark R2* lines inside the spinal cord).  
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Figure 5.12 Examples of the R2* histograms of c-spinal cord of a healthy control (left) 
and MS subject (right).  
 
In Figure 5.12, the width of the distribution (variation of the R2* values) of RRMS subject 
(12.9 s-1) is substantially greater than the R2* variation of control subject (8.32s-1) 
suggesting diffuse MS tissue damage.  
  
Figure 5.13 Images of an MS patient. Standard T2-weighted image is shown on the left; 
GEPCI score map is shown on the right.  
We can clearly see 2 lesions on the clinical T2-weighted image (left) around C1 and C2 
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area. Lesions on GEPCI image (right) showed up at similar positions.  
 
TDS (tissue damage score) of MS lesions was generated based on the R2* distribution 
shown in Figure 5.12, which indicates relative severity of the lesions. It was 
subsequently overlapped on the naturally co-registered GEPCI-T1w image. Definition of 
the lesion score here is analog to what was done for the MS brain lesions (see 5.2.1 
Tissue Damage Score)  
 
Spinal MS lesions are rarely depicted as hypointense on clinical T1w images, which 
indicates that the pathological changes in the tissue are not sufficient to produce 
contrast in T1w images (141). Similar situation is seen in our GEPCI-T1w image. 
However, quantitative R2* histograms shown in Figure 5.12 clearly differentiate normal 
from MS tissue. One of the problems with the clinical standard T2/T1 weighted images is 
that the intensity of the image is affected by the RF coil sensitivity and homogeneity of 
the RF field. Indeed we also observe image intensity variation (both up-to-bottom and 
left-to right) in our T1w images (Figure 5.11, left). However, as seen in Figure 5.11 
(middle and right), the R2* and T2* GEPCI maps, being quantitative, are exempt from 
the sensitivity problem. 
 
In summary: In this section, we demonstrated the capability of extending GEPCI 
technique to spinal cord imaging in general and quantitative evaluation of tissue damage 
in MS. High quality images were collected twice faster compared to standard clinical MS 
protocols. As a quantitative technique, GEPCI holds promise toward comprehensive 
characterization of MS abnormalities in the spinal cord. Also note that the cerebellum 
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and brain stem areas showed very good contrast with our resolution, which further 
strengthens the promise for GEPCI technique to characterize the whole CNS. 
 
5.5 Preliminary Results of GEPCI with Detecting Cortical Lesions in Ex Vivo MS 
Brain6 
Although most imaging research in Multiple Sclerosis has focused on the white matter, 
pathology can also be found in gray matter, including cerebral cortex. MS symptoms and 
signs including cognitive impairment, fatigue, and seizures have been linked to gray 
matter involvement (111). Conventional MRI techniques that are routinely used to detect 
MS lesions are T1 and T2 weighted spin-echo images and FLAIR, which detect white 
matter lesions well, but miss most cortical lesions, as reported in a postmortem tissue-
MRI correlation study (142) at field strength of 1.5 T. Though higher fields will result in 
increased detectability of both cortical and WM lesions (143), these imaging techniques 
will suffer from high specific absorption rate (SAR), especially at 7.0 T. GEPCI on the 
other hand, is a technique based on multi-echo gradient echo sequence, which has very 
low SAR. In this pilot study, we evaluated GEPCI as a way to detect and quantify cortical 
lesions.  
 
Material and Methods: Acquisition: Brain tissue of an ex vivo MS patient was scanned 
on a Varian 4.7 T MRI. Sample prepared as figure on the left. A 3 cm diameter bird cage 
coil was used to obtain a 3D version of the multi-echo gradient echo sequence with a 
                                               
 
6 All contents have been published in Luo J, Cross AH, Schmidt R, Sukstanskii AL, Yablonskiy DA. Detecting cortical 
lesions in MS tissue with Gradient Echo Plural Contrast Imaging. Proc. Intl. Soc. Magn. Reson. Med. 2012; 3123.  
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resolution of 0.11 x 0.11 x 0.5 mm3, FOV of 40 x 40 x 8 mm3 and 8 gradient echoes (TR 
= 200 ms; minTE = 4.58 ms; delta-TE = 7.6 ms; bandwidth = 40 kHz/FOV; FA = 60°, 
acquisition time = 13 min). 2D T2 weighted images were also acquired with spin echo 
sequence at different TE separately, (TR = 4000 ms; TE = 13 ms, 50 ms; acquisition 
time = 8 min x 2) and slices of same orientation. 
  
Figure 5.14 Demonstration of tissue sample and experimental set-up. 
Image Analysis: GEPCI data were analyzed assuming mono-exponential signal decay 
and attenuation due to macroscopic field inhomogeneities, describing by F-function as 
discussed in (6): 2*0( ) ( )n
R TE
n nS TE S e F TE
− ⋅= ⋅ ⋅ . The fitting to magnitude data produces 
two naturally co-registered basic GEPCI images: quantitative T2* = 1/R2* map and T1-
weighted images (S0). The frequency maps are obtained from phase data and used for 
calculation of F-function (6). As for T2 mapping, T2 weighted images at two echo times 
were fit by a mono-exponential decay: 20( ) n
R TE
nS TE S e
− ⋅′= ⋅ , which results in a T2=1/R2 
map and a Spin Density image ( '0S ). All data were Hann-filtered to improve SNR before 
fitting procedures.  
Results & Discussions: As shown in Figure 5.15, T2* map, T1-weighted image and T2 
map showed very well defined cortical lesion (red arrows). Sub-cortical structures are 
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also observed on GEPCI images and T2 map. The contrasts in cortical structures are 
not seen on the Spin Density images. It has been reported that focal cortical lesions are 
often extensive in MS (46). Unfortunately, cortical lesions are often completely missed 
with conventional MRI techniques, due to limited signal contrast between cortical grey 
matter and lesions. Double Inversion Recovery (DIR) has been reported to have 
significantly improved detection of cortical lesions (142), but it is often difficult to 
distinguish true lesions from artifacts using DIR, and problems are anticipated with high 
energy deposition at high field. 
 
Figure 5.15 Results of GEPCI technique and T2 mapping.  
 
In summary: In this pilot study, we have demonstrated that GEPCI technique is 
sensitive to cortical lesions and sub-cortical structures on ex vivo MS tissue. GEPCI 
holds much promise for the future, as the multi-echo gradient echo sequence upon 
which GEPCI is based has no problem with energy deposition at high field and it is very 
rapid; one would have to trade off resolution and/or SNR significantly to creates maps of 
T2 with similar amount of time.  
[  
GEPCI-T2* map           GEPCI-T1w                   T2 map                   Spin Density
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Chapter 6 Mapping of Phase – Application of GEPCI to 
monitoring Multiple Sclerosis7 
 
6.1 Inconsistency between magnitude image and phase image of MS brain.  
6.1.1 Overview 
MRI has played a revolutionary role toward enhancing knowledge in biology and 
medicine. Numerous MRI techniques have been developed over the years to aid 
physicians and scientists in understanding tissue structure and function in health and 
disease. One MRI technique that has been of increasing interest in recent years relies 
on phase images obtained by GE (gradient echo) MRI. It was demonstrated that phase 
images provide image contrast distinct from T1 weighted (T1W) and T2 weighted (T2W) 
images (e.g.(3,42-45,144)). However the sources of phase contrast have not been 
completely understood and are a subject of intense debate. Myelin was proposed as one 
of the main contributors to MR signal phase in white matter (145) and it was 
demonstrated that demyelination leads to a loss of phase contrast between white matter 
(WM) and gray matter (46) (54,146). This could have been explained by the difference in 
tissue cellular/molecular content (iron, lipids and proteins) between GM and WM. Yet it 
was also reported that phase contrast is practically absent between WM and CSF 
(3,144) despite substantial differences in their molecular content. Iron was shown to play 
an important role in formation of phase contrast in iron-rich areas such as caudate, 
                                               
 
7 All contents in this chapter have been accepted for publication in Yablonskiy DA, Luo J, Sukstanskii AL, Iyer A, Cross 
AH. Mapping MRI signal frequency to reveal central nervous system damage: biophysical mechanisms and application to 
multiple sclerosis. submitted to Proc. Natl. Acad. Sci. USA.  
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putamen, and globus pallidus (69,147-149). However, experimental data on the role of 
iron in WM is controversial – while a decrease of the phase contrast after iron extraction 
from the fixed brain tissue was reported in (145), this effect was not seen in (54). It was 
also concluded in (60) that the MR phase contrast between cortical gray and white 
matter can be mainly attributed to variations in myelin content, but not to iron 
concentration. Similar uncertainty exists in the study of multiple sclerosis (MS) using 
phase imaging, one of its emerging applications. In initial publications (148,150,151), a 
variety of manifestations of MS lesions in phase images were reported. It was noted that 
some lesions seen on phase images were also seen on T1W and T2W images, but 
some alterations were unique to phase images. Also some lesions detected on T1W and 
T2W images were not seen on phase images. One hypothesis proposed to explain 
phase contrast is based on an assumed mechanism that relates MR signal 
phase/frequency shift to iron content in the tissue. (148,150,151) However this 
mechanism does not take into account the hallmarks of MS lesions - the loss of axons 
and myelin (10).  
 
Bridging the gap between these controversial findings is one of the main goals of this 
Chapter. To this end we provide theoretical background to the hypothesis that the local 
contribution to the MRI signal phase depends not on bulk tissue content but on tissue 
“magnetic architecture” - distribution of magnetic susceptibility inclusions (lipids, 
proteins, iron, etc) at the cellular and sub cellular levels (144). This allowed us not only 
to shed new light on the above-mentioned controversies but also to propose a theory of 
MRI phase contrast in MS. We demonstrate herein that according to this mechanism, 
phase contrast in MS lesions could appear simply because of injury to the myelin 
sheath, even without its removal from the affected area, thus preserving bulk tissue 
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magnetic susceptibility. Our theoretical concept indicates that phase contrast is sensitive 
to mild lesions, and thus may appear abruptly at lesion onset when damage is still 
minimal. Our preliminary data in several human subjects show abnormalities seen only 
on phase and not magnitude images, within the areas with borderline abnormal tissue 
damage, which can be explained by our theoretical prediction that the phase contrast in 
MS lesions could be altered with mild injury to the myelin sheath or axonal 
neurofilaments. Hence these phase abnormalities may represent mild or early MS 
lesions. Contrary to a common-sense expectation that the phase contrast in MS lesions 
should always increase in degree along with worsening of lesion severity (as happens 
for all known MR magnitude-based contrast mechanisms), we demonstrate that phase 
contrast can actually disappear in situations of medium to severe tissue destruction. 
Moreover, we predict that the sign of phase contrast in MS lesions indicates the 
predominant type of tissue injury – myelin damage (positive sign) vs. axonal 
neurofilament damage (negative sign). In the current paper, we provide theoretical and 
experimental evidence supporting these mechanisms of phase contrast in MS lesions. 
Our findings have potential to expand the information provided by CNS imaging both for 
understanding MS pathophysiology, and as an endpoint in clinical trials (152).  
 
 
6.2 Phase Contrast in MS brain – Theoretical predictions 
6.2.1 Phase Contrast in White Matter - Theory  
Tissue magnetic architecture at the global (organ or body part) and at the cellular/sub-
cellular levels depends on the structural (geometric) arrangement of the main tissue 
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components (proteins, lipids, iron, etc) that, as far as MRI is concerned, act as magnetic 
susceptibility inclusions. In an external magnetic field B0 magnetic susceptibility 
inclusions become magnetized and induce their own magnetic fields that affect (shift) 
Larmor resonance frequencies of water molecules. White matter structure can be 
described as mainly comprised of quasi-cylindrical myelinated axons. The induced 
magnetic field in these axonal bundles (tracts) is generated by several sources: (a) 
longitudinally arranged myelin sheaths and intra-axonal neurofilaments that run mostly 
parallel to the axonal tract axis, (b) isotropically distributed free floating organelles, 
proteins, lipids, etc., and (c) the interface between the white matter tract and the 
surrounding tissue. 
 
In a GE experiment, the contribution of each water molecule, diffusing in the 
inhomogeneous magnetic field, to the MR signal at GE time TE can be represented as 
exp( ( ))i TEϕ  where 
0
( ) ( ( ))
TE
TE b r t dtϕ γ= ∫  is the phase accumulated by the diffusing 
molecule along its trajectory ( )r t ; ( ( ))b r t  is a projection of the local magnetic field, 
created by all the sources of magnetic field inhomogeneities at point ( )r t , on the 
external magnetic field B0. According to well known results followed from Maxwell 
equations, the distribution of magnetic fields in the cylinder-like structures depends 
mostly on the position in the transverse plane. Since in white matter water molecules are 
confined either to intracellular or extracellular spaces with the transverse sizes about or 
less than 1 µm, it requires less than 1 ms to sample the whole distribution of magnetic 
field within a given compartment (water diffusion coefficient is about 1 µm2/ms). Hence 
for gradient echo time TE greater than 1 ms used in experiments, all diffusing nuclei in 
the same compartment sample the whole distribution of magnetic fields within a given 
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compartment and, therefore, accumulate similar phases (motional averaging regime). 
Effectively, a diffusing water molecule “feels” an average magnetic field mb  in the 
compartment where it resides, hence 
 ( ) 2 ; 2m m m mTE f TE f bϕ π π γ= ∆ ∆ =  [6.1] 
where mf∆  is an average frequency shift in m-th compartment. Based on this 
consideration, only an average magnetic field in each compartment should be 
calculated. In what follows, we will use Eq. [6.1] and computer Monte-Carlo simulations 
to quantify influence of WM microstructure on MR signal phase. For this purpose we will 
initially use a simple model of axonal structure presented in Fig. 1.  
 
6.2.2 Monte-Carlo Simulations of Phase Contrast in Intact and Destructed 
Tissue 
 
Figure 6.1A represents a schematic structure of an intact myelinated axon (intracellular 
water, myelin sheath and extracellular water). Computer Monte-Carlo simulations of the 
MR signal frequency shift were performed in the intact myelinated axon and in an axon 
undergoing demyelination typical of MS (Figure 6.1B and C). The latter was modeled by 
fragmenting the cylindrical structure of the myelin sheath to different degrees. The 
fragments were modeled as spheres with positive magnetic susceptibility with respect to 
water (because lipids and iron each provide a positive magnetic susceptibility, whereas 
proteins have a primarily negative contribution (144)). The phase accumulated by 
diffusing water molecules was calculated based on the well known expressions following 
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from Maxwell equations for magnetic field created by cylinders and spheres (see for 
example (72)). 
 
Figure 6.1 Effect of increasing myelin sheath damage on phase/frequency of MR signal 
derived from computer Monte-Carlo simulations. A) schematic of an intact axon (internal 
cylinder) covered by a myelin sheath (bold outline of cylinder) in an extra-cellular space 
(between bold and outer cylinder) with radius R0. B) “Mildly” damaged myelin sheath – 
fragments of original structure are slightly scattered. C) “Severely” damaged myelin 
sheath - fragments of initial structure are scattered randomly. Lower panel -- 
dependence of the Lorentzian Factor (LF) in the MR signal frequency shift on the “level 
of distraction” (δR – average fragments’ displacement). Shaded zone (0-0.2) indicates 
minor injury to tissue, wherein even a small increase in the “disorder” parameter δR 
(horizontal axis) will rapidly and dramatically change the Lorentzian Factor, and hence 
will also change signal phase/frequency.  
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The calculations revealed that for all the structures in Fig. 1, the water MR frequency 
shift could be described by the following equation: 
 0f f LF χ∆ = ⋅  [6.2] 
where χ is a total (bulk) volume magnetic susceptibility of inclusions (myelin sheath 
and/or its fragments). The proportionality coefficient LF (referred hereafter as “Lorenzian 
Factor”) varies with different levels of damage to the myelin sheath. Note that the 
Lorentzian Factor is equal to 4 / 3π  only for randomly scattered fragments; this case is 
usually referred to as a Lorentzian Sphere approach (e.g., (62)). For all other cases, LF 
is less than 4 / 3π , approaching zero for the intact axon. Therefore, as previously 
suggested (144), the Lorentzian sphere approach is not valid for describing the magnetic 
susceptibility frequency shift in normal WM which is highly directional.  
An additional factor that contributes to the frequency shift is the object’s (axonal) general 
external shape: 
 0 shapef f SF χ∆ = ⋅  [6.3] 
For the structure in Fig. 1, where B0 is parallel to the axonal axis, the shape factor SF, 
Eq. [6.3], is zero and the frequency shift is completely determined by the Lorenzian 
Factor LF, Eq.[6.2].  
 
The results of Monte-Carlo simulations for an oblique direction of an axon with respect to 
magnetic field B0 are shown in Fig. 2. An important conclusion from this figure is a 
prediction of zero frequency shift for the intact axon, regardless of axonal orientation. 
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This important result is due to cancellation of contributions from Lorentzian Factor 
characteristic for longitudinal structures, 22 sin
longitudinal
LF π α= ⋅  (144), and the shape 
factor for circular cylinder, 22 sin
cylinder
SF π α= − ⋅ . At the same time, for a scattered case 
(C), the Lorentzian factor is equal to 4 / 3π  and does not depend on axonal orientation, 
whereas the shape factor does.  
 
 
Figure 6.2 Dependence of MR resonance frequency shift, derived from computer Monte-
Carlo simulations, on the angle α (in degrees) between axonal direction and the external 
magnetic field B0 for an intact axon (A) and randomly-scattered myelin fragments (C).  
 
Figure 6.1 and Figure 6.2 present results for a simplified case when only intact or 
damaged myelin sheath contributes to a susceptibility-induced MR signal phase shift. 
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The true situation is more complicated due to the presence of components in addition to 
myelin and will be discussed below. However, the contribution from proteinaceous 
neurofilaments is qualitatively similar (though with the opposite sign) because they are 
also organized in longitudinal structures. 
 
6.2.3 Theoretical Predictions of Frequency Shift between Intact Axon and 
Surrounding Tissue – Effect of WM “Darkness”  
To understand phase contrast in injured MS tissue, we first need to understand phase 
contrast in a normal brain. In general, the intact myelinated axon can be described as 
comprised of longitudinal structures with magnetic susceptibility Lχ  (myelin and 
neurofilaments) aligned along the axonal axis, and isotropic components (free floating 
organelles, proteins, lipids, etc) with magnetic susceptibility iχ . Hence, the total 
“Lorentzian contribution” to the MR signal frequency shift is a combination of the two: 
2
0
42 sin
3L iLorentzian
f f π χ α π χ∆ = ⋅ ⋅ + ⋅ . For a circular cylindrical myelinated axonal 
bundle (tract) surrounded by an isotropic media (like CSF or gray matter) with magnetic 
susceptibility eχ , the contribution from the interface (tract shape factor SF) between the 
tract and the media is equal to 22 sin ( )WM eπ α χ χ− ⋅ ⋅ − , where ( )WM L iχ χ χ= +  is the 
total susceptibility of WM. Thus, the total frequency difference between a circular 
cylindrical axonal tract and the external media can be written as 
 ( )20
42 sin
3 i eaxon
f f π α π χ χ ∆ = − ⋅ + ⋅ − 
 
 [6.4] 
Note that for non-circular cylindrical tracts this dependence is more complicated (144).  
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The fact that the longitudinal structures (myelin sheaths, neurofilaments, etc.) do not 
contribute to the total frequency shift of the cylindrical axon when magnetic field B0 is 
parallel to the axonal axis is a direct consequence of Maxwell equations: the induced 
magnetization of long cylindrical structures parallel to B0 does not create any magnetic 
field outside the structures themselves. This is not true when B0 forms an angle with the 
axonal axis. However, the average magnetic field contributing to the frequency shift 
around intact myelin sheath (or neurofilament) is zero for an arbitrary orientation of B0 
with respect to the axonal axis. Monte-Carlo simulations (see Figure 6.2) confirm this 
result, which is also in agreement with published predictions (144). 
 
One of the important consequences of Eq.[6.4] is that the terms proportional to Lχ  
cancel each other for circular cylindrical axonal bundles, i.e. the longitudinal structures 
do not contribute to frequency contrast between such a bundle and any adjacent 
isotropic media. Therefore, in the regions of the brain, such as the cortex, where gyri and 
sulci abut one another, the intact cylindrical axons in gyri should have very small 
frequency shifts relative to CSF in the sulci. This effect, first predicted by He and 
Yablonskiy (144), is counter-intuitive because there is a substantial difference between 
the total magnetic susceptibility of WM ( WM L iχ χ χ= + ) and that of CSF ( eχ ). One 
could, therefore, expect a substantial phase contrast between WM and CSF. However, 
according to Eq. [6.4], the frequency shift is determined not by the difference ( )WM eχ χ−  
but the difference i eχ χ− , where iχ  comprises a small fraction of the total magnetic 
susceptibility of WM WMχ , leading to very little contrast between WM and CSF (144).  
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In the same manner, Eq. [6.4] also explains negative WM/GM contrast which is also 
counterintuitive because WM has higher magnetic susceptibility than GM (144). 
However, according to Eq. [6.4] the phase/frequency contrast between WM and GM is 
proportional to i GMχ χ− , which is essentially magnetic susceptibility of GM (with the 
negative sign) since iχ  comprises only a small fraction of the total magnetic 
susceptibility of WM. These results are in agreement with previous observations (3,144) 
where the dominant “bright” regions in phase images belong to GM, while WM and CSF 
are usually dark. Exceptions are areas of high concentrations of iron, e.g. caudate nuclei 
(148). Such a dark background provides a convenient display for MS lesions that have 
mostly (but not always) positive phase (see examples in Figure 6.3) due to the effect of 
myelin “disordering” in MS.  
 
6.2.4 Theoretical Predictions – Frequency Shifts in MS Tissue 
An essential feature of the plot in Figure 6.1 generated by computer simulations is the 
steep growth of the LF predicted to occur with only minor damage to the myelin sheath 
(shaded zone). Thus, even small abnormalities in MS-affected CNS may cause 
substantial (positive in sign) changes in MR signal phase. A theoretical consideration for 
axonal damage (destruction of neurofilaments) leads to a similar scenario with one 
important difference – phase/frequency as a function of neurofilament destruction 
experiences negative changes. This is because neurofilaments are formed from proteins 
that have a negative magnetic susceptibility with respect to water, whereas myelin is 
>70% lipid and also contains relatively more iron, each having positive susceptibility with 
respect to water (144). Since frequency shift in Eq. [6.2] is a product of two factors – LF 
and tissue magnetic susceptibility ( Lχ  in this case), one can expect that with tissue 
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destruction, phase will experience major changes for mildly damaged longitudinal 
structures due to the steep increase in LF. On the other hand, decrease in tissue 
magnetic susceptibility due to tissue removal from the damaged area may lead to 
reduction of phase/frequency changes for severely damaged tissue. To characterize 
tissue damage in MS we use a previously introduced (40) quantitative parameter – 
tissue damage score (TDS). TDS around zero corresponds to normal tissue and TDS =1 
corresponds to severely injured tissue (‘black holes”). Both TDS and MRI signal 
frequency/phase are obtained herein using gradient echo plural contrast imaging 
(GEPCI) technique (39) which is described in the ‘experimental results’ section in 6.3. 
 
Importantly, the sign of phase/frequency changes depends on the type of injured tissue 
(axonal filaments vs. myelin). With myelin damage and intact neurofilaments, the change 
is positive, whereas in the case of damage to proteinaceous neurofilaments within intact 
myelin the change is negative. This scenario is depicted in Figure 6.3. However, the 
latter case would typically occur in the setting of myelin destruction with a possible 
additional components of lipids and iron which would offset the negative phase change. 
This is consistent with our and others (151) observation of negative phase changes in 
MS lesions being very rare.  
 
Figure 6.3 Schematic structure of the MR signal phase/frequency change with MS lesion 
severity for two types of tissue destruction: left panel – pure myelin injury, right panel – 
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pure injury to neurofilaments. Minimal myelin injury which may not be apparent on 
standard T2W and T1W images will appear positive by phase, corresponding to the 
initial ascending portion of the left figure (and also lower panel Figure 6.1). For 
moderately severe lesions with predominant myelin injury (center of the left figure, 
medium TDS score), phase will also be positive. However, axon destruction is often also 
present, and the relative degree of myelin and neurofilament destruction will affect the 
sign of the phase change. Severe lesions such as persistent black holes, with a high 
TDS score and significant destruction of both myelin and axons might disappear on 
phase images. 
 
Based on the above consideration, the following scenario describes MRI 
phase/frequency behavior according to the type and severity of MS tissue damage.  
(i) Normal WM, having mostly longitudinal structure, has little local effect on MR signal 
phase.  
 
(82) At the initial stages of MS lesion development with demyelination, small alterations 
in this longitudinal structure would become visible on phase images. This might happen 
even before detection using other techniques. Hence, MR signal phase might serve as a 
very sensitive biomarker for minimal abnormalities or early MS lesion development. 
Importantly, damage to myelin would cause an increase in signal phase (positive 
contrast), while damage to axons would cause a decrease of signal phase (negative 
contrast). When axons degenerate, the surrounding myelin is also subsequently lost due 
to Wallerian degeneration. Thus, one would expect negative phase contrast to be 
relatively uncommon. If both myelin and axons are damaged, the phase contrast could 
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disappearbecause myelin and protein-based neurofilaments have opposite magnetic 
susceptibilities resulting in opposing frequency shifts.  
 
(iii) For severely injured tissue, when cellular components (macromolecules) are 
removed from the site, magnetic susceptibility becomes small leading to decreased 
phase contrast. Hence for many cases with medium and severe damage, one can 
expect very small phase contrast. This can explain previous reports of phase changes 
being detected only for a subset of MS lesions (see for example (148,150)).  
 
6.3 Phase Mapping in MS - Experimental Results 
6.3.1 Materials and Methods 
Image Acquisition: Brain images were collected using a Siemens 3T Trio MRI scanner 
(Erlangen, Germany) and a 12-Channel phased-array head coil. 
GEPCI data were obtained using a 3D version of the multi gradient echo sequence with 
a resolution of 1x1x3 mm3, FOV of 256 mm x 192 mm and 11 gradient echoes (TR=50 
ms; First TE=4ms, δTE=4 ms; FA=30°). To generate GEPCI images raw data were 
reconstructed using Eq.[4.5]. The frequency maps were high-pass filtered to remove 
effects of macroscopic field inhomogeneities using a 7x7 (out of 256x256) in-plane 
averaging matrix. Image reconstruction and post-processing were performed using a 
standard PC computer and Matlab software (MathWorks Inc.). The automatic shimming 
procedure available on the Siemens scanner allowed substantial minimization of 
macroscopic field inhomogeneity effects in most parts of the brain. Hence, a simple 
fitting of the mono-exponential to the GEPCI signal was sufficient to generate GEPCI 
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T2* and T1W images. GEPCI-FST2Star images that are R2* maps with suppressed 
signal from CSF and GEPCI T1f images (a combination of GEPCI T1W and frequency 
maps) with enhanced GM/WM contrast (39) were also created. 
Standard clinical images were also obtained: Forty-four contiguous 3-mm axial imaging 
sections were obtained with a 24-cm field-of-view (FOV), a matrix size of 256 x 192, and 
using two types of Turbo SE (TSE) sequences: 1) T2-weighted images with TR = 6800 
ms and TE = 95 ms, Bandwidth=151 Hz/Px, Turbo factor=7; 2) FLAIR images with TI = 
2310 ms, TR = 10000 ms and TE = 83 ms, Bandwidth=219 Hz/Pixel, Turbo factor=13; 3) 
T1-weighted images using a standard SE sequence with TR = 600 ms and TE = 12 ms, 
Bandwidth=130 Hz/Pixel; Total time for these three standard sequences was 16 
minutes. 
 
Human Subjects: The human studies were approved by the Washington University IRB. 
One normal healthy subject, four subjects with relapsing remitting MS (RRMS) disease 
(gender/age/EDSS = M/42/1.5, M/52/3.5, M/39/2.5, F/42/2.0) and one with secondary 
progressive (SPMS) disease (gender/age/EDSS = F/49/6.5) (5,153) entered the study. 
Sixty lesions were studied by GEPCI magnitude and phase, and standard imaging. 
 
6.3.2 Experimental Results 
Example in Figure 6.4 shows one MS lesion that has a range of tissue damage scores 
(TDS) from normal on periphery to severe damage at the lesion center. On FLAIR image 
it manifests itself as a bright ring with a dark core. The appearance on GEPCI frequency 
map is similar to the appearance on FLAIR though the abnormality is bigger in size and 
is surrounded by two dark strips. The sign (positive frequency – myelin damage) and 
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pattern of phase changes as compared to GEPCI TDS score are in agreement with our 
prediction that phase/frequency becomes abnormal for mildly damaged tissue (blue 
TDS), grows with the level of tissue injury and disappears for highly destroyed tissue 
(lesion core – red TDS). Dark areas on the GEPCI frequency map might correspond to 
predominantly axonal damage while bright areas – to predominantly myelin damage. 
  
Figure 6.4 Example of a MS lesion (marked by a red rectangle) that has a range of TDS 
represented by colors on vertical bar. TDS is overlaid on T1f image. Data obtained from 
a subject with RRMS (female, age 42, EDSS 2.0). 
 
Examples of changes in phase image in MS lesions with no or very small TDS scores 
are shown in Figure 6.5, orange and blue rectangles. These might represent changes in 
tissue microstructure that are not observed with conventional imaging techniques. The 
positive phase contrast indicates myelin damage.  
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Figure 6.5 Example of data obtained from a subject with SPMS (female, age 49, EDSS 
6.5). Note the prominent contrast between GM and WM on GEPCI T1f image as 
compared to other images. Rectangles outline abnormalities observed on FLAIR or 
Frequency (phase) maps. Orange rectangles denote an alteration seen in phase images 
(bright contrast) but not on T1W, FLAIR or GEPCI FST2*. This may represent a very 
mild lesion with damaged myelin, and is also seen on GEPCI T1f image as negative 
dark contrast. Blue rectangle outlines a small MS lesion that is barely seen on FLAIR 
and GEPCI FST2*, and is also visible on the phase image. Red rectangle outlines a 
severe MS lesion (very high TDS score) that is seen on T1W, FLAIR and GEPCI FST2* 
but does not have a footprint on the phase image. A magnified view of this lesion is 
shown in the inset (upper right of GEPCI T1f image) with overlaid GEPCI TDS score in 
color according to the color bar. 
 
According to Figure 6.1 and Figure 6.3, the phase contrast in severe lesions (black 
holes, high TDS score) can disappear even though these lesions would have 
substantially different magnetic susceptibility from the surrounding normal WM. Example 
of such a lesion is shown in Figure 6.5, red rectangle. The absence of phase contrast 
together with high TDS in this case suggests that myelin and axonal debris are mostly 
removed from the lesion area. 
Lesions of intermediate severity (intermediate GEPCI TDS score) appear on – GEPCI 
T1W (hypointense), FLAIR and GEPCI FST2* (hyperintense) and Phase/frequency 
maps. Several examples are shown in Figure 6.6, red rectangles. The combination of 
TDS and phase appearance suggests that myelin is damaged but with myelin debris still 
present in the lesion area. At the same time the lesion denoted by an orange oval has 
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similar TDS but very little phase contrast, suggesting damage to both myelin and axon 
that offset one another.  
 
Figure 6.6 Example of data obtained from a subject with RRMS (male, age 52, EDSS 
3.5) showing multiple lesions (red rectangles) with intermediate TDS scores (overlaid on 
GEPCI T1f image). Here, lesions seen on FLAIR are also seen on GEPCI T1W, GEPCI 
FST2* (GEPCI analog of FLAIR) and GEPCI Frequency map. Area within orange oval 
also corresponds to intermediate TDS with low phase contrast.  
 
The theory of MS lesion manifestations on phase/frequency images proposed herein 
should be complemented by considerations of lesion shape, not only the internal lesion 
structure. Development of lesions of varying severity might lead to multiple appearances 
on phase images, because phase is a combination of multiple factors that include not 
only the change in tissue content and structure but also the shape and the structure of 
the surrounding tissue. One potential approach to overcoming this problem is 
Quantitative Susceptibility Mapping (QSM) (123,125-127,146), where non-local effects of 
magnetic fields on phase image are removed by solving Maxwell equations for field 
distribution on a global level. The current state of this approach however assumes that 
MR signal phase relates to tissue magnetic susceptibility by means of a Lorentzian 
sphere approximation which is not the case for WM in general, and MS lesions in 
particular, as shown in the present study. Thus, QSM technique, as a tool for analyzing 
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WM structure and MS lesions, awaits incorporation of a non-spherical Lorentzian 
relationship between MR signal phase and local magnetic field.  
 
In this chapter we focus our attention on the most pronounced injuries to tissue in MS - 
myelin and axonal damage. Other components of the MS lesion, e.g. inflammatory cell 
infiltration, gliosis, and edema/increased extracellular space can also be incorporated in 
our model. These will be a subject of our future research. Other hypotheses of phase 
contrast that were also discussed previously include frequency shifts induced by water-
macromolecule exchange in the tissue (42,55,56) and possible tissue magnetic 
susceptibility dependence upon orientation with respect to the magnetic field B0 
(58,154), though their roles are not yet clear. 
 
6.4 Summary 
In this study we propose a theory of phase contrast in MS and provide experimental and 
Monte-Carlo simulated results supporting our theoretical predictions. Our theory is based 
on the newly introduced concept - Generalized Lorentzian Approach – that allows 
relating MRI signal phase not to tissue bulk magnetic susceptibility but to tissue 
“magnetic architecture,” the distribution of magnetic susceptibility inclusions (lipids, 
proteins, iron, etc) at the cellular and sub cellular levels (144). Our theory predicts that 
the phase contrast in MS lesions could appear due to MS pathology affecting white 
matter integrity, such as mild injury to the myelin sheath or neurofilaments, even with 
preserved tissue magnetic susceptibility. Also, contrary to an expectation that the phase 
contrast in MS lesions should always increase in magnitude with lesion worsening (as 
159 
 
happens for all known MR magnitude imaging contrast mechanisms), our theory and 
experimental results indicate that phase contrast can actually disappear with extreme 
tissue destruction. We also demonstrate that the change in the phase contrast might be 
specific to a type of tissue injury – myelin (positive change) vs. neurofilaments (negative 
change). The GEPCI approach, providing simultaneous information on tissue signal 
phase, T2* and T1, shows unique potential to decipher the mechanisms underlying 
phase contrast. Our approach not only aids in understanding changes seen by phase 
imaging, but opens a door to better understanding biological underpinnings of MS brain 
pathology and has a potential to assist in optimizing design of clinical trials.  
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Chapter 7 Conclusions and Future Directions 
In this study, we extensively investigated the mechanisms behind gradient echo MRI 
signal formation, and explored the use of gradient echo MRI in Multiple Sclerosis. The 
origin and use of phase contrast have become hot topics of investigation in the field of 
MRI in recent years since it manifests superior gray matter/ white matter contrast and 
sub-cortical contrast. By measurement of phase contrast in isolated optic nerve, we have 
provided the first direct prove of the theoretical framework – Generalized Lorentzian 
Approach – developed in our group. The experiment shows that phase contrast in brain 
white matter (optic nerve) is not directly proportional to the tissue bulk magnetic 
susceptibility but is rather determined by the geometrical arrangement of brain tissue 
components (lipids, proteins, iron, etc.) at the cellular and sub-cellular levels. We have 
also provided first quantitative measurements of the contribution to phase contrast from 
the water-macromolecule exchange effect. Based on our measurement in protein 
solutions, we demonstrated that the magnitude of the exchange effect is 1/2 of 
susceptibility effect and to the opposite sign. Further we apply the Generalized 
Lorentzian Approach to better understand phase contrasts in MS lesions. 
 
In most of our studies we used Gradient Echo Plural Contrast Imaging (GEPCI) 
technique developed in our laboratory. It is based on multi-gradient-echo sequence, and 
allows generating of several base and secondary contrasts. Basic contrasts include T2* 
relaxation time constant maps, T1-weighted signal intensity images and signal 
phase/frequency maps. Secondary contrast images include SWI, T1f, FST2* and T2*-
SWI. All these base and secondary GEPCI images with multiple novel contrasts provide 
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additional information that helps with visualization and identification of brain 
abnormalities including MS.  
 
By using GEPCI quantitative T2* maps we have developed a scoring method for 
monitoring Multiple Sclerosis. With a cohort of 30 MS subjects (10 in each MS 
subtypes), we demonstrated a strong agreement between GEPCI quantitative scores 
and traditional lesion load assessment. We also established a correlation between 
GEPCI scores and clinical tests for MS patients. We found that this correlation is 
stronger than that found between traditional lesion load and clinical tests. We have also 
demonstrated the ability of GEPCI scores to distinguish between MS subtypes. 
 
Of course, there are much more in these topics that one can carry on investigating.  
1) MS disease. As a CNS disease, the pathology of MS is not restricted in the brain, but 
also cerebellum, brain stem, and spinal cord; GEPCI measurement should be 
performed on more parts of the CNS in order to reflect more closely to the patients’ 
clinical status. As demonstrated in our preliminary results (Chapter 5), we have 
already started in the direction of spinal cord imaging using GEPCI. Moreover, the 
cortical damage is also a very important aspect in evaluating CNS damage, and 
remains to be investigated. 
2) The GEPCI study needs to be taken to a bigger population in order to allow stronger 
statistical power to confirm our preliminary results. Age matched control subjects are 
also needed so that we could rule out variations in T2* due to age.  
3) Brain atrophy can be added in GEPCI scores as another dimension of abnormality 
measurement. It is especially suitable for monitoring longitudinal changes of MS 
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subjects under treatment (useful in evaluation of clinical trials).  
4) Along the road of using phase contrast in explaining MS lesions in brain white matter 
(Chapter 6), it will be important to have histological validation of our theory. 
Correlations between pathological hallmarks and MR signal from ex vivo tissue have 
been found on T1 and T2 before, and a similar experiment should offer a fairly direct 
experimental evidence for origin of phase contrast. However, our data (Chapter 2, 
and abstract) show that both magnitude and phase contrast could be very different 
from in vivo to formalin fixed tissue – which limits the adequacy of histological 
validation. Using animal model in vivo could be a promising solution to this problem. 
Marmoset is a good candidate; given it has big WM volume. 
5) From technical aspects: to improve GEPCI, one ongoing effort in our group is the 
field inhomogeneity correction. Since the quantitative measurement of T2* is actually 
susceptible to macroscopic magnetic field inhomogeneity, we always perform careful 
shimming on the field before experiments. However, there are some intrinsic sources 
of field distortion associated with the brain geometry such as sinuses and ear canals. 
A theoretical way to remove field inhomogeneity is under development in our group.  
Finally, we treated the gradient echo signal as single compartment throughout the 
study, that is we assume the tissue water is uniform in each voxel. In fact, the tissue 
water distribution is usually more complicated, and has multiple slow exchanging or 
non-exchanging components. Each of them has their own relaxation characteristics, 
and their own frequency. The role of multi-compartment model in phase contrast 
between gray and white matter; and new insights on relationship between MRI signal 
and specific disease pathologies of MS remain to be future directions of our study. 
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